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Abstract
The coenzyme B12- dependent enzyme, glutamate mutase (E. C. 5.4.99.1), 
catalyses the reversible carbon-skeleton rearrangement of (2 S)-glutamic acid to
(25.35)-3-methylaspartic acid. Glutamate mutase is the first enzyme on the 
mesaconate pathway. A variety of glutamate and 3-methylaspartate analogues 
(which also include isotopically labelled molecules), were synthesised as 
molecular probes of the enzyme.
Synthesis of stereospecifically labelled 3-ethylaspartic acid: (2 S,3 S)-[3 '-C2H3 ], 
and (2 S,3 S)-[C%2C^H3]-ethylaspartic acids were constructed using appropriately 
labelled iodoethane. (2S,3S)-2-Bromo-3-methylsuccinic acid was synthesised via 
the diazotization of (2S,3S )-3-methylaspartic acid, in the presence of bromide ion. 
(2S)-Methylsuccinic acid was synthesised by the catalytic hydrogenation of
(25.35)-2-bromo-3-methylsuccinic acid. Biological studies of the synthesised 
compounds (including the labelled isotopomers) displayed no activity against 
glutamate mutase.
3-Methylaspartate ammonia-lyase, the second enzyme in the mesaconate 
pathway, catalyses the deamination of (2S,3S)-3-methylaspartic acid to mesaconic 
acid. A range of 1-substituted cyclopropane 1,2-dicarboxylic acids were 
synthesised using short efficient routes and were found to be good to potent 
inhibitors of 3-methylaspartase. X-ray crystallographic studies have determined 
the absolute stereochemistry. The mode of action of the most potent inhibitor, 
(lS ,2 S)-l-methylcyclopropane 1 ,2 -dicarboxylic acid (2 0  pmol dm'3), is consistent 
with it acting as a transition state analogue for the central substrate deamination 
reaction catalysed by the enzyme.
p-Amino acids are constituents of many biologically active peptides. A 
general procedure for the synthesis of a-substituted-p-amino acids has been 
developed. The synthesis involves a Baylis-Hillman amine catalysed conversion 
of methyl acrylate, with an appropriate aldehyde, to give the a-(hydroxyalkyl) 
acrylate. Bromination and subsequent azide displacement furnishes the azido 
alkene, which is catalytically hydrogenated, to furnish the p-amino ester.
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Abbreviations
PAL - phenylalanine ammonia-lyase
MAL - 3-methylaspartate ammonia-lyase
CBZ - carbobenzyloxy
BOC - ^butoxycarbonyl
DMF - N,N-dimethylformamide
THF - tetrahydrofuran
DCM - dichloromethane
TFA - trifluoracetic acid
m-CPBA - meffl-chloroperbenzoic acid
KHMDS - potassium 6 is(trimethylsilyl)amide
D - deuterium
NAD - nicotinamide adenine dinucleotide
NADH - nicotinamide adenine dinucleotide (reduced form)
ATP - adenosine tri-phosphate
t.Lc. - thin layer chromatography
h - hour
IR - infra-red spectroscopy
EPR - electron paramagnetic resonance
min - minutes
rt. - room temperature
Vmax ■ maximum rate
Kjn - michaelis constant, u =
Kj - dissociation constant of inhibitor
IC50 - inhibitor concentration which reduces the rate by 50%.
Amino acid Three letter code One letter code
Glycine Gly G
Alanine Ala A
Valine Val V
Leucine Leu L
Isoleucine lie I
Phenylalanine Phe F
Tyrosine Tyr Y
Tryptophan Trp W
Serine Ser S
Threonine Thr T
Cysteine Cys C
Methionine Met M
Asparagine Asn N
Glutamine Gin Q
Aspartic acid Asp D
Glutamic acid Glu E
Lysine Lys K
Arginine Arg R
Histidine His H
Proline Pro P
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INTRODUCTION
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1 .1  Glutamic Acid Degradation By Anaerobic Bacteria
1.1.1 Introduction
The study of amino acid degradation by anaerobic bacteria has in the past been 
complicated by the fact that such organisms require complex media for growth. 
However, developments within this area, have allowed for successful methods 
to be introduced for following the break down of all individual amino acids by 
such organisms. This difficulty was partially overcome by adding a high 
concentration of one amino acid to a medium containing low concentrations of 
other nutrients and determining the predominant products formed from the 
major substrate. In this way several investigators have demonstrated that single 
amino acids, including aspartic, glutamic, histidine, lysine, glycine, alanine, 
serine, amongst many others, can serve as major energy sources for selected 
species of anaerobic bacteria.
Amino acid degradations by anaerobic bacteria always involve oxidation and 
reduction reactions between one or more amino acids or non-nitrogenous 
compounds derived from amino acids.^ The oxidation and reduction reactions 
are usually similar or identical to corresponding reactions catalysed by aerobic 
organisms, except for limitations imposed by the absence of molecular oxygen or 
other high potential oxidants.^ Thus oxidations, deaminations, transaminations, 
and a-keto acid oxidations commonly occur in anaerobic amino acid 
degradation, but oxygenation reactions and fatty acid oxidations are excluded. 
The reduction reactions are more distinctive, since each organism must generate 
one or more electron acceptors of suitable potential from the amino acid(s) that it 
can metabolise.^
One of the major interests in this area of bioorganic chemistry is the 
determination of the metabolic pathways and enzymatic reactions which are 
involved in the degradation of selected amino acids by anaerobic bacteria. One 
such amino acid which has been extensively studied is the anaerobic degradation 
of glutamic acid.^
Chapter 1: Glutamic acid Degradation by Anaerobic Bacteria_______________ 2
1 .1 .2  Anaerobic Pathways for Glutamate Assimilation
There are a variety of pathways which exist for the anaerobic and aerobic 
metabolism of glutamate. Several studies have been carried out to determine 
the possible pathways of glutamate catabolism in anaerobic bacteria.^ Both 
Clostridium tetanomorphum and Peptostreptococcus aerogenes have been 
studied extensively and, although both of these bacteria decarboxylate glutamate 
at position C-5 (see relevant pathways below) and produce acetate and butyrate, 
different metabolic intermediates were r e c o v e r e d .3 -5  c. tetanomorphum utilises 
the methylaspartate pathway (Scheme 1.3, see p.4), and P. aerogenes was later 
shown to utilise the 2-oxoglutarate pathway (Scheme 1.1), in which successive 
intermediates are 2-oxoglutarate (A), 2-hydroxyglutarate (B), vinyl-acetyl-CoA 
(C), crotonyl-CoA (D); the latter is converted to acetate (6 ), butyrate (7) and 
hydrogen.
HOgC^ 3 
(2S)-Glutamic Acid (1)
H%0 + 
NAD+
COgH
NH3 + NADH 
+ H+
Glutamate dehydrogenase
HO2Ç' CH3
H3C
2
Butyrate (7)
O + o
H3 6  3 OH 
Acetate (6 ) + Hg
. s i xCoA
Crotonyl-CoA (D )
O  ^
H02C'^ 2"Y^?02H
2-Oxoglutamic Acid (A)
NADH + H-"
( 2-Oxoglutarate reductase 
NAD+
OH
HC&^COaH
(2/î)-Hydroxyglutamic Acid (B)
ATP
•CoA
Vinylacetyl-CoA isomerase
CoA-S■ s i x 4CHg
Vinylacetyl-CoA (C)
Scheme 1,1: Glutamate Catabolism via the 2-Oxoglutarate Pathway
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A recent study^ carried out on Fusobacterium varium ferments glutamic acid 
by yet another pathway; the 4-aminobutyrate pathway (Scheme 1.2). The 4- 
aminobutyrate pathway is linked with the 2-oxoglutarate pathway. Both 
pathways require glutamate dehydrogenase for the initial reaction and both use 
the same enzymes for the conversion of vinylacetyl-CoA (Scheme 1 .2 ).
NHg
(2S)-Glutamic Acid (1)
CO2
Glutamate decaiboxylase
o u
H3C 1 OH H3 
Acetate (6)
o
oé4 OH
1
Butyrate (7) 
♦
CoA
O
Crotonyl-CoA (D)
Vinylacetyl-CoA
isomerase
S" CoA
Vinylacelyl-CoA (C)
NH2
4-Aminobutyric Acid 
2-Oxoglutarate
Aminotransferase
y  NADH 
Glutamate ^  NAD^
OHCi> ,^
3 p O a H
Succinic semialdehyde
NADH + H'" 
'"NAD"'
hoh^ c^ co h^
4-Hydroxybutyric Acid
CoA-SHF ATP
4-Hydroxybutyrate-CoA
Scheme 1,2: Glutamate Catabolism via the 4-Aminobutyrate Pathway
The 4-aminobutyrate pathway has only been detected in F. varium and F. 
mortiferum, both of which are normally isolated from the gastrointestinal tract.
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1.1.3 The Methylaspartate (Mesaconate) Pathway
A significantly large number of bacteria assimilate the fermentation of (2S)- 
glutamic acid (1 ) via a very distinctive energy yielding pathway (Scheme 1.3). 
The final products from the pathway are acetate, butyrate, carbon dioxide and 
ammonia.
NHg
HOgC * 
(25)-Glutamic acid (1)
Glutamate
Mutase HzN COgH
H-'"
NH3
GOgH Coenzyme HBi2
CH3C02H(6)♦
HsC^ ' SCoA 
Acetyl CoA
CO2 +H+
Butyric acid (7)
CH3
(2S,35)-3-Methylaspartic acid (2)
Methylaspartase HOgC Mg2+,K+ CH3
O
. A CO2H 
Pyruvic acid (5)
CH3CO2H
I
Citramalate
Lyase
Mesaconic acid (3)
Mesaconase
Fe^ + HpO
CO2H
CH3
OH
(25)-Citramalic acid (4)
Scheme 1.3: Glutamate catabolism via the methylaspartase pathway
The methylaspartase pathway was first elucidated in 1958 by Barker and co- 
workers,^ as a result of the fermentation studies carried out on the bacterium 
Clostridium tetanomorphum, strain HI (American Type Culture Collection 
15920). There is some evidence that this type of fermentation pathway also 
operates in the photosynthetic, purple non-sulphur bacteria, Rhodospirillum  
rubrumi and Rhodopseudomanas spheroides.^ However, it is thought not to be 
the major catabolic pathway.^ A similar pathway may also be used in an anabolic
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sense, by the bacterium Acetobacter suboxydans^^At although it is not the 
primary route of glutamic acid assimilation.
The initial step of the pathway involves the enzyme glutamate mutase, 
which is required for the stereospecific, conversion of (2 S)-glutamic acid (1 ) into 
(25, 3S)-3-methylaspartic acid (2). The second step of the pathway, utilises the 
newly formed amino acid (2) for the production of mesaconic acid (3) ((E)-2- 
methylbutenedioic acid), utilising the second enzyme of the pathway, 3- 
methylaspar tase. ^  2
The next stage of the pathway involves the hydration of mesaconic acid, in an 
anti- fashion, via the action of mesaconase,^^ j-q give the tertiary alcohol, (25)- 
citramalic acid (4). The final enzyme in the mesaconate pathway, is citramalate 
lyase 1^ , which catalyses a retro-aldol cleavage of (5)-citramalic acid to give 
pyruvic (5) and acetic acid (6 ).
Pyruvic acid is oxidatively decarboxylated to give acetyl-coenzyme A. Two 
acetyl-coenzyme A molecules form butryl coenzyme A and hence, butyric acid (7) 
is formed. Adenosine triphosphate (ATP) is also generated from the cleavage of 
the thioesters.
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1 ,2  Glutamate Mutase
1 .2 .1  The Biological Role and the Discovery of Glutamate Mutase
The enzyme glutamate mutase (E.C.5.4.99.1) catalyses the reversible carbon- 
skeleton rearrangement of (2 S)-glutamic acid (1 ) to (2S,3S)-3-methylaspartic acid 
(2) (Scheme 1.4) in the presence of coenzyme B12 (AdoCbl) (Fig.1.1).
HO2 C H r '  H s  HO2 C COgH
(25)-Glutamic acid (1) (2S,3S)-3-Methylaspartic acid (2)
Scheme 1.4: Conversion of (2S)-Glutamic acid to (2S,3S)-3-Methylaspartic acid
The enzyme was first discovered in the soil anaerobe C l o s t r i d i u m  
tetanomorphum^^ and is the first enzyme on the mesaconate pathway!^ (Scheme 
1.3).
Coenzyme Bj2 (AdoCbl, Fig. 1.1) is believed to serve as a reversible carrier of 
free radicals. Homolysis of the cobalt-carbon bond, affords cob(II)alamin and a 5'- 
deoxyadenosyl radical, which gives rise to the formation of a new range of 
radicals derived from the appropriate substrate (Scheme 1.5).
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C^ONHg
h^NCXî
C O N H 2
CONH2
CH^ H
© 0^
Me CONHg
5'-Deoxyadenosylcobalamin (AdoCbl,5)
Figure 1,1: Structure of 5'-Deoxyadenosylcobalamine, Coenzyme Biz-
The glutamate mutase reaction is one of ten vicinal interchange reactions 
mediated by AdoCbl in which a functional group, (may vary widely in structure), 
swaps places with a hydrogen atom from an adjacent carbon atom (Table 1.1).
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Enzyme Substrate Product E C. Number
1) (S)-Glutamate Mutase HgN HjN H CH 3 
HOgC COgH
5.4.99.1
2) (R)-Methylmalonyl- 
CoA mutase CoA-S VH3C COgH ?CoA-S CXDgH 5.4.99.2
3) Isobutyryl-CoA mutase
CoA- S ' V CH. CoA-S
O
CH,
CH-
5.4.99.3
4) a-M ethyleneglutarate 
mutase I
HOgC COgH
5.4.99.4
5) (S)-Leucine 2,3-amino- 
mutase
HgN CH3
CH. HOgC
CH3 
CH3
NHg
S.4.3.7
6) (R)-Ornithine 4,5- 
amino-mutase
HgN
H
NHc
HOgC
HgN NHg
CH.
5.4.3.5
7) (R)- a-Lysine 5,6-amino 
-mutase
HpN
((R)- p-Lysine mutase)
HOgC
H NHg
HgN NHg
HOgC-jjl----S x A
H
H NHg NHg
8) Diol dehydrase HO OH 
R
5.3.3.3
4.2.1.28
9) Glycerol dehydrase 
 >*- HO ^  'OH  OH 4.2.1.30
10) Ethanolamine
ammonia lyase 
 ► HgN*
,0H ÎHgC^^H
4.3.1.7
Reaction reversibility under physiological conditions.
Table 1,1 Coenzyme -Biz-dependent enzymes catalysing rearrangements
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atom. In four of these rearrangements (Table 1.1, entries 1-4) the migrating group 
is a substituted carbon atom.
The involvement of competent radical species has been shown for the 
carbon-skeleton rearrangement of methylmalonyl-CoA mutasel^ and glutamate 
m utase.18 The EPR signal recorded for each haloenzyme complex, after the 
addition of the substrate, showed similar characteristics to those obtained for 
other Bi2-dependent enzymes including diol dehydrases^^ and ethanolamine 
ammonia-lyase.20
1 .2 .2  Reaction Catalysed and Assays
The equilibrium for the glutamate mutase interconversion of (2S)-glutamic 
acid (1) to (2S,3S)-3-methylaspartic acid (2 ), favours the conversion of (2S,3S)-3- 
methylaspartic acid (2) to glutamic acid (1). Barker found that the Keq at 30 °C 
and pH 8.2 was 10.78.21 Although the optimum pH for the reaction is 8.5, the 
enzyme was still active between pH 6.0 and 9.88. The enzyme showed maximal 
activity at 38 °C and shows half maximal activity at 27 °C.21 These findings were 
markedly different to those obtained for the activity for methylaspartase, which 
was maximal at 55 °C.12
The only known substrates for glutamate mutase to date, are the physiological 
substrates, (2S)-glutamic acid (1) and (2S, 3S)-3-methylaspartic acid (2).22  The 
for glutamic acid is 1.5 mM and for (25, 35)-3-methylaspartic acid is 0.5 mM.23 
Barker found that (2K)-glutamic acid, 3-ethylaspartic acid, a-,p- and y-methyl- 
(2 5 /jR)-glutamic acid, (25)-glutamine, the y-methyl ester of (25)-glutamic acid and 
(5/R)-a-aminoadipic acid were not substrates for the enzyme.28 However, more 
recently Buckel has shown that (25,45)-4-fluoroglutamic acid, (2R,3K/5)-3- 
fluoroglutamic acid, 2-methyleneglutaric acid, (5)-3-methylitaconic acid and 
itaconic acid are all competitive inhibitors for glutamate mutase^^ (Table 1.2).
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C o m p o u n d s  T e s te d S u b s tra te  (s) I n h ib i to r  (s)
u w HgN
HO4C K '^ h o /  "
(25)-Glut«mic Acid (1) (25,3S)-3-Mctbyl#spaitic Acid (2)
+
" ' j __ CH,CH,
ho/  hop ^  H
(2X)-Gliitamic Acid (25,3S)-3-Ethyl«8partic Acid 01, R=Et)
—
HOP H HOP H
(2iS)-ABpait!c Acid (68) N-Mcthyl (2S,3S)-3-Mcthylaspaitic Acid (67)
-
ch;4 —
HOgC HOgC 
a-Methyl^utamic Acid p-Methylglutamic Acid
-
^2^  C^OgH "2N CONHg
HOgC CH3 HOgC 
‘y-Methylglutamic Acid (2S)-Glutaniine
—
____.COgCHa HgN
K-J'"-'" '^‘--'^COgH 
HOgC HOgC 
(25>-Glutamic acid y-methyl ester a-Aminoadipic Acid
—
HOgC F HOgC 
QiS,4S)-4-FluoiogIutamic Acid (2S,3jf/R)-3-PIuomglulamic Acid
— +
CHg CHg
HOgcAs_.----- - HOgC*"'^ '^*^
2-Melhyieneglutamic Acid Itaconic Acid
_ +
r
H^CH.
(5)-3-Methylitaconic Acid
- +
Table 1,2: Compounds Tested With Glutamate Mutase
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Studies towards substrate and/or inhibitors for glutamate mutase, within our 
laboratories, have shown that (2 S ,3 jR) and (2S,3S)-3-methylglutamic acids were 
competitive inhibitors of glutamate mutase.l^l
Two assay systems have been developed to measure the biological activity of 
the mutase.25 The first assay is based on the conversion of glutamate to 
mesaconate by the coupled action of glutamate mutase and P-methy laspar tase. 
The chromophore of the double bond within the product mesaconic acid (3) 
provides convenient measure of the extent of the reaction. Although the 
method is reliable, some methylaspartate analogues which could give valuable 
information on the glutamate mutase reaction, are also substrates for p- 
methylaspartase and thus this would interfere with the coupled assay system. 
The anaerobic assay relies on the conversion of methyaspartic acid to glutamic 
acid under strictly oxygen-free conditions.
A series of coenzyme analogues have been examined by various g r o u p s , 2 6 , 2 7  
to determine the flexibility of the coenzyme with the enzyme. The following 
changes were made to the heterocyclic base at the sixth ligand position of the 
coenzyme (Fig. 1.1), whilst conferring activity to the enzyme; 5'-hydroxy- 
benzimidazole, 2,6-diaminopurine, adenine, 5(6)-nitrobenzimidazole, 5(6),- 
aminobenzimidazole, 5(6)-trifluromethylbenzimidazole, benzimidazole, purine, 
2-chloropurine, 2-thiopurine, 6 -methylmercaptopurine and 5,6-dimethyl- 
benzimidazole. Those analogues found to be inactive included; corrinoid 
vitamins, methyl, carboxymethyl and 5-deoxyuridyl cobalamins and cobinamide 
coenzyme. The corrinoid vitamins have no deoxyadenosyl group and 
cobinamide coenzyme has no nucleotide. Thus, it can be inferred that a 
deoxyadenosyl moiety and a heterocyclic base are required for enzyme catalysis, 
but that fairly major alterations to the coenzyme can be made successfully.
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1.2.3 Structure of the Holoenzyme
In 1966 Barker showed that the active form of glutamate mutase consisted of 
two polypeptide components. One, a large air-stable thiol containing subunit 
designated as component S (a calcium phosphate supernatant fraction) and a 
component E (a gel eluate f r a c t i o n ) . 2 8 / 2 l  Barker purified each component and 
achieved a 20-25% yield of component S, and an 18% yield of component E.21/28 
Barker estimated that the molecular weight of component S was 17,000 Da and 
that of component E to be 128,000 D a . 2 1 / 2 8  The recent completion of the 
purification to homogeneity of both components by B. Hartzoulakis, in our own 
laboratories, has confirmed that the relative molecular masses of both 
components (E and S) to be the same as reported by Barker. This value is in 
accord with other recent reports from Holloway and Marsh ( 1 9 9 3 ) , 2 9  for the 
enzyme from C. tetanomorphum. Marsh has also cloned and sequenced the 
genes for components S^ O and E29 from C. tetanomorphum. The N-term inal 
sequence for component S from C. tetanomorphum is almost identical to that
from C. cochlearium.^^AO
Over the past three years enormous advances have been achieved in 
establishing how the genes in the pathway for glutamic acid catabolism are 
organised within C. tetanomorphum. In 1992 the gene for 3-methylaspartase, the 
second enzyme in the pathway, was successfully sequenced and expressed in E. 
co/i.81 In accord with expectations derived from the determination of the 
molecular mass of the native homodimeric enzyme by size exclusion 
chromatography and by sodium dodecylsulphate polyacrylamide gel electro­
phoresis (SDS-PAGE analysis), the gene was found to encode a polypeptide of 413 
amino acid residues of molecular mass 44,539 Da, This work also identified two 
large but incomplete open reading frames up- and downstream of the Me Asp  
gene.8 l These were believed to code for the E-subunit of glutamate mutase and 
for mesaconase. The suggestion that the gene for the E-subunit existed 
immediately upstream of MeAsp was later confirmed when the complete gene
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was sequenced.29 The open reading frame for the E-subunit was shown to code 
for a polypeptide 485 amino acids of 53,708 Da.
Comparison of the E component with other proteins in the data bases failed 
to reveal any significant homologies, or any noteworthy similarities with other 
cobalamin-binding proteins. However, the comparison of E component with p- 
methylaspartase performed by Marsh identified a region of significant local 
homology (Fig. 1.2). Interestingly, the alignment includes the residue Ser-173 of 
P-methylaspartase, which has been implicated in the mechanism of 
deamination.31/32 For p-methylaspartase a dehydroalanine moiety appears to be 
generated by the self catalysed dehydration of the serine residue (Ser-173) (see 
section 1.4). Furthermore, it is emerging that for enzymes which operate via the 
intermediacy of a dehydroalanine residue, there is a conserved nucleic acid 
deduced sequence motif, -Ser-Gly-Asp-,^^/33 where the serine residue becomes 
dehydrated.
170 * 180 190 200 210
p-Methylaspartase g a e in a v p v f a q s g d d r y d n v d k m iik e a d v l p h a l in n v e e - k l g l k g - e k l l e y v k
I I : : : : : I : : : I I : : : : I I I : : : : I : I : : : I : I I I : I I I :
Component E GADLLPSTIDAYTRQNRYEECE -  IGIKESEKAGRSLLNGFPGVNHGVKGCRKVLESVN 
90 100 110 120 130 140
The aligned regions are G87 to N143 of the E component and G161 to K216 of p-methylaspartase. 
Identical residues are denoted by T and cmserved residues by : The active-site serine of
P-methylaspartase is identified by *.
Figure 1 2 : Alignment of the deduced amino acid sequence of Component
and p-Methylaspartase
Other work by Marsh, identified the gene for the S component from which it 
was deduced that the S component consisted of a 137-residue polypeptide of 
14,748 Da.30 Interestingly, these studies revealed that there is a single intervening 
gene, designated L, coding for a protein of 50,171 Da, between the genes for the 
two glutamate mutase components and immediately upstream of gene for the E- 
subunit, (Fig 1.3), No role has been ascribed for the product of the intervening 
gene.
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Figure 13: Organisation of the genes for glutamate mutase components S and E, protein L, 
and 3-methylaspartase in Clostridium tetanomorphum. Restriction sites for H in dlll (H), 
Ncol (N), Pstl (P) and Sfl«3A(S3) are also indicated. Plasmids containing C. tetanomorphum 
genomic fragments are labelled pSG4 (Goda et al.^^), pGMl (Marsh and Holloway.^^) and 
pGM2 (Holloway and Marsh.^^).
MELKNKKWTDEEPFKQREEVLKQWPTGKEVDLQEAVDYLK 40 MEKKTIVLGVI 1 1
KVPTEKNFAKLVRAKEAGITLAQPRAGVALLDEHINLLRY 80 GSDCHAVGNKI 2 2
LQDEGGADLLPSTIDAYTRQNRYEECEIGIKESEKAGRSL 1 2 0 LDHSFTNAGFN 33
LNGFPGVNHGVKGCRKVLESVNLPLQARHGTPDSRLLAEI 16 0 W N IG V LSSQ E 4 4
IHAGGWTSNEGGGISYNIPYAKSVPIDKCLKDWQYCDRLV 2 0 0 DFINAAIETKA 55
GFYEEQGVHINREPFGPLTGTLVPPSMSNAVGITEALLAA 2 4 0 DLICVSSLYGQ 6 6
EQGVKNITVGYGECGNMLQDIAALRCLEEQTNEYLKAYGY 2 8 0 GEIDCKGLREK 77
NDVFVTTVFHQWMGGFPQDESKAFGVIVTATTIASLAGAT 32 0 CDEAGLKGIKL 8 8
KVIVKTPHEAIGIPTKEANASGIKATKMALNMLEGQRMPM 3 6 0 FVGGNIWGKQ 99
SKELETEMAIIKAETKCILDKMFELGKGDLAVGTVKAFET 4 0 0 NWPDVEQRFKA 1 1 0
GVMDIPFGPSKYNAGKMMPVRDNLGCVRYLEFGNVPFTEE 4 4 0 MGFDRVYPPGT 1 2 1
LKNYNRERLAERAKFEGREVSFQMVIDDIFAVGKGRLIGR 4 8 0 SPETTIADMKE 1 3 2
PENK 4 8 5 VLGVE 1 3 7
Component Ë Component S
Figure 1.4: The Amino Acid Sequences of Components E and S
1.2.4 Substrates and the Rearrangement Step
The glutamate mutase rearrangement involves a reversible [1,21-migration of 
C-2 of glutamic acid from C-3 to C-4, promoted by the enzyme. This type of 
rearrangement is the only known example, in which all three carbon atoms
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group of the 5’-deoxyadenosine portion of the coenzyme during the 
rearrangement and that one of these hydrogen atoms is transferred back to the 
product radical when the rearrangement is complete. For the glutamate mutase 
system it has been demonstrated that tritium present in the 5'-deoxyadenosyl 
portion of the coenzyme at C-5' is transferred to the substrate.35
Given that Barker had determined that both the substrate and the product 
possess the same absolute configuration at C-2, the glycyl moiety must migrate to 
C-4 of glutamic acid with retention of configuration at C-2.36 in order to define 
the stereochemical course of the rearrangement with respect to the other carbon 
centre, (C-3 of glutamic acid), Hartrampf and BuckeP^ prepared (2S)-glutamic 
acid labelled at C-3 and C-4 with all three isotopes of hydrogen in the expectation 
that the enzymic product would contain a chiral methyl group. However, 
analysis of the product indicated that the potentially chiral methyl group was, in 
fact, racemic. This is the expected result for a reversible reaction in which the 
product contains a torsiosymmetric methyl group, or where the putative 
methylene radical intermediate is able to rotate about the C-3-C-3' sigma bond 
prior to the hydrogen capture at C-3'. Thus, while it is tempting to suggest that 
the rearrangement reaction should proceed with inversion of configuration at C- 
3 of glutamic acid, because this outcome requires minimal motion (Scheme 1.5), 
it is evident that the stereochemical course of the reaction with respect to C-3 
cannot be determined directly using the natural substrate.
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involved are saturated.^7 it is believed that the homolysis of the cobalt-carbon 
bond in the coenzyme, is promoted by glutamate mutase, upon substrate 
binding. The 5 -deoxyadenosyl radical formed during the dissociation is believed 
to abstract the pro-S hydrogen from C-4 of glutamic acid. This action results in a 
[l,2]-shift involving the movement of the glycyl moiety from C-3 to C-4. The 
resulting product radical retrieves a hydrogen atom from C-5' of the 5’- 
deoxyadenosine to give the product and regenerate the coenzyme.^^
(:) '  “  "Of
OH v C — Co"* /  4-fB-face miaration.
HjN ? OH
HOjC
OH OH
OH
Ad
AdoCbi
Cob(H)alamin
T -f g , ..  ^
inversion ?
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I
(2)
H OH
J U  OH
4*AdoCbl N:
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Scheme 1.5: Proposed Mechanism of the Glutamate Mutase Reaction.
Three carbon centres are involved in the glutamate mutase catalysed 
rearrangement reaction and it is evident that to fully understand the mechanism 
of the enzyme, it is necessary to determine the stereochemical course of the 
migrations with respect to each carbon centre. Early work by Sprecher et al.^  ^
demonstrated that the 4-pro-S hydrogen of glutamic acid migrates to become one 
of the three hydrogens of the methyl group of the product ((2S,3S)-3- 
methylaspartic acid) and is replaced by the migrating glycyl moiety with 
inversion of configuration at C-4 (Scheme 1.5). It is now generally believed that 
the migrating atom(s) becomes one of the three hydrogen atoms of the methyl
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1.3 Methylaspartate Ammonia-Lyase (MAL)
Methylaspartase (E.C. 4.3.1.2) catalyses the deamination of (2S,3S)-3-methyl- 
aspartic acid (2 ) to give mesaconic acid (3) (Scheme 1.6). The enzyme is 
distributed among obligate anaerobic m i c r o o r g a n i s m s ^ ^  and was very recently 
found among facultative anaerobic b a c t e r i a . ^ ®  xhe enzyme from the soil 
anaerobe, Clostridium tetanomorphum, has been the most extensively s t u d i e d . ^ ^
Kt + NHa
Scheme 1.6: The 3-Methylaspartate Ammonia-Lyase Reaction
1.3.1 The Structure of 3-Methylaspartate Ammonia-Lyase
Methylaspartase from Clostridium tetanomorphum , has a molecular weight 
of 100,000 Da, as determined by sedimentation equilibrium measurements.^^ 
The enzyme has been cleaved into two equal molecular weight subunits, each 
weighing 50,000 Da, in the presence of 6  mol dm‘3 guanidine hydrochloride.^^/^O 
However, work carried out by Hsiang and Bright reported that the enzyme, 
cleaves into four equal weight subunits (25,000 Da = 1 unit), when the enzyme is 
exposed to an 8 -fold molar excess of p-chloromercuribenzoate. The molecular 
weight of each subunit was determined by density gradient sedimentation 
techniques.4l Electrophoretic analysis of the enzyme, suggested that the enzyme 
possessed an (ab)2 type s t r u c t u r e , ^ ^  however, more recent work by Cohen showed 
that the enzyme behaves as a homodimer having a molecular weight of 49,000 
D a . 4 3  SDS-PAGE analysis, under a variety of conditions gives no indication of 
the homodimer splitting into smaller subunits. In addition, Wu and Williams 
reported that half the total number of arginine and lysine residues were present 
within the tryptic digests of the enzyme, as compared to the native enzyme.32
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This work suggested that the enzyme was a dimer, consisting of two identical 
subunits.
The Clostridium tetanomorphum gene encoding methylaspartase, has been 
recently cloned, sequenced and expressed in E. coli by Goda et al^^ The gene 
consists of 413 amino acid residues, comprising a total molecular weight of 45,539 
Da (Fig. 1.5). This information about the structure of the enzyme unambiguously 
identifies methylaspartase to be a homodimer. The recombinant protein has 
been shown to be identical to the enzyme isolated directly from C . 
tetanom orphum .
M K I V D V L C T P G L T G F Y F D D Q R A I K K 25
G A G H D G F T Y T G S T V T E G F T Q V R Q K G 50
E S I S V L L V L E D G Q V A H G D C A A V Q Y S 7 5
G A G G R D P L F L A K D F I P V I E K E I A P K 100
L I G R E I T N F K P M A E E F D K M T V N G N R 1 2 5
L H T A I R Y G I T Q A I L D A V A K T R K V T M 150
A E V I R D E Y N P G A E I N A V P V F A Q S G D 1 7 5
D R y D N V D K M I I K E A D V L P H A L I N N V 2 0 0
E E K L G L K G E K L L E Y V K W L R D R I I K L 2 2 5
R V R E D Y A P I F H I D V Y G T I G A A F D V D 2 5 0
I K A M A D Y I Q T L A E A A K P F H L R I E G P 2 7 5
M D V E D R Q K Q M E A M R D L R A E L D G R G V 3 0 0
D A E L V A D E w C N T V E D V K F F T D N K A G 3 2 5
H M V Q I K T P D L G G V N N I A D A I M Y C K A 3 5 0
N G M G A Y C G G T C N E T N R S A E V T T N I G 3 7 5
M A C G A R Q V L A K P G M G V D E G M M I V K N 4 0 0
E M N R V L A L V G R R K 4 1 3
Figure 1.5: The Primary Sequence of Methylaspartase
Photo-oxidation studies, performed by Williams and Libano, have shown 
that the rate constant for the loss of enzyme activity, is almost identical to that 
for the cysteine sulfhydryl groups, suggesting that a thiol group was required for 
activity.44 The enzyme was also known to be inactivated by the thiol alkylating 
agent, N-ethylmaleimide. Protection from inactivation studies, provided by 
various substrates and substrate analogues, had implied that the sulfhydryl 
group (cysteine residue) was proximate to the 3-H of (2S, 3S)-3-methylaspartate.45
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EPR measurements by Fields and Bright, using manganese as the divalent 
cation, showed two metal ions were bound per enzyme m o l e c u l e . 4 6  This lead to 
the suggestion that there are two active sites. The result correlates well with the 
number of mesaconic acid binding sites available, as determined by gel filtration 
of methylaspartase in buffer containing mesaconic a c i d . ^ 2  Furthermore, Hsiang 
and Bright showed that the enzyme was completely inactivated by two 
equivalents of p-chloromercuribenzoate.^^ However, methylaspartase was 
insensitive to arsenite, indicating that the two essential thiol groups, were not 
located at the same active site.
1.3.2 Substrate Specificity of 3-Methylaspartate Ammonia-Lyase
Due to the size of the methyl binding pocket, within the active site of 3- 
methylaspartase, the enzyme can tolerate a wide variety of 3-C substituted 
aspartic acids. The following compounds; (2S)-aspartate,l2 (2S,3S)-3- 
ethylaspartate,47 (2S,3S)-3-"propylaspartate, (2S,3S)-3dpropylaspartate47 and 
(2S,3R)-3-chloroaspartate48 have all been shown to be substrates for 3- 
methylaspartase (Table 1.3). Interestingly, Asano and Kato have shown that (25)- 
aspartic acid was not a substrate for MAL, from a facultative anaerobe, but 
catalysed the amination of fumaric acid to give (2S)-aspartic acid.^8
Substrate Km  (mM) Vmax (xlO‘7 mol dm-3 S"l)
(2S,3S)-3-Methylaspartic acid 2.37+0.2 109.0
(25)-Aspartic acid 10+0.82 0.80
(25,35)-3-Ethylaspartic acid 17.08±1.4 48.7
(2R,35)-3-Chloroaspartic acid >50 -
(2S,3K)-3-Methylaspartic acid 40 2.9
Table 13 : Substrates for Methylaspartase and Deamination Kinetic Parameters
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In early work within our laboratories, Akhtar et a l  demonstrated that the 
enzyme could be used synthetically in the amination direction, to prepare 3- 
halogeno- and 3-alkylaspartic acids, of defined stereochemistry, from the 
corresponding substituted fumarates (Scheme 1.7 and Table 1 .4 ).49
Mg-K
R=H ,M e,Et,Tr , ‘Pr,
Cl,Br
Scheme 1.7: Substrates for Methylaspartase
Substrate Km Vmax(xlO"  ^mol dm"3 min‘1)
Fumaric acid 23±2.2 1702
Mesaconic acid 1.24+0.085 894
Ethylfumaric acid 1.05±0.2 583
Chlorofumaric acid 3.52+0.71 382
Bromofumaric acid 2.64+0.53 425
ï'Propylfumaric add 2.1±1.3 4.2
iPropylfumaric acid 5.5+3.0 5.3
*^Butylfumaric acid - <0.05
lodofumaric acid - <0.05
Table 1.4: Substrates for Methylaspartase and Amination Kinetic Parameters
When fluorofumarate was incubated with 3-methylaspartase, (2R,3S)-3- 
fluoroaspartatic acid was formed. However, due to the competing side reactions, 
isolation of the fluoroaspartate was difficult. Bromofumarate was found to be a 
good substrate for 3-methylaspartase but the enzymic product, (2R,3S)-3- 
bromoaspartate, was unstable under the incubation conditions and was noted to
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cyclise, giving rise to the formation of 2 ,3 -aziridinedicarboxylate (Scheme 1.8; (8 )). 
Bromofumarate was also found to cause inactivation of 3-methylaspartase as it 
was observed to behave as a suicide inhibitor. This observation may be explained 
due to the formation (2R,3S)-3-bromoaspartate.50 This suggests that alkylation of 
an essential nucleophile at the active site of the enzyme might occur during the 
catalytic turnover (Scheme 1.9). It should also be noted that inactivation may 
also be caused by the formation of the aziridine (Scheme 1 .8 ).I
Scheme 1.8: The Formation of 2,S-Aziridinedicarhoxylate
0 =0^ ^  o = c ^ \
♦NHg C O 2 " ^  I  +NH3 CO 2"
Scheme 1.9: Suicide Inhibition of Methylaspartase by 
ilR/SSyS-Bromoaspartate
The C-3 deuteriated isotopomers of the 3-halogeno- and 3-alkylaspartic acids 
have also been prepared by performing the enzymatic incubations, in deuterium 
o x i d e . 4 9  It was shown by Barker that methylaspartase deaminated (2S,3R)- 
erytfira-methylaspartic acid and that this diastereomer was generated by the 
enzyme, upon prolonged incubation with mesaconic a c i d . ^ 2  in addition. Archer 
and Gani have demonstrated that the recombinant protein also catalysed the 
formation of (2S,3R)-eryf/iro-methylaspartic acid. It was concluded that the
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formation (or deamination) of (2 S,3 R)-eryf/iro-methylaspartic acid, was inherent 
to the enzyme, and that the enzyme operates v ia  a concerted s y n  
elimination/addition reaction, during extended incubation t im e s .H o w e v e r ,  
when the reaction was repeated for ethylfumaric acid, no activity was noted.^2
Recent work within in our laboratories has shown that N-nucleophiles can 
serve as surrogates for ammonia in the direct amination of fumaric acids (Table 
1.5).53
HOgC
p 2 r3
COgH 
)2C H
^ ------------- -------- 11• 3-Methylaspartase "I n HC
r 2 r 3 Conversion Yield (%)
H Me H 55 34
Me Me H 54 35
Et Me H 60 35
Prn Me H No reaction .........
Pri Me H No reaction ■ -------
H Me Me 70 38
Me Me Me No reaction —
H N H 2 H 89 35
Me N H 2 H 91 41
Et N H 2 H 90 50
Pri N H 2 H 90 —
H OH H 90 11 1 1
Me OH H 90 —
H Et H 5 —
H OMe H 80 30
Me OMe H 70 --------
Et OMe H N o reaction —
Table 1.5: Summary of the Enzyme Catalysed Addition Reaction
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Since hydrazine was shown to be an effective surrogate for ammonia, the 
feasibility of using hydroxylamine and methoxylamine as well alkylamines, as 
nucleophiles in the conjugate addition reactions was also determined (Table 
1 .4 ).53 The rate of additions varied widely for different substrates. However, in 
general, hydrazine and hydroxylamine were found to be the fastest substrates and 
dimethylamine the slowest. The enzyme was also able to catalyse the addition of 
ethylamine to fumaric acid. However, the reaction occurs very slowly, on 
account of the steric constraints within the active site. The addition of hydrazine 
and hydroxylamine to chlorofumaric and bromofumaric acid was also catalysed 
by the enzyme. Remarkably, the enzyme catalyses the addition of dimethyl­
amine to fumaric acid to give the expected product, (2S)-N,N-dimethylaspartic 
acid. Interestingly, only fumaric acid was able to support this type of reaction, 
(Fig. 1.6(a)). Insufficient space at the active site, and in particular, unfavourable 
steric interactions between the N-methyl groups and the alkyl group of the 
substituted fumaric acids probably account for the fact that the larger compounds 
were unable to act as Michael acceptors (Fig. 1.6 (b)).
CH2-Enz
CO2
CH2-Enz
Figure 1,6: Plausible Geometry for the Enzymic Addition of Dimethylamine to
Fumaric (a) and Mesaconic acid (b)
The addition of hydrazine to mesaconic acid (3) follows the same 
stereochemical course as for the addition of ammonia and occurs at the 3-sf-face 
at C-3 in an anfj-fashion. Catalytic reduction of 2-hydrazino-3-methylsuccinic 
acid gave (2S,3S)-isomer of 3-methylaspartic acid (2), and was found to be 
identical, in all respects, with the authentic sample.53
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1.3.3 Kinetic Properties of 3-Methylaspartate Ammonia-Lyase
In 1959, Barker examined some of the fundamental characteristics of 3- 
methylaspartase. His work in this area revealed that the optimum pH for the 
enzyme is 9.7, and that the enzyme was most active at -55 °C. However, the 
optimum pH for enzyme stability at 55 °C, was 6.7. The equilibrium constant, 
Kgq, for the deamination reaction at 25 °C and pH 9.7 was 0.3.^  ^ It was also shown 
that the enzyme required a divalent and a monovalent cation for enzyme 
activ ity .M a g n esiu m  was found to be the best divalent metal ion for enzyme 
activity, although nickel, cobalt, zinc, iron, manganese and cadmium were also 
activators of the enzyme.54 Work carried out by Bright and co-workers, showed 
that the order of activation to be: Mg2+ > Mn^+> Co^+> Ni^+.SS Calcium and 
strontium were found to be inhibitors of the enzyme. It was noted that the 
enzyme activity was directly related to the ionic radius of the cation and that 
those cations which possess an ionic radius of less than 1 Â were activators, 
whereas those larger than 1 Â were inhibitors of methylaspartase.54 Of the 
monovalent cations, potassium was the most effective activator and the order of 
effectiveness for the monovalent cations was shown to be; K+ > NH4+ > Rb+> Li+ 
> Na+> Cs+.^ O The for potassium was 3 mM, under Barker's conditions. At 
high concentrations, however, potassium inhibited the reaction. The enzyme 
behaves autocatalytically in the absence of potassium, due to the formation of 
ammonium ion - a deamination product.
1.3.4 Mechanism of 3-Methylaspartate Ammonia-Lyase
Barker proposed that 3-methylaspartate ammonia-lyase, operated via a 
carbanion m e c h a n i s m . 5 6 , 5 7  One of his main pieces of evidence was that (2S,3R)- 
cryf/zro-3-methylaspartate was a substrate for the enzyme and he concluded that 
the carbanion intermediate generated at C-3 would be the same for both 
substrates. Using samples of (2S,3S)-[3-2H]-3-methylaspartic acid and unlabelled 
material. Bright showed that the rate of the deamination reaction was not
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sensitive to substitution by deuterium at C-3 at pH 5.5, 7.5 and 9.5.^  ^ It should be 
noted that in these experiments the deuterated substrate contained a considerable 
amount of protium at C-3, and thus a small isotope effect may have been difficult 
to distinguish from the limits of experimental error. Furthermore, he found 
that l^N-ammonia was incorporated into 3-methylaspartic acid at a negligible 
rate as compared to the C-3 hydrogen exchange with the solvent.54 Thus 
hydrogen exchange could apparently occur without C-N bond cleavage. Bright 
concluded that the enzyme-substrate carbanion intermediate underwent 
hydrogen exchange before the elimination of ammonia and that after rate 
determining C-N bond cleavage ammonia and mesaconic acid were released 
from the active site rapidly. Hence, it was implied that 3-methylaspartase was 
the archetypal enzyme operating via an type mechanism (Scheme 1.10).
Scheme 1.10: Elcb Mechanism of Methylaspartase
However work carried out by Dotting et a l, noted a primary deuterium 
isotope effect when the concentrations of potassium ion were lower than 50 
mmol dm"3 (Table 1.6); thus indicating that the C-H bond cleavage was at least 
partially rate limiting and therefore, this questioned Bright's p r o p o s a l . ^ 8  Primary 
deuterium isotope effects were also measured for (2S)-aspartic acid and (2S,3S)-3- 
ethylaspartic acid. Table 1.6.
Chapter 1: Methylaspartate Ammonia-Lyase 26
Substrate Km
(mM)
Vmax 
(xlO"  ^mol dm"  ^S"^ )
V /K
(xl0-4s-l)
(2S)-Aspartic acid 10+0.82 0.80 0.076
(2S,3R)-[3-2Hi ] Aspartic acid lQtO.82 0.80 0.076
(2S,3S)-3-Methylaspartic acid 2.37±0.2 109.0 46.0
(2S,3S)-[3-2H]-3-Methylaspartic acid 2.3510.25 64.2 27.3
(2S,3S)-3-Ethylaspartic acid 17.08+1.4 48.7 2.85
(2S,3S)-[3-2H]-3-Ethylaspartic acid 17.66+1.6 41.8 2.37
Table 1,6: Kinetic Isotope Parameters
The absence of a deuterium isotope effect, for the deamination of aspartic 
acid, and the reduced isotope effect with 3-ethylaspartic acid, suggested that both 
(2S)-aspartic and (2S,3S)-3-ethylaspartic acids were potentially deaminated by a 
mechanism which was less concerted and one which contained a greater 
' c h a r a c t e r ' .^ 9 This can be rationalised as being due to the orbital alignment for a 
concerted elimination; which was considered optimal in the case of (2S,3S)-3- 
methylaspartic acid. Abstraction of the 3-C-H in the two slower reacting 
substrates generates a carbanion in which the torsion angle between the 2-C-N 
and 3-C-H bond is not optimal for the elimination of a m m o n i a , 5 9  and hence 
there were no primary isotope effects were observed.
In (2S)-aspartate, a weak interaction of the 3-H with the hydrophobic methyl- 
binding pocket accounts for non-optimal orbital alignment of the carbanion and 
therefore no primary isotope effect. The substantially higher for both 
substrate and product, than for the physiological compounds, suggests that 
substrate/product dissociation was not rate limiting. These results imply that 2- 
C-N bond cleavage was rate limiting and that 3-C-H bond cleavage was non-rate 
limiting, and thus it was concluded that (2 S)-aspartic acid underwent 
deamination via an El^b mechanism.59
In the case of (2S,3S)-3-ethylaspartate, strong interactions of the ethyl group 
with the hydrophobic methyl-binding pocket, resulted in non-optimal orbital
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alignment of the carbanion, and therefore 3-C-H bond cleavage was non-rate 
limiting. However, the enzyme may still operate via an E2 mechanism since 
ethylfumarate binds more tightly in the active site than the physiological 
substrate, causing the product to debind and to become partially rate l i m i t i n g . ' ^ 8 , 5 9
It was considered that the C-H bond cleavage was at least partially rate 
limiting for the natural substrate, and thus a need to distinguish between a 
balanced stepwise El^b mechanism and an E2 type mechanism was necessary. 
Double isotope fractionation experiments, carried out by Dotting et al. measured 
the kinetic isotope effect on C-N bond cleavage in the presence and absence of 
deuterium at C-3.^0 a concerted (E2) mechanism, isotopic substitution at C-3 
should not effect the kinetic isotope effect on C-N bond cleavage. However, a 
balanced stepwise El^b mechanism would show a reduced kinetic isotope effect 
for C-N bond cleavage in the presence of deuterium at 3-C. Values of 1.0246 ± 
0.0013 and 1.0241 ±  0.0009 were obtained for the isotope effect with protium 
and deuterium at 3-C respectively. These results indicated that the reaction 
followed a concerted pathway with a single transition state involving both 3-C-H 
and 2-C-N bond cleavages, i.e. by an E2 mechanism (Scheme 1 .11).60
O2C
BH
Scheme 1.11: E2 Mechanism of Methylaspartase
Label exchange experiments were performed to explain the exchange reaction 
of the 3-C hydrogen of (2S,3S)-3-methylaspartic acid with the solvent. (2S,3S)-3- 
Methylaspartic and (2S,3S)-[3-^H]-3-methylaspartic acids were incubated in 
tritiated water, thus allowing the rate of protium or deuterium wash-out from 
the substrates to be measured as tritium washed in. The primary deuterium
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isotope effect on V^ax foi" the exchange reaction at pH 9.0 was found to be 1.6.^  ^
The size of the isotope effect was not dependent on the ratio V e x c h a n g e /  
V d e a m i n a t i o n /  which showed large changes with pH. This suggested that the 
exchange reaction occurred after the concerted elimination step and that the step 
possesses a strong reversible commitment. It also indicates that the exchange did 
not occur at the free carbanion level, as ^(Vex) was constant with pH.^l
The ammonia-lyase enzymes, methylaspartase, phenylalanine ammonia- 
lyase^2 and histidine ammonia lyase^^, which catalyse the reversible elimination 
of ammonia from their respective amino acids to give the corresponding 
conjugated acids (Scheme 1.12), are believed to operate via mechanisms which 
require the formation of a dehydroalanine residue at the active site of the 
enzyme.
HgN X^
HO2C H
R -NHq wHO2C R
R = Me, X = CO2H; Methylaspartase 
R = H, X = Ph; Phenylalanine ammonia-lyase 
R = H, X = 4-Wdazole; Histidine ammonia-lyase
Scheme 1,12: The General Reaction for the Ammonia-lyase Enzymes
For methylaspartase the dehydroalanine residue moiety appears to be generated 
by the self-catalysed dehydration of a serine residue (Ser-173) within the 
polypeptide (A, Scheme 1.13).
O S  .. G C D
-H2O
CO2H
G C D  ,'rA'
B CO2H
Scheme 1,13: Post-translational Formation of Dehydroalanine
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In the past it has been largely assumed that the dehydrolalanine residues 
within the ammonia lyases would undergo conjugate addition with the amino 
groups of the amino acid substrates to give substituted 2,3-diaminopropionic acid 
residues prior to the elimination of ammonia from the substrate (Scheme 1.14 
path A)62/63 Recent work within our laboratories reveal that such reactions are 
feasible. The authors also show that an alternative mechanism in which the 
dehydroalanine moiety behaves as an enamine and gives a conjugated imine 
which can then react with amines (Scheme 1.14 path B), should not be 
discounted as a mechanism of importance in enzymic deamination reactions.
Enz'
Enz Enz
Path A
Conjugate
addition
HOgC
-NHq BH X 
HOgC R
-H+
HpaC H H+
P a th s
Enamine
trapping
« . ' %
Me
HgN XH")— 
HOgC H
Hg^Me
H ^ X 
HO2C R
-NH3 B 
-H+
Scheme 1.14: Plausible Routes for Amine Interaction with Dehydroalanine
Model studies were perfomed on the dehydroalanine residue (Fig. 1.7, A) by 
Gulzar, et alM
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Me
NH HMe
HNMe
Me
Figure 1.7: The Reaction of Propylamine with Dehydroalanine Residues
The studies show that when dehydroalanine (Fig. 1.7, A; where R = 0*Bu or 
OBn and R'=NHEt) is treated with propylamine, in methanol at room 
temperature, the sole product is the corresponding diaminal (Fig. 1.7, B). On the 
other hand, treatment of the dehydroalanine (Fig. 1.7 A; where R = O^Bu or OBn, 
and R'=OMe) with propylamine, under the same reaction conditions, gave the 
corresponding conjugate addition product (Fig. 1.7, C). In addition, treatment of 
the dehydroalanine (Fig. 1.7, A; where R = Me and R'=OMe or NHEt) with 
propylamine, under the same reaction conditions, also gave the corresponding 
conjugate addition product (Fig. 1.7, C), thus indicating that the N-protecting 
group can profoundly influence the regioselectivity of the reaction. Taken 
together, the results of this study indicate that there is a fine balance between the 
a- and p-addition of N-nucleophiles to the dehydroalanine system. It appears 
that the loss of amide resonance in the C-1 carboxamide moiety on changing an 
N atom for an O atom promotes p-addition whilst a reduction in the 
delocalisation of the lone pair of the a-amino group on changing from acyl to 
urethane protection promotes a  addition. Since the torsion about the amide 
bonds flanking the dehydroalanine residue in enzymes can be easily controlled 
to adjust the electronic properties of the putative Michael acceptor, either of the 
two mechanisms as shown in scheme 1.14 can operate.
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1,3.5 Binding and Debinding Orders of 3 -Methylaspartate Ammonia-Lyase
It was demonstrated by Bright and Silverman that (2S,3S)-3-methylaspartic 
acid is bound as the free amino acid rather than an amino acid-magnesium 
c o m p l e x . T h e  experiment carried out to confirm this, was when 3- 
methylaspartic acid was incubated with methylaspartase, in the absence of 
magnesium ions, it was shown that mercuribenzoate had no inhibitory effect on 
the activity of the enzyme, thus suggesting that the substrate bound to the 
enzyme either first or in a random order with the divalent cation.66  Kinetic 
analysis revealed that a random order, rapid equilibrium addition of 
methylaspartate and the divalent cation to the enzyme seemed most probable.
Botting and Gani showed that methylamine did not act as an activator of 
methylaspartase, but in fact behaved as a competitive inhibitor of 3- 
methylaspartic acid, in the deamination reaction and that of ammonia and 
mesaconic acid in the amination direction.^i These experiments carried out, 
show that mesaconic acid and the ammonium ion are released at the same rate 
with random debinding. This hypothesis was also supported by the fact that 
mesaconic acid acts as a competitive inhibitor for (2S,3S)-3-methylaspartic acid.^l
Bright observed that the ammonium ion can enhance the exchange rate, over 
that for normal deamination, and that I5]sj-iabelled ammonia was not 
incorporated into the substrate in an exchange reaction. From this observation, 
it appears that the increase in V e x c h a n g e /  V d e a m in a t io n /  is caused without cleavage 
of the C-N bond.56 Botting and Gani showed that by incubating l^N-labelled 
ammonia and [3 -^H3]-mesaconic add, with unlabelled (2S,3S)-3-methylaspartic 
acid, that the rapid formation of [^^N, methyl -^H3]-3 -methylaspartic acid occurs. 
The singly labelled spedes were formed only slowly and could be accounted for 
by reaction with free unlabelled substrates. Thus the rate of mesaconic acid 
release by the enzyme was equal to the rate of ammonium ion release and that 
debinding was random.^i This result confirms Bright's findings.56
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Re-examination of Bright's work at low pH shows that the substrate and 
magnesium ion bound in a random steady state manner followed by potassium 
ion.^^ At pH 6.5 and high potassium ion concentrations, the binding order was 
compulsory, with that of potassium ion binding, after the substrate, and released 
before the first product.^1 At pH 9.0, magnesium ion bound before the substrate, 
in rapid equilibrium and the potassium ion bound after the substrate. At low  
magnesium ion concentrations, a binding order of: the substrate, then potassium 
and then magnesium was favoured. At low potassium ion concentrations, the 
substrate bound in the steady state co-operativity exists between the two active 
sites of the enzyme, which was in a new catalytic form, with a high affinity for 
potassium.6 l
Binding/ debinding experiments suggest that there was a slow step after C-N 
bond cleavage, but before the formation of the E.NH4+.Mes complex, which 
causes the products to partition between recombination (to give methylaspartic 
acid), and formation of the E.NH4+.Mes complex, from whence the product could 
escape.^^ Therefore, in labelled water, solvent-derived hydrogen could exchange 
with the conjugate acid on the enzyme (after the base removes the proton from 
the substrate at 3-C) to give labelled substrate. Since ammonium ion enhances 
the exchange reaction, the ion must prevent the formation of the E.NH4 +.Mes 
complex. Ammonium ion could easily do this if the product site for 
ammonium ion is not occupied in the intermediate complex by the amino group 
of the substrate (Scheme 1.15).^^
The evidence put forward for the second binding site for ammonia was firstly; 
that the rate of reaction was dependent upon [NH4+J2, i.e. two molecules of 
ammonium ions were involved and secondly, ammonia behaves as a non­
linear uncompetitive product inhibitor for the deamination process.
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Scheme 1.15: Exchange Mechanism of 3-Methylaspartate Ammonia-lyase
1.3.6 Active Site Structure of 3-Methylaspartate Ammonia-Lyase
Enzymes containing a catalytic dehydroalanine residue such as histidine 
ammonia lyase and phenylalanine ammonia lyase, are inactivated by sodium  
borohydride; however, methylaspartase shows no inactivation in the presence of 
sodium borohydride.^^ In addition, phenylhydrazines cause partial-irreversible 
inactivation of MAL, with some inactivation protection afforded by the substrate; 
suggesting that an electrophilic prosthetic group is present at the active site.^i
Wu and Williams showed that eight uniformly labelled peptides were 
formed upon treatment of methylaspartase with [l-l^Cj-N-ethylmaleimide (thiol 
reacting compound), followed by tryptic digestion, and assumed that eight 
cysteine residues in the protein had been labelled.^^ There was also evidence, 
provided by Bright, which show the presence of sixteen cysteine residues per 
mole of enzyme.39/40 Furthermore, an active site peptide was isolated and was 
believed to be labelled on a cysteine residue (with [l-I4 c 3-N-ethylmaleimide).^2
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This peptide corresponds to one of the eight uniformly labelled peptides obtained 
from the earlier experiment,32 and as a consequence the amino acid composition 
was determined by total acid hydrolysis.32 Upon attempting to match this amino 
acid composition to the primary structure of methylaspartase, there was no 
observable match if it was assumed to contain a cysteine. However, if the 
labelled residue was taken as a serine, a match was obtained. Moreover, from the 
primary structure, methylaspartase contains seven cysteine residues rather than 
eight. In order to explain the reaction of serine with N-ethylmaleimide, a post- 
translational modification of the serine to a dehydroalanine residue (Scheme 
1.16, A) was invoked.3^ The dehydroalanine residue could conceivably be 
attacked by the amino group of the substrate to give a 2,3-diaminopropanoic acid 
residue (Scheme 1.16, B), which could then react with N -ethylm aleim ide, 
alkylating the enzyme (Scheme 1.17).
Scheme 1.16: Formation of the 2,3-Diaminopropanoate Residue
NH
EtN
Scheme 1.17: The Reaction of N-Ethylmaleimide with 2,3-Diaminopropanoate
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1.4 P-Amino Acids
1.4.1 Introduction
Chemical synthesis of p-alanine, the simplest of the p-aminocarboxylic acids, 
was reported by Heinz in 1870^7 only 20 years after Strecker's classic, albeit 
inadvertent synthesis of a-alanine.^® Within 30 years six additional syntheses of 
p-alanine were reported. Occurrence of P-alanine as a microbial catabolite of 
aspartate was reported as early as 1911^  ^ and carnosine (P-alanylhistidine) was 
identified in skeleton muscle in 1900.70 p-amino acids were often included in 
early synthetic peptides and by the early 1900’s, it was dear that proteins were 
composed exclusively of a-amino acids and P-amino acids were increasingly 
perceived as lying outside the mainstream of mammalian biochemistry.
This perception was strongly supported by the scientific developments that 
followed. Whereas many novel and complex p-amino acids, were isolated from 
plants and microorganisms as free molecules and components of peptides and 
a n t i b i o t i c s , 7 l  few p-amino acids were found in mammals, and their metabolism 
appeared, at least initially, to be simple.
Beyond their limited metabolic role, p-amino acids hold interest as analogues 
of a-amino acids. P-Amino acids have for example, been used to probe the 
structural specificity and topology of several a-amino acid-binding sites and have 
found use as enzyme specific alternative substrates. The limited normal 
metabolism of p-amino acids suggests that many p-amino analogues of a-amino 
acids will be metabolically stable in vivo; enzyme inhibitors may thus have 
extended half-lives when designed as p- rather than a-amino acids.7l Similarly, 
incorporation of P-amino acids into peptides of pharmacological interest has in 
some cases been found advantageous in terms of biological activity, metabolic 
stability, or both.7i
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1.4.2 Nomenclature of p-Amino Acids
As illustrated in figure 1.8, there are three different p-amino acids which are 
plausible analogues of an a-amino acid. In type I analogues the a-amino group 
is 'moved' to the p-carbon whereas in type II or type III analogues an extra 
methylene group is inserted between the original carboxyl and amino groups. 
Type I and II analogues are named systematically as 3-amino derivatives of the 
parent acid but are frequently referred to by the nomenclature shown in figure 
1.8. It is noted that there is some redundancy (P-leucine = p-homovaline, etc.); in 
such cases the type I name is preferred. a-Substituted-P-alanines (type III 
analogues) are named systematically as substituted propanoic acids or, less 
commonly, as 2 -aminomethyl derivatives of the parent acid {e.g. 2 - 
aminomethyl-4-methylpentanoic acid in the example shown). With the 
exception of P-proline (3-carboxypyrrolidine), a-substituted-p-alanines are not 
named by reference to the homologous a-amino acid. The prefix 'iso' is, 
however, used with some a-substituted-p-alanines. Isoserine and isocysteine are 
a-hydroxy- and a-mercapto-p-alanine, respectively; isothreonine is p-amino-a- 
hydroxybutanoic acid. Many di- and trisubstituted-p-alanines bear trivial names 
related to the plant, microorganism, or antibiotic in which they were 
discovered.7i
.............
COOH COOH COOH COOH
H2N—O—H 
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HgN-C-H
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CH(CH3)2 CH(CI^ )2 CH2
CH(CH3)2
ch(CHî)2
I n III
LrLeucine p-Leucine P-Homoleucine 3-Amino2~(2-methyl- 
propyO-propanoic acid
Figure 1,8: p~Amino Acid Analogues of L-Leucine
Both a- and p-substituted-p-alanines generally have at least one chiral carbon 
and thus occur in R- and S-configurations. Although all of the protein L-a-
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amino acids except cysteine are S-enantiomers, the configurationally analogous 
p-amino acids may be R or S. The enantiomers shown in figure 1.8, all 
analogues of L-a-leucine, are K-p-leucine, S-p-homoleucine and R-3-amino-2-(2- 
methyDpropyl-propanoic acid. The D and L designations common to a-amino 
acids are frequently applied to type I and type II analogues by evaluating the 
configuration at the P-carbon as if it were the a-carbon. The D and L designations 
are less clearly assigned with type III analogues. R-p-Aminoisobutyrate, the type 
III analogue of L-alanine, is, for example, referred to as D-P-aminoisobutyrate. 
Correspondingly, in the sense illustrated in figure 1.8, S- or L-p-aminoisobutyrate 
is an analogue of D-alanine^Z
1.5 p-Amino Acids as Analogues of a-Amino Acids
1.5.1 p-Amino Acid-Containing Peptides
Early studies carried out by Abderhalden suggested that peptide bonds 
involving P-amino acids are resistant to enzymatic h y d r o l y s i s . 7 3 / 7 4  However, 
later studies tempered this view.75 Interest in the synthesis, hydrolytic stability 
and conformational characteristics of p-amino acids-containing peptides 
continues.
As reviewed in depth by Drey,7l several peptide antibiotics contain P-amino 
acid residues and analogues of these peptides and others (e.g, enkephalins) have 
been prepared in an effort to achieve greater stability or specificity of action. 
Since pure enantiomers of p-amino acids are not readily available, p-alanine is 
most frequently used to replace glycine, or less commonly, another a-amino acid. 
Several analogues have substantial or full biological activity, whereas in other 
cases the activity spectrum is modified. Replacement of the C-terminal Gly-NHz 
of vasopressin with p-AlaNHz, for example yields an analogue with antidiuretic 
and uterotonic activity but without pressor activity.76 On the other hand, 25 
analogues of the sweetener Aspartame ((2 S)-Asp-(2 S)-Phe-O CH 3 ) were
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synthesised with the Phe residue replaced by any several a- or p-substituted-p- 
alanines; none approached the sweetness of the parent molecule/^
Limited information on the topology of binding sites and on the 
conformational effects of inserting p-amino acids into peptides precludes reliable 
prediction of the biological activities of analogues.
1.5.2 Chemical Synthesis of P-Amino acids.
P-Amino acids although less abundant than their a  analogues, are also 
present in peptides,^8 and in free form they show interesting pharmacological 
effects.79 Furthermore, p-amino acids are synthetic precursors of p-lactams,^0 
which are potentially biologically active and of current interest.®  ^ In this respect, 
several methods for the synthesis of racemic P-amino acids have been 
developed,®^ but only recently has the preparation of enantiomerically pure 
compounds emerged as an important and challenging synthetic endeavour
The main procedures developed thus far for the enantioselective synthesis of 
p-amino acids can be tentatively separated into seven categories (A-G), as detailed 
below. (An example of each category will be mentioned briefly, within this 
section).
1.5.2.1 A. The "Chiral Pool”
The chiral pool refers to the utilisation of inexpensive, readily available 
natural products as substrates to be converted into enantiomerically pure p- 
amino acids via conventional organic synthesis. According to this strategy, 
Balenovic and co-workers®^ described the application of the Arndt-Eistert 
reaction to (-)-l-diazo-3-phthalimidobutan-2-one (9), prepared from (2S)-alanine, 
to give (+)-p-aminobutyric acid (1 0 ) (Scheme 1.17).
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CO2HI 1. Phthalic anh.
H2N 'CH3 2 .SOCI2 
3.CH2N2 (25)-Alanine (-)-9 0
CHgNg CO2H
CH2V,. l.A g 2 0 /C H 3 0 H  J
® 2. HVAcOH H2N CH3
3. Amberlite (+)-10
Scheme 1,17: Asymmetric Synthesis of P-Aminobutyric Acid
1.5.2.2 B. Asymmetric addition of amines to a,P-Unsatnrated Esters
Ter ente V and co-workers reported the first example of an enantioselective 
addition of a chiral amine to crotonic acid,^4 nevertheless, the enantiomeric 
ratios obtained were quite low.
An improvement in this methodology, by Hawkins and c o - w o r k e r s , 8 5  gave 
better results, utilising the C2 symmetric chiral secondary amine (11). Initially, 
treatment of (±)-(ll) with methyl crotonate gave the amino ester (±)-13 as a 78:22 
mixture of diastereomers in 68% yield (Scheme 1.18). More useful Michael 
additions of the lithium amide (S)-(12)-Li occurred with very good 
diastereoselectivity to afford (R)-(13) as a 98:2 mixture of diastereomers in 81% 
yield (Scheme 1.18).
<H>
(a)(5)(H),R=H
(b)(5)-(12)-Li,R=Li
0 0 2 ^ 6
(R)-(13)
NH2
Scheme 1,18: Enantioselective Addition of Chiral Amines with a ,p -
Unsaturated Esters
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1.5.2.3 C. Addition of C-Nucleophiles to Chiral Imines
Pioneering efforts in this direction were first reported by Furukawa and 
collaborators in 1978.®  ^ However low enantiomer ratios of the p-amino acids 
were obtained. More recently, Kunz and S c h a z e n b a c h ® 7 , 8 8  described the 
asym m etric synthesis of N -u n su b stitu ted  P-amino acids via  the 
diastereoselective Mannich reaction of Schiff bases of 2,3,4,6-tetra-O-pivaloyl-p-D- 
galactosylamine. One advantage of this method is the recovery of the chiral 
auxiliary group (Scheme 1.19).
.O SiM ea
r  OMePivO. PivO,
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Scheme 1.19: Asymmetric Synthesis of N-Suhstituted p-Amino Acids
1.5.2.4 D. Enantioselective Hydrogenation of 3-amino-acrylic acid Derivatives
Early pioneering work in this area was carried out by Achiwa and Soga.89 
They performed asymmetric hydrogenation on prochiral, p-(acetylamino)acrylic 
acid derivatives, using biphosphines as the chiral ligands, to give the 
corresponding optically active product. Unfortunately, these reactions had only 
modest success, affording the desired products in low enantiomeric purities.
Improvement in the efficiency and understanding, in this area of asymmetric 
synthesis, was achieved by the Noyori group.90 They demonstrated that BINAP- 
Ru(II) metal complexes [BINAP = 2,2'-bis(diarylphosphino)-l,l'-binaphthyl]
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serve as excellent catalysts for enantioselective hydrogenation of p-substituted 
(E)-p-(acylamino)acrylic acids (Scheme 1.20).
H
MeOaC"JT H2 (1 atm), BINAPRu(n)Ac2 0.5% H CH 3COaMe 
e.e. = 98:2
Scheme 1.20: Enantioselective Hydrogenation of 3-Amino Acid Derivatives
Interestingly, the (Z) double bond isomers (which possess an intramolecular 
hydrogen bond between amide and ester groups) are more reactive but are 
hydrogenated with poor enantioselectivity with the opposite sense of
enantioinduction.^O
1.5.2.5 E. Stereoselective Alkylation of p-Amino Ester a-Enolates
N-Acyl-P-amino acid derivatives have been doubly deprotonated and then a- 
alkylated with moderate to excellent selectivity.^! Enantiomerically pure 3- 
aminobutanoic acid derivatives were prepared by Seebach and Estermann92 ma 
dilithiated methyl- or ethyl-N-benzoyl-3-aminobutanoates (Scheme 1 .2 1 ). The 
selectivity with which these reactions took place was usually very high, affording 
the enantiomerically pure product
XP h ^ N H  O
OR 2 LDA
(R)ot(S) R = Me,Et
OLI 
P h '^  NH
C(OLI)(OR)
H
OAPh NH O
Ê
Scheme 1.21: Synthesis of Enantiomerically Pure 3-Aminobutanoic Acid
D erivatives
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More recent work in this area by Cativela and coworkers^^ describe the 
diastereoselective alkylation of the enolate of isobornyl derivative (15). This 
alkylation takes place with very good yields and selectivity. The products were 
subsequently reduced to P-amino esters (16), which were then cyclised to p- 
lactams (Scheme 1.22).
CN l .LDA
(15)
(16)
Scheme 1,22: Stereoselective Alkylation of P-Amino Ester a-Enolates
1 .5 .2 .6  F. Self-Regeneration of Stereogenic Centres
Konopelski et al^^ developed a methodology in which the acétalisation of the 
potassium salt of (S)-asparagine formed pyrimidinone carboxylate (17) 
diastereoselectively. Carbomethoxy derivatisation of the secondary amine group 
followed by oxidative decarboxylation gave the unsaturated heterocycle (18). 
Although the original stereogenic centre is converted to a trigonal centre, the 
bulky ferf-butyl group on the acetal carbon induces the stereoselective formal 
conjugate addition of aryl iodides in the presence of catalytic amounts of 
Pd(OAc)2  to afford derivatives (19). Treatment of (19) with NaBH4 followed by 
hydrolysis gave the desired enantiomerically pure p-amino acid hydrochlorides 
(Scheme 1.23).
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Scheme 1.23: P-Amino Acids via Self-Regeneration of Stereogenic Centres
1.5.2.7 G. Enzymatic Methods
Recently, enantiomerically pure p-amino acids have been prepared by routes 
involving the enzymatic resolution of racemates.^^‘ 7^ por example, the fifty 
percent conversion of racemic N-phenylacetyl derivatives of P-amino acids with 
penicillin acylase allowed for the separation of the (S)-amino acid from the (R)- 
N-protected derivative (Scheme 1,24).97
R -C H -C H 2 CO2 H
R-& H-CH2C02H enzym e
■................ NH2  (&')
N -  COCH2Ph 
H \ R -C ^-C H 2C 02H--------------- ► N -  COCH2Ph
"  (/?)
Scheme 1.24: Enzymic Resolution of P-Amino Acid Racemates
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2.0 Glutamate Mutase
2.1 Introduction
The transformation catalysed by glutamate mutase is a uni-uni reaction. 
(2S)-Glutamic acid (1) and (2S,3S)-3-methylaspartic acid (2) are the only known 
substrates to date.
HO2C Hr Hs
Coenzyme Bj2 
Glutamate Mutase
/ > H r
HgC*
CO2 H
Inversion
CO2H
H2N' f  "'C0 2 H 
H
Scheme 2.1: The Glutamate Mutase Reaction
The high selectivity of the enzyme for these two co m p o u n d s,sev ere ly  
restricts the physico-chemical methods that can be used in order to delineate 
details for the rearrangement. The discovery of appropriate molecular probes, 
substrates or inhibitors, which might interact with the enzyme and provide 
information about the mechanism and the radical chemistry involved, is 
therefore of highest priority.
No information is currently available on the three dimensional structure of 
glutamate mutase, and at present, there is no information known about the 
overall shape of the active site. Nevertheless, some data has recently been 
collected, and can be used to address three main issues. First, is the design of 
novel structures to probe the mechanism of the rearrangement in relation with 
the shape of the active site. A second issue, is highlighting the role of the
Chapter 2 : Results & Discussion: Glutamate Mutase 45
different functional groups on the natural substrates. Another important area 
which we have considered, is to look at a new class of transition-state analogues 
(Fig. 2.4), which can be used to gain valuable information about the active site of 
the enzyme. Finally, the various mechanistic aspects of the rearrangement step 
can be evaluated and a satisfactory working hypothesis can be proposed.
The structures initially identified as possible mechanistic probes were (+)- 
cis/frflws-2,3-methanoaspartic acid (2 1 , 2 2 ), (2 S,3 S)-[3 '-CH2C7H3]-3 -ethylaspartic 
acid (23), (2 S,3 S)-[3 '-C2H2C2H3]-3 -ethylaspartic acid (24), 1-substituted cyclopro­
pane 1,2-dioic acids (25) and (3S)-methylsuccinic acid (26). Our efforts towards 
these synthetic targets are discussed later in this chapter.
.CO2H Hi CO2H
H2N" " CO2H 
(+.-)-(21)
(Cw)-23-Methanoaspartic acid
H0 2C  ^ NH2 
(+.-)-(22) 
(7>a«j)-23-Methanoaspartic acid
H2N HCH2CH3
HO2C CO2H 
(23)
(2S3 5 )-[3'-C%3]-3-Ethylaspartic acid (253S')-[3'-C^H2C%3]-3-Ethylaspartic acid
HO2C CO2H 
(24)
Hi .CO2H
CH3
HO2C CO2H 
(26)
X = CH3 and Br
(±)-l-Substituted cyclopropane 1,2-dioic acid (25)-3-Methylsuccinic acid
H02C^
(+ ,-)-(25)
Figure 2.1: Mechanistic Probes for the Enzyme Glutamate Mutase
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2.2 General Synthesis of 3-Alkyl Aspartic acids
It has been demonstrated in our laboratories,^^ that 3-alkyIfumaric acids (30) 
undergo enzymic amination in the presence of P-methylaspartase, to give the 
corresponding 3-alkylaspartic acids (31, Scheme 2.2). The general preparation of 
3-alkylfumaric acids (30) is shown in scheme 2.3, where ethyl acetoacetate is 
treated with anhydrous sodium ethoxide, generating a stabilised anion, which 
undergoes a nucleophilic attack on the appropriate alkyl halide, giving rise to the 
formation of the corresponding alkylated ester (28). The alkylated ester is treated 
with bromine (2 equivalents), forming the dibromoketoester (29). The dibromo- 
ketoester (29) then undergoes the Favorskii rearrangement (Scheme 2.3) to give 
the desired fumaric acid (30),
HgC
O O
(27)
H
HOaC COgH (31)
i. NaOEt
ii. R-Br
^  Methylaspartase 
Mg \^K+
O O
H3CV'H R OEt(28)
üi. Bf2
iv. KOH, EtOH
H CO2H
HO2C R (30)
R = -C%2C^3, -CH2(?H3, -CH2CH2CH3and -CH(CH3)b 1
Scheme 2.2: General Synthesis of 3-Alkylaspartic Acids
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O O
OEt -------► OEt
R H 
(28)
H R B r
/  \Br R
O
H
HO2C R Base Hydrolysis
(30)
OH O 
OEt OEt
Scheme 2,3: The Favorskii Rearrangement
Improved yields of the alkylated esters (28) were obtained by increasing the 
amount of alkyl halide (1.5 equivalents), used in the alkylation step. The 
percentage yields obtained of the alkylated esters ranged between 65 - 76%. The 
alkylated esters were then transformed into the desired fumaric acids as described 
in scheme 2 .2 , and the table below shows the isolated yields obtained.
Compound 30 (R = ) % Yield Mpt °C
-CH2CH3 45 195 -197
-C2H2C2H3 50 195 -197
-CH2C2H3 50 190 -192
-CH2CH2CH3 45 172 -173
-CH(CH3>2 48 180 -183
Table 2.1: Synthesised Fumaric Acids
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The next stage in the preparation of the 3-alkyl aspartic acids (31), involved 
the stereospecific enzymic conversion, of the appropriate fumarate, by p- 
methylaspartase, in the presence of Mg2+ and K+.
2 .2 .1  Synthesis of Labelled 3-Ethylaspartic Acids.
[ l , l , l - 2H 3 ]-Ethanol (33) was synthesised by the method of Friedman and 
Jurewicz, from the reduction of C2H3CO22H (32) by LiAlH4 in dry ether, in 8 8 % 
yield (Scheme 2.4).^ ® Since the product of this type of reduction was low boiling 
and water soluble, isolation procedures usually recommended^^ was generally 
unsatisfactory. The efficient procedure employed by Friedman and Jurewicz, is 
based on the use of high-boiling ether alcohols as product liberating reagents and 
isolation of product by distillation directly from the reaction mixture. The 
reduction was conducted in 2 -butoxyethanol, as this proved to be the most 
suitable alcohol.98
-, ^
0u LiAlH4 ^  
E th e r
(32) (33)
Scheme 2.4; Synthesis of Labelled d^-Ethanol
The preparative procedure, in the synthesis of the alkyl halides, was very 
simple; the alcohol was treated with triphenylphosphite methiodide (36, Scheme
2.5) (which need not be purified) and merely mixed in equivalent proportions; 
this is followed by reflux, and the product (alkyl halide) is worked up either by 
direct distillation or by washing out the phenol produced in the reaction, with 
alkali, followed by distillation.
Triphenylphosphite methiodide (36) was easily prepared, by treating the 
triarylphosphite (34) with iodomethane, and the mixture then heated under 
reflux for 36 hours, with the exclusion of moisture. The temperature was
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maintained between 110-115 °C, during the course of the reaction, as this effects 
the yield of the reaction. The quasi-phosphonium compound (36), was isolated 
as yellowish-brown needles, and the yield of the reaction was excellent, ranging 
between 90-95%; mpt 145-146 (lit.,^00 14 5  oQ.
PhOVjjxOPh CH3P h O ^ / +
PhO PhO(34) (35) (36)
Triphenyl phoshite Iodomethane Triphenyphosphitemethiodide
Scheme 2.5: Synthesis of Triphenylphosphite Methiodide
The synthesis of the alkyl halides employs the Arbuzov reaction, as 
demonstrated by Landauer et The preparation of labelled iodoethane (37) 
was performed using the above procedure (Scheme 2 .6 ), employing labelled 
ethanol (33), and treating it with the methiodide (36), after isolation, the yield of 
the labelled iodoethane (37), ranged between 65-70%.
CHgPhO,
PhoCPP^
(36)
H3CH2C-O ..' + " 
PhO 'O Ph
4. PhOH
(33)
PhO(37)
Scheme 2.6: Synthesis of Labelled Ethyl iodide
2 ,2 ,2 -% 3-Iodoethane (37) and commercially available perdeuteroiodoethane 
(38) were utilised in the synthesis of corresponding ethylfumaric acids (30,
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R=CH2C2H3  and R=C^H2C^H3 ) as shown in scheme 2.2. Following incubation of 
the labelled fumarates (30, R=CH2 C^H3  and R=C^H2 C^H3 ) with p- 
methylaspartase, the correspondingly labelled ethylaspartic acids, were isolated in 
55-59% yield, respectively.
H COaH 
HO2C R p-Methylaspartase HOgC COgH
3 -Alkyl F u m a r ic  a c id  (30) Y ie ld  (% ) Mpt °C
R= -CH3 67 272-276
R= -CH2CH3 59 244-245
R=-C2H2C2H3 59 256-258
R= -C H 2C 2H 3 55 255-256
R= -CH2CH2CH3 55 235-236
R=-CH(CH3)3 45 240-242
2.3 Synthesis of (±)-Cfs/Trflws-2,3-Methanoaspartic Acid.
Cyclic analogues of glutamic acid^^  ^e.g. c/s/frflws-2,3-methanoaspartic acid (2 1  
and 2 2 ), are molecules of considerable importance, due to their structural 
resemblance to a possible transition state for the rearrangement catalysed by 
glutamate mutase. A number of methods are available for the preparation of 
cyclopropanes bearing carboxyl substituents (See Chapter 2.7).^02,103
Recent approaches towards the synthesis of cyclopropane 1,2-dicaboxylates 
include the dipolar addition of diazo compounds (e.g. N 2CHC0 2 Et (40)) to 
dehydroalanine derivatives (39, Scheme 2 .7 ) . Both stereoisomers of 
compound (41) were prepared (the E isomer predominating). Although both 
carboxyl groups could be deprotected to give the free diacid uneventfully, no
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cyclopropane was isolated when the amino group was l i b e r a t e d . ^01 This is in 
accordance with earlier reports that 2 -aminocyclopropanecarboxylic acids or esters 
undergo rearrangement with release of ring strain to form the corresponding 
imino compounds, which hydrolyse during work up .^02
NHCOgR NaCHCX32R"(y)) / ^ C O a R '
COaR' "ROaC NHCOaR
(39) (41)
,COa'
OaC NHCOaR
(21,22)
Scheme 2.7: Cyclopropanation via Dipolar Addition of Diazo Compounds
Contrary to the above report, one such synthesis of the desired amino acid ( 4 1 )  
was published by Kraus et W.104 in 1990 (Scheme 2.8). The authors of this work 
describe the preparation of the desired amino acids (2 1  and 2 2 ) via the bromo 
diester ( 4 2 ) ,  which was readily synthesised in gramme quantities from glutaric 
a c i d . 104 The authors of this work report that dehydrobromination of ( 4 2 ) ,  
produced the amino diesters ( 4 4 )  and ( 4 5 )  in 35-55% yield, presumably via the 
reactive cyclopropene diester ( 4 3 ) .
Br,
Me0 2 C KHMDSC0 2 Me
(42)
AMe0 2C C0 2 Me HgNNH3 Me0 2 C XY
(43) (44) X =C 02M e, Y=H
(45) X=H, Y =C 02M e
Scheme 2.8: Reported Synthesis of 2,3-Methanoaspartic Acid
The authors of this work suggest that the reaction proceeds via the 
regioselective addition of ammonia to the double bond of the cyclopropene 
diester ( 4 3 ) ,  furnished during the course of the reaction. The structures identified 
as the desired amino diesters were assigned after comparison of their NMR
spectra to that of dimethyl l-*butoxy-ds-cyclopropane-l,2-dicarboxylate.i05 The
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amino diesters (44 and 45) were hydrolysed, to afford the amino acids (21 and 22), 
which were then separated from one another, by preparative HPLC (gradient 
elution using TFA in acetonitile). Despite the low yields obtained, the synthetic 
method to the desired compounds (2 1  and 2 2 ) seemed to be short and reliable.
Our efforts to reproduce the Kraus synthesis, gave, apparently, the required 
compounds in similar low yields to that Kraus had reported. The crude reaction 
mixture was purified using column chromatography on silica (3:1 hexaneiethyl 
acetate) and the desired compounds isolated (compound (44); t.l.c (3:1 
hexane:ethyl acetate), Rf = 0.42, litl04 = 0.42) and (compound (45); t.l.c (3:1 
hexane:ethyl acetate), Rf = 0.44, lit^ l^  ^Rf = 0.44).
On examination of the 1R- and l^C- NMR spectra, together with mass 
fragmentation and accurate mass spectrometric analysis, infra-red analysis and 
elemental analysis, it became apparent that compounds (44) and (45) were 
actually the cis- and trans- isomers of dimethyl-l-methoxycyclopropane-1 ,2 - 
dicarboxylate (46 and 47). We were able to verify that Kraus had incorrectly 
identified his isolated compounds, by careful examination of his data, reproduced 
here in Table 2.3, and discussed below.
The reported NMR data obtained in deuterochloroform, is essentially identical to 
our own data and all of the signals assigned to the amino compound (44) match 
those obtained in our laboratories for the methoxy compound (46). The NMR 
spectra were performed in deuterated chloroform for both cases. In addition to 
the NMR data, the mass spectral data provided by Kraus was found to be 
incorrectly assigned. The authors obtained an accurate mass measurement for 
compound (44), which they identify as the parent ion peak. However, on re­
examination we found this mass ion to be a fragmentation of the methoxy- 
compound (46), (i.e. C7H9O5, which corresponds to the methoxy compound (46), 
in the absence of a CH3+ fragment).
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HaSoaC
(Cij)-Dimethyl 1-aminocylopiopane 
1,2-dicarboxylate
Xx
HaSoaC
(Cw)-Dimethyl 1 -methoxycylopropane 
1,2-dicarboxylate
N M R -data /(C^HClj) Atom Label NMR - data /(C^HCls)
1.53 (dd, /  = 5.7,10.2 Hz, IH) 1 1.53 (dd, J = 5.8,10.2 Hz, IH)
1.88 (dd, /  = 5.7,10.2 Hz, IH) 2 1.88 (dd, /  = 5.8,10.2 Hz, IH)
2.28 (dd, /  = 8.1,10.2 Hz, IH) 3 2.28 (dd, /  = 8.1,10.2 Hz, IH)
3.46 (s, 2H) 4 3.46 (s, 3H)
3.69,3.76 (2xs, 2x3H) 5,6 3.69,3.76 (2xs, 2x3H)
No 13c Data Published 2 0 .1  (C-3), 30.2 (C-2 ), 53.3 & 53.4 (2x 
CO2CH3 ), 58.2 (OCH3 ), 66.4 (C-1) and 
168.3 & 170.1 (2x CO2CH3)
MASS SPEC-DATA MASS SPEC.-DATA
MS - m /z MS - m /z
45,55,69,75,85,101,113,129,156,173 85,101,113,129,156,173
Accurate Mass Measurement Accurate Mass Measurement
tn/z for C7H11NO4 m/z (Cl) for CsHisOs
calculated 173.0688, found 173.0452 calculated 189.0759, found 189.0763
Mass ion found should be : tn/z for C7H9O5 : calculated 173.0447 found 173.0452
Table 2.3: A Comparison of the Spectral and Analytical Data for (44) and (45)
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Br,
MeOgC: KHMDSC O gM e
(42)
(47) X =C02M e, Y=H 
(46) X=H, Y =C02M e
Me0 2C C0 2 Me 
(43)
NH3-5 ^
HaN
Me0 2 C
X
H2NCX“W xin n
(45) X zCOzM e, Y=H 
(44) X=H, YzzCOzMe
M eQ
Me0 2 C
Y (47a) X =C 0N H 2, Y=H 
(46a) X =H, Y =C0N H 2
Scheme 2,9: Unsuccessful Synthesis of Dimethyl 2,3-Methanoaspartate
Since only moderate quantities of product (46 and 47) could be isolated (55- 
63%), we concluded that the formation of cis/trans-methoxycyclopropane (46 and 
47, Scheme 2.9) was due to the loss of methanol from the ester groups contained 
within the bromocyclopropane (42). We suspect the side products to be the bis- 
amides (46a, 47a). The liberated methoxide anion, effects the elimination of HBr, 
to give the cyclopropene intermediate (43). Methoxide adds to the cyclopropene, 
giving the observed products (46 and 47, Scheme 2.9). In keeping with the results 
of Kraus, we found that by treating dimethyl cis-1 -bromo-cyclopropane-1,2-dioate 
(48) with KHMDS, in the presence of anhydrous methanol, that the sole product 
isolated, was the cis isomer of dimethyl 1-methoxycyclopropane 1,2-dioate (46) 
(Scheme 2.10).
Br,
Me0 2 C KHMDS
(48)
C0 2 Me
AMe0 2 C C0 2 Me 
(43)
M eO
MeOH
Scheme 2.10: Synthesis of Dimethyl 1-Methoxycyclopropane 1,2-Dicarboxylate
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In our attempt to synthesise the desired cyclopropane amino acids (21 and 22), 
we sought a different synthetic route. One such approach, was to synthesise 
dimethyl 1-nitrocyclopropane 1,2-dioate (53), which would then be reduced 
under mild conditions, to give the corresponding aminocyclopropane (54, 
Scheme 2.11).
The synthesis towards the nitrocyclopropane (53), was expected to proceed via 
a 1,4-conjugate addition of commercially available, methyl nitroacetate (50) to 
methyl a-bromoacrylate (51), under mild basic conditions (Scheme 2.11).
(50)
.oase
U
MeO
(51)
hfeN C02Me O2N C02Me
OgN
MeO ^O
proton transfer 
O
OMe
Scheme 2,11: Proposed Synthetic Approach to Dimethyl 2,3-Methanoaspartate
Potassium carbonate was employed as the base for initial abstraction of the 
acidic proton within methyl nitroacetate (50). The nitroacetate conjugate 
addition was expected to result in the rapid protonation of the intermediate 
enolate anion, (pKg ^20) by a proton transfer, via the a-nitroacetate function 
(pKg "~5 .8),^06 giving rise to the more thermodynamically stable nitronate anion
(52). The resulting anion would then undergo an electrocyclic ring closure, with 
concomitant loss of the bromide anion, to furnish the cyclopropane derivative
(53).
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The synthesis of methyl a-bromoacrylate (51) was achieved in quantitative 
yield, via bromination of the methyl acrylate (5 5), follow ed by 
dehydrobromination of the dibromo- compound, (56a, Scheme 2.12).
Scheme 2.12: Synthesis of 2-Halogenoacrylate Esters
Attempts to follow the designed route (Scheme 2.11) for obtaining the 
nitrocyclopropane (53), led to the formation of a white crystalline solid (57). On 
examination of the ^H- and NMR, it was not fully conclusive as to whether 
or not, we had obtained our target compound (53). On comparison of and 
l^C- NMR with other 1-substituted cyclopropane 1,2-dioates, we noticed that the 
proton and carbon NMR shifts were too high {ÔH (200 MHz; C^HClg) 3.70 (2H, m, 
CHg), 3.88 (6H, s, 2x CO2CH3) and 5.15 (IH, dd, CH); ÔC (50.31 MHz; C^HClg), 34.7 
(CH2), 53.3 & 53.7 (2 x CO2CH3), 71.6 (CH), 106.1 (NO2CCH2-), 159.3 (CH2-CO), 159.3 
(CH2-CO) and 169.4 (CH-CO)}. On the other hand, elemental, mass fragmentation 
and accurate mass measurement analysis, displayed the correct elemental 
composition to the target compound (53). Since the isolated compound (57) was 
a solid and readily crystallised, the structural identity was determined by X-ray 
crystallography. The result of such studies revealed that compound (57) was the 
isoxazoline-N-oxide (Fig. 2.2).
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02
0 4 C5
N il01 C l
C4
C30 5
0 3
6  C2C6
0 6
Cl
Figure 2.2; X-Ray Crystal Structure of the Synthesised IsoxazoUne-N-Oxide
This result meant that an electrocyclic ring closure must operate via the 
stabilised nitro group, at C-4, with concomitant loss of the bromide anion and 
thus furnishing the isoxazoline-N-oxide (57, Scheme 2.13)
O M e ?
N
M eO O  p ro to n  
a b s tra c tio n
O 
MeO
Br O M e M eO
O
O M e
3,5 -N 5 ~ (c a rb o m e th o x y )-  
i s o x a z o l in e -N -o x id e  (57)
Scheme 2,13: Formation of the Isoxazoline-N-Oxide
2.3.1 Modification of Kraus Synthesis.
Having followed the work carried out by Kraus et we were confident
that the isolated products (46 and 47) were due to the addition of a methanol to 
the intermediate cyclopropene (Scheme 2.10) and not due to the proposed attack 
by ammonia (Scheme 2.9). In order to confirm our findings, we opted to expose 
the intermediate cyclopropene (43) to different nucleophiles. Since we had not
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obtained the desired cyclopropane amino acids (21  and 2 2 ), when we treated the 
cyclopropene (43), with ammonia, it was our goal to try different nitrogen 
containing nucleophiles. We opted to attack the cyclopropene intermediate (43), 
with a nitrogen nucleophile, which had a similar pKa to that of methanol (15.2). 
One such nitrogen containing compound would be a carbamate, which has a pKa 
of -17. ^Butylcarbamate, was considered to be the ideal molecule to try with the 
cyclopropene intermediate (43), as the resultant cyclopropane would be the 
protected amino ester (58, Scheme 2.14).
MeOpC C0 2 Me
AMeOgC COaMe
(43)
u. MeOaC
NH
COaMe
(58)
Reagents and Conditions’, i. KHMDS, THF, -78'C, 10 min.; ii. ^Butylcarbamate, THF, -78°C, 2 h , 65%.
Scheme 2,14: Synthesis of the Protected Cyclopropane Amino Acid
The protected cyclopropane amino acid (58), was obtained in 65% yield as a 
white crystalline solid after column chromatography (10% ethyl acetate: 90% 
hexane, Rf = 0.2), (m/z (Found: [M + H]+, 274.1285. C12H 19NO6 Calc, for 274.1290). 
As expected on the basis of the previous experiment (Scheme 2.10) where the 
isolated product was the cis-regioisomer of the 1-methoxycyclopropane (46), we 
assigned compound (58) as the cis-regioisomer. However, in order to confirm 
our findings, NMR and X-ray crystallographic studies need to be performed.
Attempted removal of the %utoxycarbonyl group (^BOC) (TFA, O °C to 25 °C) 
in compound (58), led to the destruction of the cyclopropane ring (59), 
presumably induced by amine assisted ring opening via the p-carboxylate 
(Scheme 2.15 A). A similar ring opening reaction was reported for compound 
(60, Scheme 2.15 B).l07
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ring opened products
(A)OMe(59)
HN,
OR
(60) OR
Scheme 2.15: Ring Opening Reactions of 1-Aminocyclopropane Dicarboxylates
In addition, a similar report was published by Burgess et alA^  ^ (Scheme 2.16), 
where the isolated materials were the ring opened products as shown in scheme 
2.15.
t'BuOaC.^  mhbog<COOH
Boc-Z-cyclo-Asp-Ot-Bu
TFA
—X —
HOOC.<NH,COOH 
Z-cyclo-Asp
Scheme 2.16: Burgess's Attempted Synthesis of Z-Cyclo~Aspartic acid
Considering the importance of cyclopropanes with glutamate mutase, we 
have successfully synthesised a variety of 1-substituted cyclopropane dioic acids 
(25) and at present we are testing these compounds for biological activity against 
glutamate mutase. The synthesis of these molecules will be discussed in Chapter 
2.7.
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2.4 Synthesis of (2 S)-Methylsuccinic Acid
(2S)-Methylsuccinic acid (62) is an analogue of (2S,3S)-3-methylaspartic acid 
(2). This molecule is thought to be important in determining the active site 
geometry of glutamate mutase. Our aim was to determine whether one of the 
protons at C-3 of (2 S)-methyIsuccinic acid (62), would interact with the amino 
pocket within the active site of glutamate mutase, and if so, would there be any 
radicals generated after interaction with the cobalamin.
Our efforts towards obtaining the optically active compound (62, Scheme 
2.17), involved the diazotization of (2S,3S)-3-methylaspartic acid (2 ) in the 
presence of bromide ion, thus yielding (2S,3S)-2-bromo^3rmethylsuccinic acid 
(61). Catalytic hydrogenation of the bromo- compound (61) furnished the desired 
compound as a white solid, in excellent yield (81%), {[aJo -13.7 (c 1.15, EtOH)} and 
m.p 113-114 °C (lit.,:09 {[a]o -13.5 (c 1.15, EtOH)} and m.p 113-114.5 °C).
H2N H Br H H H
CH3  h ^  CH3-------ÎL— ^  CH3
HO2C CO2H HO2C CO2H HO2C CO2H
(2) (61) (62)
Reagents and Conditions: i. NaN0 2 , HBr» KBr, H2O 0-25'C, 2 h.» 75-80%; ii. H2, Pd/C, 
MeOH/AcOH 25*C, 6h, 80%.
Scheme 2.17: Synthesis of (IS)-Methylsuccinic Acid
We found that the method we employed, was very reliable and efficient 
towards obtaining enantiomerically pure (2S)-methylsuccinic acid (62). Other 
literature synthesis, involve the conversion of (-)-3-methylcyclopentanone (63) to 
(2 S)-methylsuccinic acid (62) via the ozonolysis of the (-)-dibenzylidene 
derivative (64, Scheme ).^^0
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.-CHg
► /  \"CH3
HOgC H
Scheme 2.18: Literature Synthesis of (2S)-Methylsuccinic Acid
More recent methods in obtaining enantiomerically pure (2S)-methylsuccinic 
acid (62), involve the resolution of the racemic acid (65), by means of solid salt 
formation with an optically active amine, such as (R)-(-)-2 -am ino-l-benzyl- 
oxybutane (6 6 , Scheme 2.19).^09
HgC^^COgH El
CO2H OCHzPh
H CO2H
4^ /  \  CHgHO2C H
(±)-65 (-)-66
)
(±)-62
Scheme 2.19: Optical Resolution of (±)-a-Methylsuccinic Acid
2.5 Mechanistic Studies
2.5.1 (2S,3S)-3-Methylaspartate Analogues as Inhibitors or Substrates
(2 S,3S)-Methylaspartic acid (2), N-methyl-(2S,3S)-methylaspartic acid (67)^3, 
(2 S)-methylsuccinic acid (62), and aspartic acid (6 8 ) were tested with glutamate 
mutase by Dr. B. Hartzoulakis, as potential inhibitors of the enzyme.^^^'^^2 xhe 
findings of this work reveal that there was no interaction between them, and the 
active holoenzyme. The above analogues of methylaspartic acid were also 
incubated with the enzyme, but no rearrangement products were detected.
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(2S,3S)-2-Bromo-3-methylsuccinic acid (61) was another potentially promising 
molecule, but was found to react with the 2 -mercaptoethanol present in the 
incubation and assay mixtures.^^^
2.5.2 (2S,3S)-3-Ethylaspartic Acid as a Plausible Substrate and/or Inhibitor.
In order to gain further insights into defining the stereochemical course of the 
glutamate mutase reaction, with respect to the reaction at C-3 of glutamic acid, 
was a long standing objective of our research. As discussed earlier (Chapter 1.3.4), 
the stereochemical course of the rearrangement at C-3 cannot be easily defined 
due to the torsiosymmetry of the methyl group formed on 3-methylaspartic acid 
(2).
Barker had reported that 3-ethylaspartic acid (31, R= CH2CH3 ) was not a 
substrate for glutamate mutase. His conclusions were solely based on a 
chromatographic comparison (by t.l.c.) with the starting material. As a 
consequence, there was the possibility that if ethylaspartic acid (31, R= CH2CH3) 
was a slow binding substrate, as compared to 3-methylaspartic acid (2), the 
product may not have been detected. In addition. Barker used impure enzyme 
for his investigations, which would hinder any conclusions made about substrate 
specificity.
Our aim was to re-investigate the possibility of ethylaspartic acid (31, R= 
CH 2CH3 ) serving as a useful substrate analogue, which would preserve the 
stereochemical information introduced by the enzyme, if rearrangement were to 
take place. This can be investigated by replacing one of the three protons of 
methylaspartic acid (2 ) with a methyl group and a second proton, with 
deuterium, thus forming the specifically labelled 3-ethylaspartic acid (31, R= 
C2H 2CH3 , Scheme 2.20). We were initially confident that the presence of an 
additional methyl group on the substrate apart from reducing the rate of the 
reaction, would not interfere with the fundamental aspects of the rearrangement. 
Furthermore, the methyl group is in a suitable position which would allow it to
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lock* the methylene group of the 3-ethylaspartic acid (31, R= C2H2CH3) in such 
an orientation that only one of the two prochiral protons present would be 
removed. The identity of the proton removed and the stereochemistry at the C-3 
the (2S,3R or 2S,3S)-3-methylglutamic acid product ((69 or 70), Scheme 2.20), 
would be sufficient to establish if the rearrangement proceeds via an inversion or 
retention of configuration.
( 1)
CH3
HO2C
(69) or (70)
HgN H HO2C CH3
H'}-----------------   ) = {
HO2C CO2H H CO2H
(2) (3)
H2N H
H0 2C C0 2 H
(31)
fH )
HO2C CHCH3
H CO2H
(30)
Scheme 2,20: Enzymic Route Defining the Stereochemical Course of Reaction.
2.5.3 Incubation Studies of 3-Ethylaspartic acid with Glutamate Mutase.
Incubation of 3-ethylaspartic acid (31, CH2CH3) with the mutase was carried 
out in our laboratories by Dr. B. Hartzoulakis. His findings revealed that there 
was no formation of 3-methylglutamic acid (69 or 70) as judged by ^H-NMR 
spectroscopic analysis of the incubation solutions.
It was clear at this stage of our research, that 3-ethylaspartic acid (31, CH2CH3) 
was not a substrate for glutamate mutase and the satisfactory mechanistic 
explanation was simply that the ethyl- group was too big for the active site. The 
relevant information we sought, was whether or not the holoenzyme in the
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presence of 3-ethylaspartic acid, activated the coenzyme and as a result, does this 
give rise to the generation of the 5'-adenosyl radical. If the 5'-adenosyl radical is 
formed, then a proton would almost certainly be abstracted from a molecule of 3 - 
ethylaspartic acid, which would be occupying the active site. In short, the lack of 
rearrangement products was not conclusive as far as it concerned any hydrogen 
exchange between ethylaspartic acid and the coenzyme.
In order to investigate this possibility, our strategy was to synthesise a variety 
of deuterated ethylaspartates: (2 S,3 S)-[l’-C2H2]-3 -ethylaspartic acid (Fig. 2.3, (72)), 
(this compound was prepared by S. Gulzar)^^ ,^ (2 S,3 S)-[2 '-C^H3]-3 -ethylaspartic 
acid (Fig. 2.3, (73)) and (2 S,3 S)-[3 -C2H2C2H3]-3 -ethylaspartic acid (Fig. 2.3, (74)). 
These molecules, where incubated with unlabelled 3-ethylaspartic acid or (25)- 
glutamic acid in several different molar ratios. (2 S,3 S)-3 -[3 '-2H3]-3 -Methylaspartic 
acid (71) (this compound was prepared by B. Hartzoulakis),^^2 ^^s also incubated 
with the enzyme in the presence of unlabelled 3-ethylaspartic acid. A 
combination of spectral techniques, such as ^H- and 2H-NMR spectroscopy, was 
employed so as to detect any exchange of d e u t e r i u m . ^ ^ 2
C^ HoC^ Hg
CHgC^ Hg C^ HgCHg
Figure 2.3; Deuterated 3-Ethyl Aspartic Acids Employed
A  mixture of [3-2H3]-3 -methylaspartic acid (71) and unlabelled ethylaspartic 
acid (31, R= CH2CH 3 ), was incubated with pure glutamate mutase, under 
standard conditions. After an incubation period, P-methylaspartase was added.
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the alkyl aspartic acids present were transformed into the alkyl fumarates (30a), 
(30 b), followed by an ether extraction. If any deuterium label had been 
transformed from [ 3 3]-methylaspartic acid into ethylaspartic acid (31, R= 
CH2CH3, Scheme 2.21) it would have been easily detected by means of ^H-NMR 
spectroscopy, since now all three sets of protons present in the product mixture 
were different. Complete lack of deuterium exchange confirmed that the 
holoenzyme could not abstract hydrogens from either 3'- or the 4'-position of 3- 
ethylaspartic acid (31, R= CH2CH3).
H2N v ^ ^ X ^ C 0 2 H
GLUTAMATE
MUTASE
HgN
H-;H0 2C
H
- } --------------------------------- ( 7 1 )
•C^ Hg 
CO2H
HgN H^ \ _ ^ . . ‘CH2CHg
HO2C CO2H
Possible
Label
Exchange
( 3 1 )I
Easily 
identifiable 
sets of 
protons by 
NMR
spectroscopy.
HO2C H
Hg(^ H)CH2(^ H)C CO2H (30a)
HOga My = /
Hg{2H)CH2(2H)G CO2H (3®b)
Scheme 2.21: Label Exchange experiments with glutamate mutase.
Enzymic incubations of the labelled compounds mentioned have revealed no 
sign of protium/deuterium scrambling. This result concluded that (2S,3S)-3- 
ethylaspartic acid does not generate a radical within the active site of glutamate 
mutase and more likely, serves as an inhibitor.
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2.5.4 Cyclopropanes as Molecular Probes for Glutamate Mutase
trflns-2,3-Methanoaspartic acid (22), is a molecule of importance, for probing 
the mechanism of glutamate mutase. The cyclopropane amino acid (22) was 
envisaged to be a possible transition state analogue, for the rearrangement 
catalysed by glutamate mutase (Scheme 2.22).
(25)-Glutamic acid (1) (2S,3*S)-3-Methylaspartic acid (2)
Scheme 2.22: Glutamate Mutase Rearrangement via a Cyclopropane
Our attempts to synthesise compound (2 2 ) were unsuccessful, however, we 
gained valuable information about the stability of this molecule. We have 
synthesised a variety of cyclopropane dioic acids (25, Chapter 2.7) where the 
substituent group in the C-1, position has been varied, according to the size of an 
N H 3 + ion. It is conceivable that one of these molecules can be accommodated 
within the active site structure of glutamate mutase, and perhaps these 
molecules could behave as possible substrates and or inhibitors of the enzyme. 
This is the basis of future work within this research area.
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2.5.5 The Mechanism of the Rearrangement
Two main reaction mechanisms have been proposed for the glutamate 
mutase rearrangement (Scheme 2.23).
Merkekelbach and co-workers^^^ suggested that the glutamate mutase 
rearrangement may proceed via an enolate cyclopropane anion (75) such as the 
control of stereochemistry of methylaspartate (C-3) by electronic rather than steric 
factors. Although it has been established that enzymes can generate enolates,^^^ 
it is very difficult to anticipate a link between the generation of the 5'-adenosyl 
radical and the abstraction of a proton to afford the anion (7 5 ). 2^,73
An alternative involves proton abstraction by the 5'-adenosyl radical, to form 
the radical species (76) on C-4 of glutamic acid (Scheme 2.23, B). The radical 
species (76) can break down into two plausible intermediates, namely the glycyl 
radical (77) and the acrylic acid (78). These two intermediates are likely to be 
bound strongly to the enzyme and thus, are not likely to vacate the active site. It 
is reasonable to suggest that recombination of the two (77 and 78) is likely to 
occur, giving rise to the formation of 3-methylaspartic acid (2, Scheme 2.23, B).
Glycyl radicals such as (77), are considered to be very stable due to a combined 
action of an electron withdrawing (CO2 ) and an electron-releasing group 
(NH 2).^ ®^'^ ^^  This well documented phenomenon is called the captodative effect 
and the pair of the amine and the carboxyl group is one of the best known 
stabilising pairs known.
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0 2 C (76)
(75)
O2C
Scheme 2.23: Plausible Intermediates/Transition States for the Rearrangement
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2.6 Methylaspartase Ammonia-Lyase (MAL)
2.6.1 Introduction
The synthetic utility, together with the proposed elimination mechanism of 
3 -methylaspartase, have been established by the extensive work carried out 
within our research group since 1986.^9,58-60 Recent work has allowed us to 
tackle the problem and gain further details about the structural requirements 
necessary for enzyme catalysis. Results obtained from kinetic, inhibition and 
primary sequence studies for methylaspartase, suggest the presence of a 
dehydroalanine residue within the enzymes active site and that such a residue 
would be important for enzyme c a t a l y s i s . ^ ^ , 6 4
As yet there is no X-ray crystallographic information available for any enzyme 
which operates via the intermediacy of a catalytic dehydroalanine residue. 
However, the enzyme in question, can be studied in the presence of potent 
reversible inhibitors. These molecules are likely to bind to the active site of an 
enzyme, in a manner similar to the substrate, but will remain unchanged. It is 
therefore envisaged, that such molecules can be used to co-crystallise the enzyme. 
By inspection of a three-dimensional model of the enzyme it is then possible to 
work out the active-site residues. Such compounds had not been described, and 
were therefore important to biological targets for MAL. Our aim was to design 1- 
substituted cyclopropane 1 ,2 -dicarboxylic acids to serve as potential transition 
state (TS) analogues (Fig. 2.4), of the MAL reaction (Scheme 2.24).
Chapter 2 : Results & Discussion: Methylaspartase Ammonia-Lyase 70
CL
Zx-z
X
LU X
CM
X - Z
‘w
N
CL
X
X —z
CD
X —Z
•52%
!
<N
I
Chapter 2 : Results & Discussion: Methylaspartase Ammonia-Lyase 71
The transition states for the formation (Scheme 2.24, Step 1) and the break 
down (Step 3) of the covalent substrate (82) or covalent product (83) complexes 
are difficult to mimic because a large part of the TS structure involves protein- 
protein interactions. Therefore, attention was focused on a TS analogue for the 
central substrate deamination step (Step 2). In the flanking catalytically active 
complexes (82) and (83) in Scheme 2.24, the enzyme should exist in a closed 
conformation with both metal ions bound and in broad terms, the ground states 
should differ only in the C-3 dehydroalanine N-substrate bond length or distance 
and the hybridisation state at C-3 of the substrate. Substituted frans-cyclopropane
1 ,2 -dicarboxylic acids (Figure 2.4) accurately mimic the expected TS structure for 
the substrate and it was hoped that such analogues might allow the 
simultaneous occupation of the cleft of the enzyme by ammonia.
Substituent
Ha
Substituent groups envisaged : 
NH2, Br, Cl, Me H and Et.
Figure 2.4: Substituted Cyclopropane Dicarboxylic Acids
A  variety of substituents were used as molecular probes for the enzyme active 
site. Our objective was to determine the size, electrostatic nature and 
hydrophobicity of the amino- binding pocket within the enzyme active site. This 
was done by introducing subtle variations in the substituent size. The partial
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charge and hydrophobicity of the substituent were also varied as can be seen in 
Table 2.4.
Substituent Group Vaan der Waals 
Radius / nM
Partial Charge Hydrophobicity
-H 0.1 0 Hydrophobic
-Br 0.195 Ô- H ydrophilic
-C l 0.18 Ô- H ydrophilic
-M e 0.21 0 Hydrophobic
0.2 4- H ydrophilic
-E t 0.36 0 Hydrophobic
Table 2.4; Van der Waals Radius of Cyclopropane Substituents
2.7 Synthesis of l-Substituted Cyclopropane 1,2-Dicarboxylic Acids
1 -Substituted cyclopropane-l,2-dicarboxylic acids (25) were thought to be 
molecules of considerable importance for MAL, as they closely resemble a 
possible transition state (TS), which may exist between the enzymic 
transformation of (2S,3S)-3-methylaspartic acid (2) to mesaconic acid (3). A 
variety of methods exist for the preparation of cyclopropane ring bearing carboxyl 
substituents (87 and 90). The S i m m o n s - S m i t h ^ ^ O  méthylation of olefins (8 6 , 
Scheme 2.25, A) and the use of halogenoacetates (89) together with the 
appropriate acrylate analogues (8 8 ), as developed by McCoy et and
McDonald and Reitz (Scheme 2.25, B),122 are the best known approaches.
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CuCI, CH;lg ^
R2 R4
(86)
Ri R3
+ /CHC0 2 R
R2 CO2R ^4
(88) (89)
X = Br, Cl
Ri
Ra ^  (A)
(87) R4
Ri R4
b 0 .R
(B)
Scheme 2.25: General Methods for the Preparation of Functionalised
Cyclopropane Rings
Our initial goal was to synthesise a variety of regioselectively pure (±) 1-sub- 
substituted cyclopropane 1,2-dicarboxylic acids (25). We considered attempting 
the preparation of these compounds via the Simmons-Smith r e a c t i o n , ^  2 0  
however, the low yields of similar cyclopropanes prepared by this m e t h o d ^  2 2  
discouraged us. On the other hand the alkali-metal hydride catalysed formation 
of 1-substituted cyclopropane 1,2-dicarboxylic esters (93 and 94) from 2- 
dihalogeno-ethanoate esters (91, Scheme 2.26) and acrylic ester (92) is well 
established and the cis-isomer (93, Scheme 2.26) is the predominant product, 
when the reaction is performed in a non-polar medial05,i23
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HgC
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Scheme 2.26: Regioselective Formation of l-Suhstituted Cyclopropane l,2~Dioates
The reaction is believed to proceed via the conjugate addition of the 
haloacetate (91) with the acrylate (92) and concomitant cyclisation giving rise to 
the formation of the cyclopropane compounds (93 and 94). The preference for 
the cis-isomer is believed to arise because the metal counter ion can chelate to 
both of the carboxylic ester groups of the initial conjugate addition product prior 
to the formation of the cyclopropane ring. Scheme 2.26. Since we required the 
trflnS”l,2”Cyclopropanedioic acids (96), to test as potential inhibitors and expected 
that frflnS'l,2-cyclopropanedioate esters (94), would predominate in the absence 
of the metal ion chelating effect, the ratio of the cis- to trans - products formed in 
different solvents was examined (Table 2.5). In toluene, the ratios of products 
[(93) to (94)] formed respectively from the reaction of methyl 2-chloropropanoate 
(91, X= Me, Y= Cl) and methyl 2-dichloroethanoate (91, X,Y= Cl) and methyl 2- 
dibromoethanoate (91, X,Y= Br) with methyl acrylate (92) was ca, 10:1. However, 
in DMF, the ratio increased in favour of the trans- isomer to 0.73:1, for the 1- 
bromo derivatives (93 and 94, X = Br) to 1:3 for the 1-chloro derivatives (93 and 
94, X = Cl) and to 1:5 for the 1-methyl derivatives (93 and 94, X = Me) in the best 
case Scheme 2.26. Isolated yields of the trans- isomer ranged from 42-65% (Table
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2.5). The dihalogenoethanoate, monohalogenoethanoate esters (91, Scheme 2.26) 
were synthesised from the corresponding, commercially available acids, via the 
acid catalysed estérification in the presence of methanol.
C^OgMe
A
H
(91)
COgMe .  H a C = /\  SolventH
(92)
X^^COgMe
XXHr COgMe M eO gC ^  
(+,-)-93 (+,-)-94
\
Substituent Group Solvent employed Cis : Trans % Yield
X = C H 3  
Y = C1
DMF
Toluene
1:5
10:1
61
74
X = Br 
Y = Br
DMF
Toluene
2:3
10:1
42
58
X = C1 
Y = C1
DMF
Toluene
1:3
10:1
51
70
X = CH2 CH3  
Y = Br
DMF
Toluene
1:5 65
Table 2.5: Observed Regioselectivity in 1-SubsHtuted Cyclopropane-1,2-Dioates
(±)-frflns-Diethyl cyclopropane-l,2-dioate (94, X= H), was not prepared under 
the above conditions, as this compound was commercially available.
2.7.1 Improved Synthesis of 1-Substituted Cyclopropane 1,2-Dioic Acids
In an attempt to enhance the regioselectivity, percentage yield and in a bid to 
lower the cost of the general reaction employed (Scheme 2.26), an alternative 
procedure was envisaged. The alternative method pursued, was based upon the 
general reaction, which had been developed by McCoy et fl/.i2i,i23 (Scheme 2.25, 
B).
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COgMe
H
(91)
X = ClorBr 
Y = ClorBr
COgMe
+ H2C=/
\  DMF
(97)
C^OgMe
"COgMe
Minor Isomer 
(+.-)-(93)
MeOgC^
.COgMe
H
Major Isomer 
(+,-)-(94)
Scheme 2.27: Improved Synthesis of Dimethyî-1-Suhstituted Cyclopropane-1,2-
Dioates
By placing the group which is retained in the cyclopropane product on the 2- 
position of the acrylate ester (97), such that the anion of a mono­
halogenoethanoate ester (91), serves as the nucleophile in the conjugate addition 
reaction, was expected to reduce the steric repulsion in the transition state 
compared to the situation in which the anion is derived from a dihalo­
genoethanoate ester (91, X,Y= halogen). Accordingly, the 2-halogenoacrylate 
esters (97, X= Cl or Br), were prepared and treated with 2-chloro- (91, Y= Cl) and 2- 
bromo- ethanoate methyl ester (91, Y= Cl), respectively in the presence of sodium 
or potassium hydride. Scheme 2.28. Under optimised conditions, reaction times 
were reduced to 6-12 h and the yields of the esters (93,94, X = H, R = Cl; and X = H, 
R = Br) were increased to 80 and 83% respectively, after column chromatography 
on silica (Table 2.26).
Substituent Group Solvent employed Cis : Trans % Yield
X = Br DMF 1:5 83
Y = Br
X = C1 DMF 1:5 80
Y = CI
Table 2.6: Improved Synthesis of 1-Substituted Cyclopropane 1,2-Dioates
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The required dioic acids (95, 96, X = H, Me, Et, Cl and Br) were obtained in 
excellent yield (90-95%) through acid catalysed hydrolysis (Scheme 2.28), and each 
compound and synthetic intermediate, displayed the expected spectral and 
analytical properties (Table 2.7).
C y c lo p r o p a n e MpUC L it  
Mpt X
N M R  D a t a ( l H , l 3 c )
4  (..) 140 140-141
:H: 1.80 dd Ha, 2.02 dd Hp, 2.60 dd 2-H.
13C: 23.48 (C-3), 31.62 (C-2), 32.41 (C-1), 171.86,173.67 (2xC02H).
B, <»«
174-175 175
1.73 dd Ha, 1.94 dd Hp, 2.61 dd 2-H.
:3C: 25.68 (C-3), 32.21 (C-2), 37.4 (C-1), 171.8,174.9 (TxCOgH).
a  co=H
178-180 —
1.85 dd Ha, 2.05 dd Hp, 2.80 dd 2-H.
20.57 (C-3), 28.69 (C-2), 41.12 (C-1), 169.48,170.2 (2xC02H).
120-122 —
1.81 dd Ha, 2.25 dd Hp, 2.58 dd 2-H.
13C: 25.1 (C-3), 35.4 (C-2), 46.08 (C-1), 173.48,174.73 (2xCC>2H).
q  ) 139-140 139-141
iH: 1.21 dd Ha, 1.34 s CHg, 1.63 dd HP, 1.98 dd 2-H.
:3C: 17.8 (CH3), 17.89 (C-3), 26.88 (C-2), 27.62 (C-1), 173.17, 174.68 
(2XCO2H).
168-170 170
:H: 1.25 dd Ha, 1.38 s CH3, 1.70 dd Hp, 2.28 dd 2-H.
13.9 (CH3), 21.8 (C-3), 27.8 (C-2), 29.1 (C-1), 174.18, 177.53 
(2xCO%H).
H Æ H ,C * y  COzH
158-160 —
:H: 0.911 (CH3CH2), 1.26 dd Ha, 1.46 dd HP, 1.75-1.9 m (CH3CH2), 
2.31 dd 2-H.
13C: 12.5 (CH3CH2), 21.3 (C-3), 22,1 CH3CH2), 28.3 (C-2), 34.2 (C- 
1), 174.5,176.6. (2XCO2H)
H^OOÜ
hoæ’^ h
176-177 177
H^: 2.85 dd 3-H, 3.53 m 1-H + 2-H.
13C: 18.7 (C-3), 25.9 (C-1 + C-2), 178.3 (2XCO2H).
Table 2.7: Analytical Data for 1-Substituted Cyclopropane 1,2-Dioic Acids
Synthesised
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(±)-frfl«s-2,3-Methanoaspartic acids (22), is a molecule of considerable 
importance, due to its structural resemblance to a possible transition state, which 
may exist between step 1 and step 2 (Scheme 2.24). However, as discussed earlier 
within this chapter (Glutamate Mutase, p.51), this molecule was found to be 
unstable and as a consequence, we were unable to perform any kinetic studies on 
this compound.
2.8 Optical Resolution of 1-Substituted Cyclopropane 1,2-Dioic Acids.
The racemic cyclopropane compounds synthesised (93, (X= Me) and 94, (X= H, 
Me, Et, Cl and Br)), were initially tested for biological activity against MAL (Table
2.9). We observed that the enzyme was inhibited by these compounds and that 
there was a significant degree of inhibition dependant on the substituent group 
(Table 2.9), placed on the cyclopropane dioic acid. In an attempt to probe the 
geometry of the active site and to identify the stereochemistry of the most active 
inhibitors, we sought to resolve the racemic cyclopropane dioic acids (94., (X= Me 
and Br)
1-Substituted cyclopropane 1,2-dicarboxylic acids, (Fig. 2.4), contain two 
stereogenic centres and it is possible to obtain up to four different enantiomers. 
The number of stereoisomers is of course dependant on the substituent group on 
the cyclopropane dioic acid. There are the (±)- forms of the regioselectively pure 
cis isomers and concomitantly, there are (±)- forms of the regioselectively pure 
trans isomers (Fig. 2.5).
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The (±) forms of 1-substituted cis cyclopropane 1,2-dioic acids
The (±) forms of 1-substituted trans cyclopropane 1,2-dioic acids
Figure 2.5: Different Stereochemistries of l-Substituted Cyclopropane 1,2-Dioic
Acids
There are reported procedures for the enzymic resolution of meso-dimethyl 
cyclopropane-, cyclobutane and cyclopentane dicarboxylates. 2^4,125 These 
procedures are reliable for 1-alkyl substituted cyclopropane dicarboxylates, 
however, they are not convenient for 1-halo-substituted cyclopropane 
dicarboxylates. Furthermore, these procedures are not designed for preparative 
scale synthesis.
Diastereomeric amides (A)/(B) (Fig. 2.6) with OH groups located in the y or 8 
position to the carbonyl group [Ri or R2 = (CH2)nOH and or or X2 = (CH2)n- 
lOH, n= 2,3] (Fig. 2.6) show high separation factors in liquid absorption
chromatography.^26
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Figure 2.6: Diastereomeric amides containing polar substituents
To take advantage of this kind of chemistry, racemic 1-bromo- and 1-methyl- 
tran s- dioic acids (96, X= Br and Me) were resolved by separating the 
diastereomeric bis-amide derivatives of ( + ) - ( 2 R ) - p h e n y l g l y c i n o l l 2 6  (gga and 98b) 
and (99a and 99b) by flash column chromatography on silica. Scheme 2.28.
Y^^^COaMe
(91)
K OOaMe
(or from Scheme 2.26) ho
X (97)
H^ ^COaH
IV, V.
X = ClorBr
VI.
2V-' X 
(+,-)-(96)
X = H, Me, Et, Cl and Br
Ph
H'
HO
^OH
H
X = Br; (98a and 98b) 
X = Me; (99a and 99b)
Vll.
O
and
X = Br; (100a) 
X = Me; (101b)
X = Br; (100b) 
X = Me; (101a)
Reagents and Conditions: i. KH, DMF 25*C, 6 h,, 80-83%; ii, column chromatography on silica ; iii. 
6 mol dm'  ^HCl, if, 2-4 h., 90-95%; iv. SOCI2, if, 45 min.; v. (+)-(R)-2-phenylglycinol, EtgN, 25*0, 
6-12 h., 85-90%; vi. column chromatography on silica; vii. 3 mol dm'  ^HCl, rf, 12 h., 80-90%.
Scheme 2.28: Diastereomeric Resolution of l-Substituted Cyclopropane 1,2-Dioic
Acids
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Cyclopropane dioic acids (96 X= Br, Me), were treated with neat thionyl 
chloride, to give the cyclopropane bis-acid chloride (quantitative yield). The bis- 
acid chloride was converted to the appropriate bis-amides (98a,b and 99a,b), upon 
treatment with (+)-(R)-2-phenyIglycinol. The diastereomeric amides (98a,b and 
99a,b), were resolved by column chromatography (Table 2.8). Finally, the 
separated diastereomers were each, easily hydrolysed under mild acid conditions, 
without causing the stereogenic centres to racemise. The required enantiomers 
of the 1-bromo and 1-methyl cyclopropane dicarboxylic acids (100a,b and 101a,b), 
were isolated in excellent yield (85-90%).
Diastereomeric bis-amide Chromatography Solvent Rf Value
2 % Methanol in Ethyl acetate 0.21
«y ®
100 % Ethyl acetate 0.29
HO
2 % Methanol in Ethyl acetate 0.15
100 % Ethyl acetate 0.15
Table 2.8: Chromatographic Polarities of the bis-Amides
To determine the absolute configuration of each enantiomer, the most polar 
diastereomers of each bis-am ides (98b) and (99a) was subjected to X-ray 
crystallographic analysis using the known (2R)-stereochemistry of the 
phenylglycinol moiety for reference in each case. The analysis revealed that the 
samples were derived from the (1 S,2 S)-l -bromo-1,2-cyclopropane-dicarboxylic
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acid (100b) and (IR,2R)-l-methylcyclopropanedicarboxylic acid (101a) respectively. 
Figures 2.7 and 2.8.
04
C15
C l l  C12
Figure 2.7 X-Ray Crystal Structure of (lS,2S)-l-Bromo-trans-l,2-diamido[N- 
(2R)-phenyl ethanol] Cyclopropane
C l l C12
Figure 2.7: X-Ray Crystal Structure of (lR,2R)-l-Methyl-trans-l,2-diamido[N- 
(2R)-phenyl ethanol] Cyclopropane
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2.9 Synthesis of 2-Methyl Oxtrane and Aziridine 2,3-Dicarboxylic Acids.
Encouraging inhibition results (See Section 2.10), by (±)-l-methylcyclopropane 
1,2-dioic acid (96 X= Me), with MAL, prompted us to investigate whether the 
insertion of a heteroatom (such as oxygen and or nitrogen) in place of C-3 of the 
1-substituted cyclopropane dioic acid (96 X= Me), would have any effect on the 
mode and extent of inhibition against MAL. We envisaged, that perhaps due to 
the electrostatic nature of oxygen and nitrogen, a tighter binding may occur, 
between the heteroatom and the enzymes active site (Fig. 2.10 - where C-3 is a 
heteroatom). The two obvious synthetic targets to determine our hypothesis 
were; (±)-trflMs-2-methyl-oxirane-2,3-dicarboxylic acid (102) and {±ytrans~2- 
methylaziridine-2,3-dicarboxylic add (103).
H O a C ^ H
HaC CO2H
±-(102)
H
ho, c^ h
HaC CO2H
± - ( 1 0 3 )
Figure 2.9; Desired Oxirane and Aziridine Dioic Acids
Synthesis of the oxirane (102), was achieved via the method employed by 
Sharpless (Scheme 2 .2 9 ).^27 This method involves the aqueous tungstate- 
catalysed epoxidation of an a,p-unsaturated acid (104) by hydrogen peroxide, to 
yield the corresponding epoxide (105).
Scheme 2.29: Epoxidation of a,p-Unsaturated Acids
This method of epoxidation was a modification of the original procedure 
described by P a y n e . ^ 2 8  sharpless utilised this modified procedure to epoxidise
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both di- and trisubstitued unsaturated acids. The epoxides isolated were 
synthesised in excellent y i e l d . ^ 2 7
Mesaconic acid (3) was treated with hydrogen peroxide in the presence of 
sodium tungstate catalyst (Scheme 2.30) at pH 6.0. The reaction was carefully 
monitored by t.l.c and the pH kept between 5.8 and 6.8. The desired epoxide (102), 
was obtained in 70% yield, and was isolated as a white crystalline solid. The 
epoxide (102), was dérivatised to the corresponding dimethyl ester (106), via 
diazomethane. The dimethyl ester (106), showed the required spectral and 
analytical data (Rf (ether/hexane (3:2)) = 0.47, literature, Rf (ether/hexane (3:2)) = 
0.47;129 m/z (Found: [M+H]+, 175.0598. Calc, for C7H11O5: 175.0606)).
H COjH H3 C P . COjH .. H3 C O COjCHs
) = /  .  >  y - K  -  y - K
HO2 C CH 3  HO2 C H H3 CO2 C H
( 3 )  ( ± ) - ( 1 0 2 )  ( ± ) - ( 1 0 6 )
Reagents and Conditions: i. Na2W0 4 .H /), H2O, H2O2,6 5 ‘C, 3-4 h., 70%; ii. diazomethane, 
ether, 25*C, 30 min, 95%.
Scheme 2.30: Hydrogen Peroxide-Tungsten Catalysed Epoxidation of Mesaconic
Acid
Our approach towards obtaining the corresponding aziridine (103), was to 
employ the Blum reaction (Scheme 2.31). This reaction involves the synthesis of 
aziridines (109), from oxiranes (107), via azido alcohols (108), in the presence of
phosphines.^^0
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" A "Ph^ Ph 
(107)
NaN.
Na Ph 
(108)
"A"Ph Ph 
(109)
Scheme 2.31: Blum, Aziridine Synthesis
This work is currently being followed up within our laboratories, with the 
aim of obtaining the desired aziridine dicarboxylic acid (103, Scheme 2.32). Our 
approach involves the formation of the azido alcohol (110), from the ring 
opening reaction of the oxirane (106), by sodium azide, followed by the 
concomitant cyclisation of the azido alcohol (110), giving rise to the formation of 
the corresponding aziridines (111 and 112).
% H HM e O z C y / y H  N aN ^  ^ M e O g C y - ^ C H s  p p h g ^  M e O a C y N  H h f a C y N  H
COaMe H^'M'^COaMe HgC COgMe MeOgC COgMe
OH±-(106) ±-(111) ± -(112)
Scheme 2.32: Proposed synthetic route towards Dimethyl-2-Methyl Aziridine 2,3-
Dicarboxylate
2.10 Kinetic Studies on l-Substituted Cyclopropane 1,2-Dioic Acids
In order to test whether 1-substituted cyclopropane dioic acids behave as 
reversible inhibitors of MAL, kinetic (inhibition) studies were performed for 
each of the cyclopropane compounds. The results of our studies are shown in 
Table 2.9.
To determine the extent and the mode of inhibition, the kinetic turnover of
(2S,3S)-3-methylaspartic acid (2) by the enzyme MAL (of fixed activity and of fixed
Chapter 2 : Results & Discussion: Methylaspartase Ammonia-Lyase_______ 86
concentration), was examined in the presence of various concentrations of 
potential inhibitor.
The cyclopropane 1,2-dioic acids (Table 2.9), when tested for biological activity, 
the racemic trans-cyclopropane 1,2-dioic acids (96, X = H, Cl and Br), served as 
weak competitive inhibitors for the enzyme with Ki values of 7.69 mmol dm'3, 
4.15 mmol dm‘3, and 6.1 mmol dm-3, respectively (Table 2.9). The racemic czs-1- 
methylcyclopropane 1,2-dioic acid (95, X= Me), was a very poor inhibitor (Kj 5.42 
mmol dm“3) but the corresponding traws-compound (96, X = Me) served as a 
good competitive inhibitor, Ki = 67 pmol dm-^. Table 2.9. Note that the Km for
(2S,3S)-3-methylaspartic acid (2), is 2.3 mmol dm"  ^ and that the value of Ki for 
the competitive product inhibitor, mesaconic acid (3), is 3 mmol dm“3.13l 
Replacement of the methyl group in the best inhibitor by an ethyl group (96, X = 
Et), reduced the efficacy of the inhibitor by 10-fold (Table 2.9) in accord with the 
previous finding that Km for (2S,3S)-3-ethylaspartic acid (31, R= Et), is large, 17.1 
mmol dm-^.58 Thus it would appear that the series of inhibitors displayed the 
properties that might be expected if they were serving as TS analogues for the 
central substrate deamination step. Step 2, Scheme 2.24.
2.10.1 Inhibition Studies of the Resolved Cyclopropane Dioic Acids
When tested for activity the (lS,2S)-l-methylcyclopropane (101b) {[aJo +191.4 
(c 1.0, MeOH)} was a potent inhibitor (K* = 20 pmol dm'3) and was six times more 
effective than the (lK,2R)-antipode {[aJo -191.4 (c 1.0, MeOH)}, whereas the 
(lR,2R)-l-bromocyclopropane (100a), {[aJo +91.5 (c 1.0, MeOH)}, displayed a Ki of 
920 pmol dm”3 and was at least six times more effective than the (lS,2S)-antipode 
(100b). Note that the spatial arrangement of similar groups is identical for the 
(1S,2S)-1 -methylcyclopropane (101b), and the (lR,2R)-l-bromocyclopropane 
(100a), but that there are priority assignment changes. From these results, it is 
evident that each of the inhibitors prefer to bind with the 1-substituent in the 
pocket for the methyl group of the substrate. Thus each carboxylate group can
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bind to the enzyme and metal ion cofactors as for the substrate with the 
cyclopropane methylene moiety disposed on the same face of the pseudo-plane 
described by C-l'-C-l,C-2-C-2' as the dehydroalanine residue (Fig. 2.7 and 2.8).
Dehydroalanine>v8
2+
Substrate
H
Base
Dehydroalanine
Inhibitor
M+
B Base
A) Expected transition state for C-N bond cleavage In the substrate.
B) Possible interaction of (lS,2S)-1-methylcyclopropane-1,2-dloic acid (101b) with the enzyme.
Figure 2.10: Interaction of substrate and inhibitor with dehydroalanine
This is in keeping with the observation that there is enough space to 
accommodate hydrazine or methylamine in place of ammonia and that such 
species support catalysis for the reverse reaction.^^
2.10.2 Inhibition in the Presence of Ammonia.
Given that compound (101b), can only bind to the enzyme as a partial 
substrate analogue in the absence of ammonia because the compound lacks an 
amino group and the ammonium ion is released before the dioic acid in the
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forward reaction direction. Scheme 2.24, it was of interest to examine the 
inhibitory properties of the compound in the presence of ammonia. Accordingly 
a new set of kinetic experiments were performed in the presence of 10 mmol dm“ 
3 ammonium chloride (-0.2 times Km for the species behaving as a substrate in 
the reverse direction). Under these conditions compound (101b), behaved as a 
highly potent competitive inhibitor and displayed a reduced Ki value of 11 pmol 
d m "3 (Table 2.9, last entry). The result indicates that ammonia and the 
cyclopropane dioic acid can simultaneously bind to the enzyme and together 
mimic the TS structure for the central deamination process (Fig. 2.10, B). This 
result is at odds with the notion that the dehydroalanine residue of the related 
enzyme phenylalanine ammonia lyase, serves as a Friedel-Crafts donor rather 
than an amino group acceptor as has been recently suggested (Scheme 2.33).^32
E + S
COO- \ :B-E
ES
H-B-E
COO-
ES'
B-E = Enzyme Base, E = Enzyme, S = Substrate, P = Product, 
ES and ES' = Enzyme-Substrate compexes.
Scheme 2.33; Proposed Mechanism for PAL
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2.10.3 Summary of Properties of Methylaspartase Inhibitors
89
C^OgH
HOgC
H^ ^COgH
.5,
Reaction
C onditions
Stereo­
chem istry X
Ki
(mmol dm‘3)
Mode of 
Inhib ition
C om p.
N o ,
standard (+rhtrans~ H 7.69 competitive 96
standard (+,-)-cis- Me 5.42 competitive 95
standard (+r)-trans- Me 0.067 competitive 96
standard (+,-)-trans- Et 0.69 competitive 96
standard (+r)-trans- Cl 4.15 competitive 96
standard ('hr)-trans- Br 6.09 n.d., IC50 96
standard (lR,2R)-trans- Br 0.92 mixed 100a
standard (lS,2Shtrans~ Br 6.520 n.d., IC50 100b
standard (lS,2S)-trans~ Me 0.020 competitive 101b
standard (lR.2R)-trans- Me 0.120 competitive 101a
std + NH4+ (lS,2S)-trans- Me 0.011 competitive 101b
Table 2,9: Kinetic Data for the Methylaspartase Inhibitors
The enzyme was assayed according to the method of Barker,!2 where 1 unit of 
enzyme catalyses the formation of 1 pmol of mesaconic acid min*! at pH 9.0 at 30 
°C as determined by the increase in optical density (OD240) at 240 nm, under the 
assay conditions. 12 The reaction rates were determined in triplicate under the 
standard assay conditions^® for several different substrate and inhibitor 
concentrations and data was fitted using non-linear regression analysis. Errors in 
Ki values are within ±5% of the stated value.
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2.11 Conclusions and Future Work
2.11.1 Cyclopropane Containing Inhibitors
The usefulness of rigid inhibitors for probing active conformations of enzyme 
substrates is well documented.!33 Their binding in the active site is entropically 
favoured and they can offer reliable information about the arrangements of the 
protein residues. Cyclopropane containing structures possess a number of 
advantages over unstrained inhibitors; for example they do not contain any 
additional atom(s) that will prevent their entrance into an active site. The 
cyclopropyl group is found as a basic structural element within a wide variety of 
naturally occurring compounds in plants and in microorganisms, both fungal 
and bacterial. It is also generated transiently in primary and secondary 
metabolism. Therefore, it is present in compounds of biological importance.!34 
The cyclopropane chemical reactivity not only resembles that of an olefinic 
double bond but moreover, involves rearrangements: i.e., ring opening 
reactions, ring enlargements and ring contractions.!35/l36
Racemic 1-substituted cyclopropane-!,2-dioic acids which were kinetically 
assayed for inhibition against MAL, showed varied degrees of inhibition (Table
2.9). From the data obtained, we can speculate the kind of functionality which is 
required within the active site. Furthermore, we have shown for the first time 
that 1-substituted cyclopropane-!,2-dioic acids (Fig. 2.4) are biologically active 
against MAL. We envisage that these cyclopropane dioic acids, mimic a TS 
which exists during the catalytic turnover of (2S,3S)-3-methylaspartic acid (2) to 
mesaconic acid (3) (Scheme 2.24).
The impact of the stereochemistry on activity requires regioselective, as well 
as stereoselective synthesis of the three membered ring moiety. We observed 
that the regioselectively pure, cis-cyclopropane dioic acid tested (95, X= Me), was 
biologically active, but showed poor inhibition. On the other hand the 
regioselectively pure fra«s-cyclopropane dioic acids (96, Table 2.9), were much 
more potent inhibitors of MAL. Since, the best racemic frans-cyclopropane (96,
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X=Me, (67 |imol dm~3)) possessed the methyl substituent in the 1-position of the 
cyclopropane, the only cis-cyclopropane dioic acid that was tested against MAL, 
was (95, X= Me, 5.42 mmol dm“^ ). We concluded that no further kinetic 
inhibition experiments were necessary on the other, cis-cyclopropane dioic acids 
as we did not expect to find further information about the enzyme and we 
therefore focused our attention on the frflns-cyclopropanes.
Enantiomerically pure frflns-cydopropane 1,2-dioic acids (96), showed good to 
potent inhibition (Table 2.9). From the inhibition data we could deduce the 
stereochemistry required by a potential substrate/inhibitor for the active site of 
MAL. We observed that compounds (100a) and (101b) were the more optically 
active compounds as compared to their counterparts (100b) and (101a).
Substituent group (CHaorBr)
Fig. 2.11: The Conformational Requirements for MAL
The cyclopropane dioic acids studied in general bound reversibly to the active 
site of the enzyme and prevented the natural substrate (2), binding and vice 
versa. From the data collected we concluded that the cyclopropane dioic acids 
were competing for the active site against the natural substrate (2). The 
cyclopropane dioic acids, in general, behaved as competitive inhibitors of MAL. 
The only exception to this observation, was that of ( lR,2R) - l -bromo-  
cyclopropane-l,2-dioic acid (100a), which displayed mixed inhibition. We 
consider this a significant result and we believe that the halogen within 
compound (100a), may be able to interact with one of the metal ions in the 
enzyme-bound complex. However, at this stage, this is a highly speculative 
suggestion. We envisage that supporting experimental work must be carried out.
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to determine the cause of the mixed inhibition. This is one of the programmes 
which is currently under investigation in our research group.
Our determination of the inhibitory properties of the cyclopropane 1,2-dioic 
acids with ammonia was only conducted on cyclopropane (101b). The reason for 
this one study was because this compound (101b) was by far the best inhibitor. 
We do not expect that there would be a change in inhibition mode with the less 
good inhibitors and indeed, this work has a lower priority within our research 
programme.
X-ray crystallography has given a wealth of detail about the structures of 
enzymes. It is clear that we need to be able to locate the active site in MAL and 
examine carefully the mode of binding of the different inhibitors/substrates in 
order to pinpoint the functional amino acid side chains which are involved in 
the catalytic mechanism. Compound (101b), a potent competitive inhibitor of 
methylaspartase, which allows the simultaneous occupation of the active-site by 
ammonia, is ideally suited for gaining such information.
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2.12 p-Amino Acids
2.12.1 Introduction
As mentioned in chapter 1 (Section 1.4), p-amino acids are used as 
constituents of many biologically active peptides. P-amino acids are used to 
replace their parent a-amino acid analogue and due to their limited normal 
metabolism, suggests that many p-amino acids are metabolically stable in vivo; 
enzyme inhibitors may thus have extended half-lives when designed as the p- 
rather than the a-amino acids. Similarly, incorporation of p-amino acids into 
peptides of pharmacological interest has in some cases been found advantageous 
in terms of biological activity, metabolic stability, or both (see section 1.4 for 
examples).
Our research in this area is focused on the synthesis and biological properties 
of peptidic phosphonamidate esters. These compounds are moderate to good 
inhibitors of the HIV-1 protienase, showing comparable potency to other
inhibitor c l a s s e s . ^ 3 7 - 1 4 0
Our target phosphonamidate inhibitor (Fig. 2.13) was modelled on the 
peptidic analogue of Ro-31-8959^^® (Roche’s leading peptidic inhibitor of HIV-1 
protienase. Fig. 2.12) and was designed to contain the biologically active p-amino 
acid (111).
OH NHSu
R o 31-8959
Figure 2,12: Ro 31-8959, A Potent and Selective Inhibitor of HIV-1 Proteinase
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Biologically active
CONHg
Peptide under investigation
Figure 2.13: Target Peptide Containing p-Amino Acid
Our efforts were directed towards the synthesis of the P-amino acid (111) and 
initially it was our aim to obtain the amino acid (111) in a racemic form, so that 
its biological activity could be assessed by comparing the activity of peptide (Fig. 
2.13), (which contains the P-amino acid (111)) against the same peptide which 
contains the in the parent a-amino acid.
2.13 Synthesis of (±)-a-Benzyl-P-Amino Propioinic acid
(±)-a-Benzyl-P-amino propionic acid (111), is an example of an a-substituted- 
p-amino acid and is a type III analogue of (2S)-alanine (see Fig. 1.7, Chapter 1). 
The P-amino acid (111), has received little attention in the literature and the only 
reported synthesis of this compound was achieved by Seebach et a l (Scheme 
2.34),14l in 1991. Seebach and co-workers synthesised a variety of a-substituted- 
P-amino acids, via P-alanine (112), as the starting material.
HOHO
p-alanine (112) (±) p-amino acidCyclic heterocycle (113)
Scheme 2.34: Seebach's Synthesis of a-Substituted-p-Amino Acids
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p-alanine (112), was converted into the heterocycle (2-terf-butyl perhydro- 
pyrimidin-4-one derivative, 113), which was alkylated with high diastereo- 
selectivity via the corresponding enolate. The high stereoselectivity observed in 
this reaction was due to steric hindrance generated by an axial disposition of the 
ferf-butyl group at C(2) (113), which directs addition from the enolate face 
opposite to this group. The hydrolysis of the resulting adducts proceeds with 6 N  
hydrochloric acid to afford the (±)-a-substituted-P-amino acid.
Due to the severe reaction conditions which were employed in the synthesis 
of the cyclic heterocycle (113) and a generally tedious procedure overall, we 
sought to synthesise our target compound (111), via a different synthetic route 
(Scheme 2.35).
1,R H 
(114)
R = Ph
OH O
OCH3
(92)
R' Y  OCH3  
(115)
u.
H2N
O O
(±)-P-am ino ester (118)
N f Y  OGH3 ^m . Br
(117)
O
OCH3
(116)
Reagents and Conditions: i. l,4-Diazabicyclo[2.2.2]octane, 25*C, 7 days, 98%; ii. HBr ^SO,*, 
25*C, 12 h., 99%; iü. NaNa, acetone (aq), if, 4 h., 90%; iv. H2 (g), Pd,C, MeOH, 25*C, 6  h., 80-85 %.
Scheme 235: Alternative Approach to a-Suhstituted-fi-Amino Acids
The synthesis described in the above scheme (Scheme 2.35), represents a short 
and very efficient synthesis of (±)-a-substituted-p-amino acids. The first step of 
the reaction scheme, originates in a patent granted to Baylis and H i l l m a n . ^ '^2  
These authors describe the reaction between a,p-unsaturated esters, nitriles, 
amides or ketones together with a broad spectrum of aldehydes (Scheme 2.36).
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H2C=C
X = C02R,CNandCN
Scheme 2.36: The Baylis Hillman Reaction
The reaction is carried out in the presence of a cyclic tertiary amine, such as 
l,4-diazabicyclo[2.2.2]octane (DABCO, Fig. 2.13 A), which behaves as a catalyst for 
the reaction (Scheme 2.37).
The catalyst constitutes between 0.1% and 10% of the reactant weight. 
Reaction temperatures can be varied between 0 and 200 °C and the pressure may 
be atmospheric, however, the reaction can proceed at higher pressures or under 
vacuum. Solvents such as dioxane, THF, ethanol or chloroform are all suitable 
for the reaction, but in many cases the solvent is not required. Baylis and 
H i l l m a n l 4 2  refer to the use of tertiary cyclic amines such as DABCO (Fig. 2.13 A) 
and quinuclidine (Fig. 2.13 B), but non-cyclic tertiary cyclic amines such as 
triethylamine have also been employed by other r e s e a r c h e r s . ^ 4 3
DABCO 
( 1,4-Diazabicyclo[2.2.2]octane Quinuclidine
Figure 2.13; Tertiary Cyclic Amines as Catalysts for the Baylis-Hillman Reaction
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H3CO
DABCO Methyl acrylate (92) Benzaldehyde
(114,R=Ph)
OH
Hydroxyacrylate (115)
Scheme 237: Mechanism of the Baylis-HUlman Reaction
It seems reasonable to suggest that the first step in the synthesis, involves a 
Michael addition of the tertiary amine (Fig. 2.13 A), to the corresponding a,p- 
unsaturated carbonyl compound (92). This is concomitantly followed by a 
nucleophilic attack on the aldehyde (114, R= Ph), which is then followed by the 
subsequent elimination of the tertiary amine (Fig. 2.13 A). This type of 
mechanism was confirmed by Hoffman and Rabe,^44 ^ho carried out 
conformation studies on this type of reaction.
Treatment of the hydroxyacrylate (115), with hydrobromic acid-sulphuric 
acid^45 led to the formation of the rearranged allylic bromo-ester (116), in 
quantitative yield (Scheme 2.35). The p-bromo ester (116), contains the labile 
carbonyl allyl system, and as such it is possible that it can undergo nucleophilic 
substitution at the allylic position or nucleophilic attack can occur at the vinylic
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carbon, C-3 (Scheme 2.38), followed by concomitant rearrangement with the loss 
of the bromide anion.
NuNu
Path
Allylic Attack
Path B Nu
Vinylic Attack
Scheme 2,38: Different Pathways for Nucleophilic Attack/Substitution
It was our aim to follow the reaction so that a nitrogen nucleophile, such as 
sodium azide, would be able to substitute for the bromide anion, at the allylic 
position. We found that by carrying out the reaction in aqueous acetone and in 
the presence of sodium azide, under reflux conditions, that the sole product was 
allylic azide (117).
Having obtained the desired allylic azide (117), we attempted to reduce the 
azide and the double bond in one pot. We achieved this by hydrogenating 
compound (117), in the presence of (5%) palladium on carbon catalyst in neat 
methanol. The desired compound (118), was obtained in excellent yield (80-85%, 
Scheme 2.35). The spectral and analytical data of the P-amino ester (118), 
displayed the expected properties when compared to the literature compound.
2.14 Asymmetric Synthesis of P-Amino Acids
Having obtained our target P-amino ester (118), in a short and efficient 
synthesis, we focused our attention towards obtaining enantiomerically pure p- 
amino acids, utilising our synthesis (Scheme 2.35).
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Our first approach towards the synthesis of enantiomerically pure p-amino 
acids, was directed at inducing asymmetry on the prochiral carbon atom (C-2) in 
compound (117, Fig. 2.14).
Na O
Prochiral J
Centre 
(C-2)
‘OCH3
Allylic azide (117)
Figure 2,14: Introducing Chirality
One method of inducing chirality at C-2 (117), was by the enantioselective 
hydrogenation of the olefin (117), in the presence of a chiral catalyst. As described 
in chapter 1 (Scheme 1.19), Nyori performed asymmetric hydrogenations on 
prochiral, a-(acylamino)acrylic acid derivatives, using BINAP-Ru(II) metal 
complexes to serve as excellent chiral catalysts (Scheme 1.19).^0
The analogous p-(acylamino)acrylic ester (120, Scheme 2.39), was synthesised 
by the selective reduction of the azide functionality within compound (117), to 
the corresponding amino-acrylic ester (120). The selective reduction, was 
achieved in quantitative yield, using triphenylphosphine as the reducing 
agent.f^^ The P-amino acrylate (120), was then treated with acetic anhydride to 
give the desired compound as a white crystalline solid (121, Scheme 2.39).
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Ï M OCH3OCH3 + pph
not isolated
(5-azidoacrylate (117)
i.(b)
NHNH
OCH3  + PhsPO11.
N-acetyl- p-aminoacrylate (121) p-aminoacrylate (120)
Reagents and Conditions: i.(a) PPl^,THF 25*C, 2 h., i.(b) H2 0 ,25°C, 4 h., 90-95%; ii. acetic 
anyhydride, THF O'C, 2h., 92-98%.
Scheme 2.39: Synthesis of Methyl-p~(acylamino)acrylate
Commercially available ([Rhodium((S)-binap (norbornadiene)]perchlorate 
(122, Fig. 2.15), was hydrogenated in methanol at room temperature to produce 
norborane and two Rh complexes, (S)-123 and 124, (Fig. 2.15), in a ratio of 9 : 1 as 
described by Nyori.^0 The major, methanol-soluble complex was isolated as deep 
red prisms and was shown to have the same spectral properties as the literature 
compound. The minor complex (124), was insoluble in methanol and was 
isolated as a brown solid.
Chapter 2 : Results & Discussion: p-Amino Acids 101
{CeHsla H +/OCH3
(C6H6>2 "
[Rh((5)-binap (Me0 H)2 ]C1 0 4  (123)
(CsHslz
(CeHslgf  ^ P 
Rh+
P PjCeHsja 2CI04-
(CeHslg
X " CIO4
Dinuclear species (124)
[Rh((5)-binap (norbomadiene)]CIO4  (1 2 2 )
Figure 2,15: Rhodium-Binap Complexes
The p-(acylamino)acrylate (121), was dissolved in dry methanol and treated to the 
chiral catalyst (123), under an inert atmosphere of argon. This mixture was added 
to a pre-purged (sealed), pressure bottle, which was filled with 3 atmospheres of 
pure hydrogen. The reaction mixture was stirred and the reaction was followed 
by chromatography (tl.c.). After several days, we observed no change in starting 
materials and it was concluded, that the chiral catalyst did not have any effect in 
co-ordination to the p-(acylamino)acrylate (121), as opposed to the case for the a- 
derivative according to literature (Scheme 1 .19).^0
We expected that the reaction between the P-(acylamino)acrylate (121), and the 
chiral catalyst (123), would have started in a similar manner, as is shown in 
scheme 2.40, where initial coordination of the olefinic substrate (II, Scheme 2.40), 
would chelate to the rhodium (Rh) atom (III, Scheme 2.40). Since we observed 
that the olefin (121), was not reduced, we concluded that the type of coordination 
as shown (III, Scheme 2.40), does not occur.
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[Rh{blnap)]+ + 2ROH
H COaR^
* , M
[Rh(blnap)(R0H)2]''
I
H COaR^
'R NHCOR® [Rh(Wnap) ( ir^ nhcor= )  + RON
c^ ,V  b=^CO2R2NH + RON
III
III + H2 (Rh(blnap)] + +  ^RH2C—g  — ^
C02R^
nhcor3
Scheme 2A0: Mechanism of Asymmetric Hydrogenations
Another approach towards the construction of enantiomerically pure p- 
amino acids, was to induce asymmetric induction, on the prochiral carbon atom, 
C-2 (Fig. 2.16). The induction was envisaged to be caused via a chiral auxiliary, 
which would be attached as the chiral ester (Fig. 2.16).
OX
Prochiral Carbon Atom
X = Chiral auxilliary
Figure 2,16: Chiral Induction on the Prochiral Centre
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Once again, the synthetic route developed towards the synthesis of (±)-a- 
substituted-p-am ino acids (Scheme 2.35), was utilised towards the synthesis of 
enantiomerically pure p-amino acids. We employed enantiomerically pure (-)- 
m enthol (127), as the chiral auxiliary, which was expected to cause chiral 
induction on the azidoacrylate. (Fig. 2.16).
The synthesis of the optically active, 2-(l-hydroxyalkyl)acrylate (126), was 
achieved according to the method employed by B a s a v a i a h , i 4 7  where (-)-menthyl 
acrylate (125), was coupled to benzaldehyde (114, R= Ph), under the influence of 
DABCO (Scheme 2.41).
0
>
OH O 
DABCO » 1 H
(114) (125) (126) "
R = Ph
X = (-)-Menthol
Scheme 2.41: Diastereoselective Synthesis of Hydroxyalkyl Acrylates
(-)-Menthyl acrylate (125), was easily prepared via the synthetic route 
developed  by M e t h - C o h n . ^ 4 8  The reaction involves the efficient trans­
estérification of methyl acrylate (92), with the chiral alcohol ((-)-menthol, 127), in 
the presence of butyl-lithium in THF solution (Scheme 2.42).
\  L. i.BuLi.THF-80!C-------- Ï---------- ^
ii. Methyl acrylate
(-)-Menthol (127) 90%(-)-Menthylacrylate (125)
Scheme 2.42: Transestérification of Methyl Acrylate
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In an attempt to synthesise the bromoacrylate (128, Scheme 2.43), the hydroxy­
acrylate (126), was treated with hydrobromic/sulphuric acid and the reaction was 
monitored by t.l.c. Since there was no observed change in starting materials and 
having  changed the reaction conditions, such as reaction tim es and  
temperatures, we concluded that the bromide anion was sterically hindered from 
attacking the double bond in compound (126). We suggest that the steric 
hindrance is caused by the menthyl group (126, Scheme 2.43).
OH
BrDouble bond attack by the bromide 
anion is sterically hindered by the 
menthyl group.
Hydroxyacrylate (126)
Bromoacrylate (128)
Scheme 2.43: Sterically Hindered Hydroxyalkylacrylate
We have chosen to abandon the above approach (Scheme 2.43), as the 
optically active bromoacrylate (128), was not obtained via the synthetic approach 
as described in scheme 2.43.
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2.15 Conclusions and Future Work
The stereoface-selective addition of hydrogen to various olefinic bonds 
rem ains a practical and intellectual problem , despite the achievements of 
enantioselective hydrogenations of prochiral a-acylaminoacrylic acids.^o o u r  
approach to obtain stereoface-selective hydrogenation of the prochiral p- 
aminoacrylate (120), is to extend the work of Oppolzer.l^^ Oppolzer and co­
workers have obtained excellent stereoface differentiation on palladium catalysed 
hydrogenations of a,p-olefinic imides (129, Scheme 2.44), to provide, after 
saponification, P-substituted carboxylic acids in high enantiomeric purity (>95% 
enantiomeric excess).^^^
O Ri
100psi,EtOH
Ri = CH3, C2H5, nCgH?, 1C3H7,11C4H9, nCfiCia, nQ H n, (CH2)2^H=C(CH 3)2 
R2= CH3, (CH2>2CH=C(CH3)2
Scheme 2.45: Asymmetric Hydrogenations of Camphor Sultam-Imide-
Conjugated Alkenes
We are currently following this approach, by synthesising the analogous 
chiral cam phor sultam-imide conjugated alkene (132), followed by catalytic 
hydrogenation of the olefin (132, Scheme 2.45).
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(131) NPthI
NH
PthIN
(130)
H P^d/C^  
lOOpsi, EtOH
PthIN PthINNPthI(132)
F h^l = Pthlamide protection
Scheme 2.45: Synthetic Approach Towards Enantiomerically Pure P-Amino
Acids
The chiral imide (132), can be synthesised by treating the camphor sultam 
(131), with sodium hydride and the corresponding acid chloride (130), to give the 
imide (132)M^
It is anticipated that asymmetry will be induced at the a-centre (Fig. 2.17, B) as 
opposed to the p-centre, as is the case for the trisubstituted olefinic compound 
(Fig. 2.17, A).
NPthI
O2S,
Metal Metal
Figure 2.17: Diastereoface Differentiation on Pd/C Catalyst
CHAPTER 3
EXPERIMENTAL
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3.0 Experimental
Synthesis of Substrates and Inhibitors
Elemental m icroanalyses were perform ed in the departm ental micro- 
analytical laboratory. NMR spectra were recorded on a Broker AM-300 (300 MHz; 
FT iH-NMR, and 75 MHz; l^C-NMR), or a Varian gemini 200 (200 MHz; FT ^H- 
NMR and 50.31 MHz; l^C-NMR) spectrometers. ^H-NMR spectra are described 
in parts per million downfield shift from TMS and are reported consecutively as 
position (5h or §c)/ relative integral, multiplicity (s - singlet, d - doublet, t - triplet, 
q - quartet, dd - double of doublets, sep - septet, m - multiplet, and br - broad), 
coupling constant (Hz) and assignment (numbering according to the lUPAC 
nomenclature for the compound). ^H-NMR were referenced internally on % 2 0  
(4.68 p.p.m.), CHCI3 (7.27 p.p.m.) or DMSO (2.47 p.p.m.). l^C-NMR were 
referenced on CH3OH (49.9 p.p.m.), C^HCl3 (77.5 p.p.m.), or DMSO (39.70 p.p.m.).
l.R. spectra were recorded on a Perkin-Elmer 1710 FT IR spectrometer. The 
samples were prepared as Nujol mulls, solutions in chloroform or thin films 
between sodium chloride discs. The frequencies (u) at absorption maxima are 
given in wavenumbers (cm'i) relative to a polystyrene standard. Mass spectra 
and accurate mass measurements were recorded on a VG 70-250 SE, a Kratos MS- 
50 or by the SERC service at Swansea using a VG AZB-E. Fast atom 
bombardment spectra were recorded using glycerol as a matrix. Major fragments 
were given as percentages of the base peak intensity (100%). UV spectra were 
recorded on Pye-Unicam SP8-500 or SP8-100 spectrophotometers.
Flash chromatography was performed according to the method of Still et 
using Sorbsil C 60 (40-60 pm mesh) silica gel. Analytical thin layer 
chrom atography was carried out on 0.25 mm precoated silica gel plates 
(Macherey-Nagel SIL g/UV254) and compounds were visualised using UV 
fluorescence, iodine vapour, ethanolic phosphomolybdie acid, or ninhydrin.
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Melting points were taken on an Electrothermal melting point apparatus and 
are uncorrected. Optical rotations were measured at 23 °C on a Optical Activity 
AA-1000 polarimeter using 10 or 20 cm path length cells.
The solvents used were either distilled or of Analar quality. Light petroleum 
ether refers to that portion boiling between 40 and 60 °C. Solvents were dried 
according to literature procedures. Ethanol and methanol were dried using 
m agnesium  turnings. Isopropanol, isopentanol, DMF, toluene, CH2CI2, 
acetonitrile, diisopropylamine, triethylamine, and pyridine were distilled over 
C aH 2- THF and diethyl ether were dried over sodium /benzophenone and 
distilled under nitrogen. Thionyl chloride was distilled from sulphur, and the 
initials fractions were always discarded. BuLi was titrated according to the 
method of Lipton.l^^
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Diazomethane:
Potassium hydroxide (10 g) was dissolved in isopropanol (40 cm^) with 
heating using the minimum amount of water (2-3 cm^). Diethyl ether (40 cm^) 
was added to the solution and the temperature was raised to 50 °C. Diazald (42 g), 
dissolved in ether (250 cm^), was introduced into the solution over 45 min. The 
yellow distillate was collected in a flask immersed in an ice bath and the whole 
system was fitted with a drying tube. An additional amount of ether (100 cm^) 
was added until the ether distilling over was colourless. The ethereal solution in 
the receiver (-400 cm^) contained around 8 g of diazomethane.
3-Ethylfumaric Acid (30, R= CH2CH3)
H CO 2 H
HOgC CH2 CH3
To a solution of sodium ethoxide, prepared by the addition of anhydrous 
ethanol (29 cm^) to sodium (1.84 g, 80 mmol) was added ethyl acetoacetate (6 g, 
53 mmol) dropwise over 10 min. The solution was stirred for an additional 
5 min and ethyl iodide (10.8 g, 69 mmol) was slowly added dropwise. Following 
the addition, the reaction was heated at reflux for 2 h and was then allowed to 
cool. The solution was poured into water (40 cm^) and then extracted with 
diethyl ether (3 x 40 cm^). The pooled organic extracts were washed with water (3 
X 20 cm ^ ) and dried (MgSO^). The solvent was removed under reduced pressure 
to give a pale yellow oil, 2-ethyl acetoactetate ethyl ester (28, R= CH2CH3) (8.38 g, 
65.5%). The product was used in the following reaction w ithout further 
purification.
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To a vigorously stirred solution of the ester (4 g, 25 mmol) in dry diethyl ether 
(30 cm^) was slowly added bromine (8 g, 50 mmol) and the solution was then 
refluxed for 3 h. The solvent and hydrogen bromide, were removed under 
reduced pressure, to give the dibromide as a pale yellow oil (29, R= CH2CH3).
The dibromide (29, R= CH2CH3) was added slowly to a solution of ethanol (32 
cm3) containing powdered potassium hydroxide (9.6 g, 17.12 mmol) with rapid 
stirring. The mixture was heated at reflux for 30 min and was then steam 
distilled until 170 cm^ of distillate had been collected. The acidified solution was 
extracted with diethyl ether (4 x 65 cm^) and the pooled extracts were dried 
(MgSO^) and concentrated under reduced pressure to give an amorphous off- 
white solid. The product was decolourised with active charcoal and recrystallised 
from diethyl ether/hexane to give 3-ethylfumaric acid (30, R= CH2CH3) as white 
crystals (1.65 g, 45% overall yield), m.p. 195-197 °C (lit.,49 194-95 °C); Umax 
(Nujol)/cm-l 1688; 5h (200 MHz; ^ O /N a O ^ H )  0.9 (3H, t, /  7, CH3), 2.35 (2H, q, /  
7, CH2) and 6.23 (IH, s, C=CH); 6c  (50.31 MHz; 2H2 0 /N a 0 % ) 13.81 (CH3), 22.93 
(CH2), 128.05 (3-C), 147.52 (2-C) and 175.30 & 174.20 (2 x CO2); m /z  (El) 126 (48%, 
[M - H20]+) and 98 (100, [M - CH2O2]-*-).
[^Hsl-Ethylfumaric Acid (30, R=
HO2C C^ H2C^ H3
Ethyl acetoacetate (0.62 g, 4.78 mmol) was added dropwise to a stirred solution 
of sodium ethoxide in anhydrous ethanol (1.9 cm^, 2.74 mol dm'3, 5.2 mmol). 
After 15 min of further stirring, pHgj-iodoethane (1.0 g, 6.2 mmol) was added 
dropwise. The reaction mixture was heated at reflux for 2 h  and allowed to cool. 
The solution was poured into water (15 cm^), extracted with diethyl ether (5 x 
10 cm^) and dried (MgSO^). Solvent was removed under reduced pressure to
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give [% 5]-2-ethyl acetoacetate ethyl ester (28, R= C % 2C % 3)/ as a yellow oil (0.63 
g, 81%); 8h  (200 MHz; C^HClg) 1.27 (3H, t, /  7, CH2CH3), 2.22 (3H, s, CH3), 3.31 (IH, 
s, CH) and 4.18 (2H, q, /  7, CH2CH3); Ôc (75 MHz; C2HCI3) 13.96 (CH2ÇH3), 21.1 
(C2H 3), 26.55 (Ç2H 2C2H 3), 28.63 (ÇH3CO), 60.88 (ÇH2CH 3), 61.09 (CH), 169.71 
(ÇO2CH2CH3) and 203.21 (CH3CO).
The crude ester was converted into [2H5]-ethylfumaric acid (30, R= C2H2C2H3), 
using the same procedure outlined for unlabelled ethylfumaric acid (30, R= 
CH 2CH 3). The crude product was recrystallised from diethyl ether/hexane to 
give pHsJ-ethylfumaric acid (30, R= C2H2C2H3) as an off white solid (0.21 g, 50%), 
m.p. 195-197 °C; (Found: [M + H]+, 150.0819. C6H42H5O4 requires 150.0815); Umax 
(Nujol)/cm-l 2400-3500 and 1740; Ôh (200 MHz; 2H2 0 /N a02H) 6.70 (IH, s, CH); 8c 
(75 MHz; 2H2 0 /N aQ 2H) 12.36 (m, C2H3), 21.15 (m, C2H2), 128.50 (C-3), 151.0 (C-2) 
and 173.10 & 174.23 (2 x CO2); m /z (Cl) 150 (35%, [M + H]+), 134 (20, [M - OH]+), 106 
(100, [M + H - C02]+) and 57 (46, [C2H02]+).
pHal-Iodoethane (37)
To a stirred suspension of L1A1H4 (2.97 g, 78 mmol) and dry diethyl ether (30 
cm^) was added dropwise, dry labelled acetic acid (C2H 3CO2H) (5.0 g, 78 mmol) 
over 1 h and at 0 °C. The mixture was heated at reflux for 1 h and then 
hydrolysed w ith 2-butoxyethanol (31 cm^, 234 mmol) whilst maintaining the 
temperature between 0 - 10 °C during the addition. The desired alcohol (33) was 
isolated by distillation (77-79 °C) (3.8 g, 100%) and was used in the next stage of 
the synthesis without further purification.
TriphenyIphosphite (34) (31 g, 100 mmol) and methyl iodide (21 g, 148 mmol) 
were heated under reflux with exclusion of moisture for 36 h. The temperature 
of the refluxing mixture rose from 70 °C to 115 °C during the course of the 
reaction. Treatment of the product with anhydrous diethyl ether gave small 
yellowish-brown needles of the methiodide (36) which were repeatedly washed
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with anhydrous ether and finally dried and weighed under reduced pressure (42 
g, 94%), m.p. 145-146 °C ( lit.,100 146 °C).
T ripheny Iphosphite m ethiodide (36) (22.14 g, 49 mmol) was dissolved in 
ethyl-2,2,2-2Hs alcohol (33) (2.0 g, 41 mmol) and left to stir at room temperature 
for 3 h. The iodide (37) was isolated by distilling the reaction mixture. The 
distillation was carried out under reduced pressure and collected in a trap at -80 
°C. The condensate was collected and stored in the absence of light (4.65 g, 72%), 
b.p. 20 °C (0.5 mmHg). The labelled iodide was used in the preparation of the 
labelled fumarate (30, R= CHzC^Hg) without further purification.
[C2H3CH2l-Ethylfumaric Acid (30, R= CHzC^Hs)
H COgH
HOgC CHgC^Hg
Ethyl acetoacetate (2.56 g, 20 mmol), was added dropwise to a stirred solution 
of sodium ethoxide in anhydrous ethanol (8.0 cm^, 2.75 mol dm"^, 22 mmol). 
After 15 min of further stirring [C2HsCH2]-iodoethane (37) (3.44 g, 22 mmol) was 
added dropwise. The reaction mixture was then refluxed for 2 h  and allowed to 
cool. The solution was poured into water (50 cm^) and extracted with diethyl 
ether (5 x 25 cm^) and dried (MgSO^). The solvent was removed under reduced 
pressure to give [CH2C2H3]-2-ethyl acetoacetate ethyl ester (28, R= CH2C2H 3) as a 
yellow oil. The crude ester (28, R= CH2C 2H 3) was purified by column 
chromatography (10% ethyl acetate/ 90% hexane) to yield the pure product as a 
colourless oil (2.32 g, 72%), Ôh (200 MHz; C2HCI3) 1.28 (3H, t, /  7.2, CH2CH3), 1.85 
(2H, d, /  7.4, CH2C2H3), 2.21 (IH, s, CH3CO), 3.34 (IH, t, /  7.4, CH) and 4.22 (2H, q, 
/  7.1, CH.2C H 3); ÔC (75 MHz; C2H C I3) 11.73 (C2H 3), 13.96 (CH2Ç H 3), 21.22 
(ÇH2C2H 3), 28.59 (ÇH3CO), 61.08 (ÇH2CH3), 61.2 (CH), 169.7 (CO2CH2CH3) and 
203.13 (CH3ÇO).
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The ester (28, R= CH2C2H3), was converted into [C2H 3CH2]-ethylfumaric acid 
using the same procedure outlined for unlabelled ethylfumaric acid (30, R= 
CH 2CH 3). The crude product was recrystallised from diethyl ether/hexane to 
give p H 3]-ethylfumaric acid as an off white solid (0.55 g, 50%), m.p. 190-192 °C; 
(Found: [M + H]+, 148.0686. Calc, for C6H62H3O4: m /z, 148.0689); 'U^ax (Nujol)/cm‘ 
11683; ÔH (300 MHz; 2H2 0 /N aQ 2H) 1.20 (3H, m, CH2C2H3), 2.35 (2H, s, CH2C2H3) 
and 6.28 (IH, s, CH); ôc (75 MHz; 2H 2 0 /N aQ 2H) 11.31 (C2H3), 19.98 (CH2C2H 3), 
125.41 (CH), 143.36 (C=CH) and 174.76 & 175.65 (2 x CO2H); m /z (Cl) 148 (48%, [M 
+ H]+), 130 (24, [M + H - H20]+), 104 (100, [M + H - C02]+) and 90 (26, [C2H202]+).
3.npropylfumaric Acid (30, R= CH2CH2CH3)
H COgH
HO2C CH2CH2CH3
3-*'Propylfumaric acid (30, R= CH2CH2CH3), was prepared from ethyl acetoacetate 
and "propyl bromide (1.5 eq), using the procedure described for 3-ethylfumaric 
acid (30, R= CH2CH3), to give an overall yield of 45% for the fumaric acid (30, R = 
CH2CH 2CH3), m.p. 172-173 °C (lit.,49 175 °C); Umax (Nujol)/cm-i 1700; 8h  (200 
MHz; 2R 2 0 /N a02H) 0.75 (3H, t, /  7.5, CH3), 1.28 (2H, m, /  7.5, CH2CH3), 2.32 (2H, t, 
/  7.5 -C=C-CH2), and 6.28 (IH, s, C=CH); ôc (50.31 MHz; 2H2 0 /N a 02H) 13.8 (CH3),
22.0 (CH2), 30.3 (CH2), 128.4 (3-C), 143.4 (2-C) and 174.4 & 176.0 (2 x CO2H).
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3-iPropylfumaric Acid (30, R= CH(CH3)2)
H COgH
HOgC CH(CH3)g
3-iPropyl fumaric acid (30, R= CH(CHg)2) was prepared from ethyl acetoacetate 
and ipropyl bromide, using the procedure described for 3-ethylfumaric acid (30, 
R= CH2CH3), in an overall 48% yield, m.p. 180-183 °C (lit.,49 183-184 °C); Umax 
(Nujol)/cm-l 1700; Ôr (200 MHz; ^ O /N a O ^ H )  1.05 (6H, d, /  7, -CH(CHs)2), 3.05 
(IH, m, CH(CH3)2) and 5.8 (IH, s, C=CH); Ôc (50.31 MHz; 2H 2 0 /N a Q 2H) 13.8 
(CH3), 22.8 (CH2), 128.0 (3-C) 148.0 (2-C) and 174.4 & 175.4 (2 x CO2H).
(2S,3S)-3-Methylaspartic Acid (31, R= CH3)
Diammonium mesaconate [mesaconic acid (13 g, 0.1 mol) and NH3 to pH 7.0], 
potassium chloride (2.63 g, 4.5 mmol), magnesium chloride hexahydrate (2.13 g, 
10.5 mmol), ammonium chloride (10.7 g, 200 mmol) and tris-buffer (6 g, 50 
mmol) were dissolved in water (150 cm^) one after the other. The pH of the 
solution was adjusted to 9.0 using KOH pellets. 3-Methylaspartate ammonia 
lyase (40 cm^, 680 units/cm^) was added to the reaction mixture and incubated at 
30 °C until no further decrease in absorbance at 240 nm was observed (ca. 40 h).
The protein was denatured at 100 °C for 2 min and was removed by filtration 
on a Celite pad. The filtrate was evaporated to dryness and was crystallised at pH 
3 from 2:1 water:ethanol (80 c m ^ ) . The product was recrystallised from hot 
water/ethanol, to give pure product (10.1 g, 67%), m.p. 272-276 °C (lit.,49 276-278 
°C); (Found: C, 40.70; H, 6.25; N, 9.50. Calc, for C5H 9N O 4: C, 40.80; H, 6.15; N,
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9.50%); m/2  (Found: [M + H]+, 148.0610. Calc, for C5H10NO4: m/z 148.0607); [a]“  
-10.1 (c 0.6 in H2O), |lit,.49 [a]“  -10 (c 0.42 in H2O)); Umax (Nujol)/cm-i 1680; ôh 
(200 MHz; 2H 2O, pH 9) 1.12 (3H, d , } 7.5, 3-CHs), 3.10 (IH, m, (AB splitting), 3-H) 
and 4.10 (IH, d, /  3.0, 2-H); ôc (75 MHz; 2H2O, pH 9) 12.15 (CH3), 40.55 (CH), 55.86 
(CH) and 175.70 & 171.00 (2 x CO2); m /z  (El) 128 (12%, [M - H30]+) and 102 (100, [M 
-C02H]+).
(2S,3S)-3-EthylasparUc Acid (31, R= CH3CH2)
n.-CHoCHg
(2S,3S)-3-Ethylaspartic acid (31, R= CH3CH 2) was synthesised as described 
above for (2S,3S)-3-methylaspartic acid (2), using 3-ethylfumaric acid (30, R= 
CH3CH2) (0.5 g, 3.8 mmol) as the starting material. The product was obtained as 
white crystals (0.33 g, 59%), m.p. 244-245 °C (lit.,49 245-246 °C); [a]^ +14.8 (c 0.6 in 6 
mol dm"3 HCl) {lit.,49 [a ]^  +15.0 (c 0.6 in 6 mol dm"^ HC1)|; ôh  (200 MHz; 
2H 2 0 /N a 02H) 1.00 (3H, t, J 8.3, CH2CH3), 1.3 (2H, m, CH2CH3), 2.55 (IH, m, 3-H) 
and 3.75 (IH, d, J 4.2, 2-H); Ôc (50.31 MHz; 2H2 0 /N a 02H) 11.5 (CH3), 20.5 (CH2),
46.1 (2-C), 55.3 (3-C) and 173.9 & 171.0 (2 x CO2H).
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(2S,3S) -[C2H2C2H3]-3-Ethylaspartic Acid (31, R= C^HzC^Hs)
HgN H ^ C^ HgC^ HgH
HOgC COgH
[C^HzC^Hg] -E thy If um ar ic acid (31, R= C^HzC^Hg) (0.23 g, 15.4 mmol) was 
suspended in water (10 cm^) and then the pH adjusted to 9 (concentrated 
ammonia). This was then evaporated to dryness, to give the diammonium salt. 
The salt was re-dissolved in water (10 cm^) and potassium chloride (7.5 mg, 0.1 
mmol) and magnesium chloride hexahydrate (0.012 g, 0.2 mmol) was added. The 
pH was readjusted to 9, and after the addition of methylaspartase (25 cm^/ 680 
units per cm^), the mixture was incubated at 30 °C until no further decrease in 
absorbance at 240 nm was observed.
The protein was denatured at 100 °C for 2 min and was removed by filtration 
on a Celite pad. The filtrate was evaporated to dryness and was crystallised at 
pH 3 (the pH was adjusted to 3.0 by the addition of 12 mol dm*^ HCl). The 
product was recrystallised from hot water/ethanol to give pure product (0.15 g, 
59%), m.p. 256-258 °C; m /z  (Found: [M + H]+, 167.1078. C6H 72H 5NO 4 requires 
167.1080); [a]p +10.9 (c 1.0 in 0.5 mol dm"^ HCl); Umax (Nujol)/cm"l 2400-3500 and
1630; ÔH (200 MHz; ZHzO/NaO^H) 2.71 (IH, d, J 4 ,3-CH) and 3.90 (IH, d, /  4 ,2-CH); 
ÔC (50.31 MHz; ^HzO/NaO^H) 11.81 (3H, m, C^Hg), 20.05 (2H, m, C^Hz), 48.33 (C-3), 
56.12 (C-2), and 173.40 & 179.97 (2 x COz); m /z (Cl) 167 (59%, [M + H]+), 149 (100, 
[M + H - HzO]+), 121 (96, [M + H - CHzOz]+) and 77 (87, [CzHyNOz]+).
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(2S,3S)-pH3l-3-Ethylaspartic Acid (31, R= CH2C2H3)
HgN H
 ^ ..C H a C H
HOgC COgH
(2S,3S)-[C2H3CH2]-3-Ethylaspartic acid (31, R= CHzC^Hg) was synthesised as 
described above for (2S,3S)-[C2H3C2Hz]-3-ethylaspartic acid (31, R= C^HzC^Hg) 
using 3-[2Hg]-ethylfumaric acid (30, R= CHzC^Hg) (0.4 g, 27.2 mmol) as the starting 
material. The product was obtained as white crystals (0.25 g, 55%), m.p. 255-256 
°C; (Found: [M + H]+, 165.0948. C6Hg2HgN04 : requires 165.0955); [a]^ +10.6 (c 1.0 
in 0.5 mol dm"3 HCl); u^ax (Nujol/cm 'l) 1733; Ôh (200 MHz; ^HzO/NaQZH) 1.65 
(2H, m, CHzC^Hg), 2.86 (IH, m, 3-CH) and 4.05 (IH, d, J 5, 2-CH); Ôc (75 MHz; 
2HzO/NaQ2H) 11.50 (m, C2Hg), 21.80 (CHz), 50.10 (C-3), 58.4 (C-2) and 175.30 &
181.10 (2 X COzH); m/z (Cl) 165 (100%, [M + H]+), 147 (20, [M + H -  H 20]+) and 119 
(27,[M  + H -C O z M .
(2S,3S)-3-nPropylaspartic Acid (31, R= CH3CH2CH2)
HgN H\____^ «-CHgCHgCH3
HOgC COgH
(2S,3S)-3-n-Propylaspartic acid (31, R= CHgCHzCHz) was prepared as described 
above for (25,35)-3-methylaspartic acid (2), using 3-^propylfumaric acid (30, R= 
CHgCHzCHz) (3.0 g, 19 mmol), as the starting material. Since this compound is a 
poor substrate an extended incubation time was required. Time-dependent 
enzyme activity loss therefore became significant, so fresh aliquots of enzyme 
were added at 48 h intervals. When no further decrease in absorbance was 
observed {ca. 2 weeks) the incubation mixture was heated to denature the 
enzyme. The solution was subjected to cation exchange chromatography on
Chapter 3: Experimental /  Glutamate Mutase__________________________ 118
Amberlite IR-118(H), eluting with water and then 1.0 mol dm"  ^ aqueous 
ammonia. Fractions containing the amino acid were pooled and concentrated 
under reduced pressure. The residue was recrystallised from water/ethanol (1.8 
g, 55%), m.p. 235-236 °C (lit.,49 235-237 °C); [a]g +7.4 (c 0.5 in 6  mol dm-3 HCl), 
{lit.,® [a]g +7.6 (c 0.5 in 6  mol dm‘3 HCl)}; ôh (200 MHz; ^zO /NaO^H) 0.85 (3H, t, 
J 7.2,3' CHs), 1.35 (2H, m, CH2CH3), 1.6 (IH, m, y-CHCHzCHs), 2.95 (IH, m, 3-CH) 
and 3.95 (IH, d, /4.40,2-CH); ôc (50.31 MHz; ^HzO) 14.03 (CH3), 21.29 (CHz), 30.06 
(CHz), 46.26 (3-C), 56.201 (2-C), and 173.16 & 178.5 (2 x COzH).
(2S,3S)-3->Propylaspartic Acid (31, R= CH(CH3)z)
HgN H
1^  CH(CH3)2
HOgC COgH
(2S,3S)-3-‘Propylaspartic acid (31, R= CH(CHs)z), was prepared as described 
above for (2S,3S)-3-"propylaspartic acid (31, R= CHgCHzCHz) using 3- 
ipropylfumaric acid (30, R= CH(CH3)z) (3.0 g, 19 mmol), as the starting material. 
The product was obtained as white crystals after recrystallisation from hot 
ethanol (1.5 g, 45%), m.p. 240-242 °C (lit.,® 239-242 °C); [a]“  +7.3 (c 0.4, in 6  mol 
dm-3 HCl), {lit,® [a]“  +7.35 (c 0.4, 6  mol dm-3 HCl)); ôh (200 MHz; ^HzO) 0.9 (6 H, 
dd, J 6.34 and 22.46,3'-CH(CHs)z), 1.85 (IH, m, 3 '-CH(CHs)2), 2.6 (IH, dd, J 5.13 and 
8.06, 3-CH), and 3.9 (IH, d, /  5.13, 2-CH); ôc (50.31 MHz; ^HzO) 20.74 (CH3), 21.43 
(CHs), 27.50 (CHs), 53.56 (3'-CH), 55.50 (2-C) and 173.72 & 178.43 (2 x CO2H).
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(2S,3S)-2-Bromo-3-methyl Succinic Acid (61)
HC^ C CC^ H
To a saturated solution of potassium bromide, was added 3-methy lasp artic 
acid (2 ) (2.0 g, 13.6 mmol). The mixture was cooled to 0 °C, and a solution of 
hydrobromic acid (48%, 6 .8  cm^) was added dropwise, followed by sodium nitrite 
(1.9 g, 27.2 mmol) over 20 min. The reaction mixture was left to stir for 30 min at 
0 °C and then left to stir for a further 2 h at room temperature. The reaction 
mixture was extracted with diethyl ether (3 x 20 cm^) and the organic layers were 
combined, dried (MgS0 4 ) and concentrated under reduced pressure to yield a 
white solid, which was recrystallised using diethyl ether/light petroleum to yield 
(61) (2.35 g, 82%), m.p. 142-144 °C (lit.,153 142-144 °C); [a]^ -40.1 (c 0.6 in HzO) 
{lit.,153 [a]23 -40.42 (c 0.6 in HgO)}; ôh (200 MHz; ^HzO) 1.27 (3H, d, /  7, CHg), 3.05 
(IH, m, 3-H) and 4.51 (IH, d, J 8.5,2-H); ôc (50.31 MHz; ^ O )  17.11 (CHg), 46.18 (C- 
3), 50.59 (C-2) and 175.64 & 179.81 (2 x COzH).
(2S)-Methyl Succinic Acid (65)
To a stirred solution of (25,35)-2-bromo-3-methyl succinic acid (61) (100 mg, 
2.82 mmol) in aqueous methanol (1 :1 ) (1 0  cm^), was added palladium on 
activated carbon (10 mg). The mixture was then hydrogenated under an 
atmosphere of hydrogen, and the reaction mixture allowed to stir at room 
temperature for 6  h. The solvent was removed under reduced pressure to give a 
white solid which was recrystallised using ether/ light petroleum to yield (65) as
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a white crystalline solid (51 mg, 81%), m.p. 113-114 °C (lit.,^09 114-I14.5 °c); [a]ü 
-13.7 (c 1.15 in Ethanol) {lit.,^09 -13.5 (c 1.15 in Ethanol)}; Dmax (Nujol)/cm“l
1699; ÔH (300 MHz; ^HzO, NaO^H) 1.05 (3H, d, J 4, CH3), 2.10 (IH, dd, /  4.2, Ha), 
2.50 (IH, dd, /  4.2, Hp) and 2.65 (IH, m, 3-H); ôc (75 MHz; % 2 0 , NaO^H) 15.30 
(CH3), 38.29 (C-3), 40.56 (C-2) and 180.03 & 183.78 (2 x CO2H); m /z  (Cl) 114 (64%, 
[CsH6 0 3 ]+), 8 6  (8 8 , [C2H6 0 2 ]+), 73 (100, [C3Hs0 2 ]+), 60 (24, [C2H4 0 2 ]+) and 45 (81, 
[C0 2 H]+).
(±)-3,5-bis-[Carbomethoxyl Isoxazoline-JV-oxide (57)
To a stirred solution of methyl nitroacetate (0.2 g, 1.7 mmol) in 
dichloromethane (15 cm^) was added methyl a-bromoacrylate (51) (0.28 g, 1.7 
mmol). Potassium carbonate (0.28 g, 2.0 mmol) was then added and the reaction 
mixture was left to stir for 48 h after which time the inorganic residue was 
filtered. The organic solution was evaporated under reduced pressure to give a 
yellow oil. The crude product was purified by flash chromatography on silica gel 
(50 % ethyl acetate in hexane) to yield a white crystalline solid (0.30 g, 90%), m.p. 
64-66 X ; (Found C, 41.55; H, 4.45; N, 6.90. C7H9NO6 requires C, 41.40; H, 4.35; N, 
6.90%); m/z (Found: [M - COzCHg]^ 144.0291. [M - C0 2 CH3]+ requires 144.0295); 
ÔH (200 MHz; C^HCb), 3.70 (2H, m, CH2), 3.88 (6H, s, 2 x OCH3) and 5.15 (IH, dd, /  
4, 8 , CH); ÔC (50.31 MHz; C^HCb) 34.70 (CH2), 53.30 & 53.70 (2  x OCH3), 71.60 (CH),
106.10 (NO2ÇCH2), 159.30 (CH2-C=0 ) and 169.40 (CH-C=0); m /z  (El) 203 (3%, M+), 
172 (5, [CH3 0 J+), 144 (23, [M - 2 x CH3 0 H]+), 59 (76, [C0 2 CH3J+) and 43 (100, 
(CH3OH)).
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(±)-DimethyI cfs/tm«s-l-MethoxycycIopropane-l,2-dicarboxyIate (46,47)
C0 2 Me
H CO2 M6
C0 2 Me
Me02C H
Following the procedure reported by Kraus^® ,^ to a solution of the bromo- 
diester (42) (1.0 g, 4.2 mmol) in dry liquid ammonia (30 cm^) (liquid ammonia 
was dried by stirring with potassium amide) and dry THF (30 cm^) at -78 °C was 
rapidly added potassium hexamethyl disilazide (KHMDS) (1.0 mol dm-3' 
toluene, 4.2 mmol).
The resulting light yellow solution was stirred at -78 °C for 1 h. The reaction 
mixture was quenched with water (2 .0  cm3), extracted with dichloromethane (3 x 
50 cm3), dried (Na2S0 4 ) and concentrated under reduced pressure. The crude 
product was purified by flash chromatography (3:1 hexane:ethyl acetate) to afford 
pure dimethyl-frfltts-l-methoxycyclopropane-l,2-dioate (47) (0.1 g, 15%) and 
dimethyl-czs-l-methoxycyclopropane-1,2-dioate (46) (0.35 g, 48%). The overall 
yield of the reaction, varied from 55-63% over several runs.
Trans isomer (47); (Found: [M+H]+, 189.0759. Calc, for CgHisOs: m/z, 189.0763); 
Umax (Neat)/cm-l 3483, 3425, 1731 and 1680; Ôh (200 MHz; C^HClg) 1.63 (IH, dd, /  
5.4, 9.1, Ha), 1.91 (IH, dd, J 5.4, 7.5, Hp), 2.50 (IH, dd, /  7.5, 9.1 2-H), 3.41 (3H, s, 
OCH3) and 3.73 & 3.80 (6H, 2  x s, 2  x CO2CH3); m /z  (Cl) 189 (100%, [M + H]+), 157 
(35, [M + H - CH3 0 H]+), 129 (30, [M + H - C2H4 0 2 ]+), 73 (85, [C2Hs0 2 ]+) and 59 (70, 
[C0 2 CH3]+); Rf(hexane:ethyl acetate (3:1))= 0.44, (lit.,^04 R^(hexane:ethyl acetate 
(3:1))= 0.44).
Cis isomer (46); (Found : [M+H]+, 189.0754. Calc, for C8H 13O5 : m/z, 189.0763); 
Umax (Neat)/cm-l 3481, 3423,1730,1683; ôh (200 MHz; C^HCls) 1.53 (IH, dd, J 5.8, 
10.2, H a), 1.88 (IH , dd, /  5.8, 8.1, Hp), 2.28 (IH, dd, /  8.1, 10.2, 2-H ), 3.46 (3H, s, 
OCH3) and 3.69 & 3.76 (6 H, 2  x s, 2  x CO2CH3); Ôc (50.31 MHz; C^HCls) 20.1 (C-3),
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30.23 (C-2 ), 53.30,53.40 (2  x CO2ÇH3), 58.20 (OCH3), 66.42 (C-1) and 168.33 & 170.10 
(2 X CO2CH3); m /z (Cl) 189 (96%, [M + H]+), 157 (100, [M + H - CH3 0 H]+) and 129 
(29, [M + H - C2 H 4 0 2 ]'**); Rf(hexane:ethyl acetate (3:1))= 0.42, (lit. ,1 0 0  
Rf(hexane:ethyl acetate (3:1))= 0.42).
(±)-Dimethyl cis-l-Methoxycyclopropane-l,2-Dicarboxylate (46)
COpM©
COoMe
To a solution of the bromo-diester (42) (0.5 g, 2.1 mmol) in dry THE (30 cm )^ at 
-78 °C was added dry methanol (0.40 g, 12.6 mmol). To this mixture was rapidly 
added potassium hexamethyl disilazide (1.0 mol dm"  ^ in toluene, 2.52 mmol). 
The resulting pale yellow solution was stirred at -78 °C for 1 h and then allowed 
to warm up to room temperature. The reaction mixture was quenched with 
diethyl ether (20 cm^). The ethereal solution was washed with water (3 x 10 cm^), 
dried (MgS0 4 ) and concentrated under reduced pressure. The desired compound 
was obtained as a pale yellow oil, (0.32 g, 80%), (Found: C, 50.75; H, 6.30. Calc, for 
C8H12O5: C, 51.05; H, 6.45%); Umax (Neat)/cm"l 3480, 3423, 1731 and 1684; Ôr (200 
MHz; C2HC13) 1.53 (IH, dd, J 5.8,10.2, H«), 1.87 (IH, dd, /  5.8, 8.1, Hp), 2.27 (IH, dd, 
7 8.1,10.2,2-H), 3.46 (3H, s, OCH3) and 3.70 & 3.76 (6H, 2 x s, 2 x CO2CH3); Ôc (50.31 
MHz; C2HCI3) 19.61 (C-3), 29.66 (C-2 ), 52.2 and 52.57 (2  x CO2ÇH3), 57.76 (OCH3), 
66.44 (C-1) and 168.27 & 171.21 (2 x CO2CH3); Rf(hexane:ethyl acetate (3:1))= 0.42 
(lit.,104 Rf(hexane:ethyl acetate (3:1))= 0.42).
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(±)-Dimethyl“cis-JV-(tert-butoxycarbonyl)-2,3-methanoaspartate (58)
O'^  .C0 2 Me
H
H CO2MG 
(58)
To a solution of the bromo-diester (42) (0.3 g, 1.27 mmol) in dry THF (15 cm )^ 
at -78 °C was added a dry THF solution containing ^butylcarbamate (0.90 g, 7.62 
mmol). To this mixture was rapidly added potassium hexamethyl disilazide (1.0 
mol dm"3 in toluene, 1.65 mmol). The resulting pale yellow solution was stirred 
at -78°C for 1 h and then allowed to warm to room temperature. The reaction 
mixture was quenched with diethyl ether (10 cm^). The ethereal solution was 
washed with water ( 3 x 5  cm^), dried (MgSO^) and concentrated under reduced 
pressure. The crude product was purified by column chromatography 
(hexaneiethyl acetate (9:1)) to yield the desired compound as a white crystalline 
solid (0.23, 65%), m.p. 161-162 °C; m /z  (Found: [M + H]+, 274.1283. C12H20NO6 
requires 274.1291); Umax (Nujol)/cm'l 3284, 1722, 1653 and 1593; Ôr (200 MHz; 
C^HClg) 1.46 (9H, s, -C(CH3)s), 1.7-1.9 (3H, m, 3 -H2, -NH), 2.74 (IH, t, J6.5,2-H) and
3.69 & 3.74 (6H, 2  x s, 2  x CO2CH3); ôc (50.31 MHz; C^HC^) 24.01 (C-3), 28.59 (- 
C(CH3)3), 30.75 (C-2 ), 53.02,53.26 (2  x CO2ÇH3), 57.87 (C-1), 6 6 .47 (-C(CH3)3), 156.91 
(ÇONH) and 171.30 & 174.47 (2 x CO2CH3); m /z  274 (23%, [M + H]+), 218 (82, [M + 
H - C0 2 ]+) and 174 (100, C7Hi4N0 4 ]+).
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Methyl 1,2-Dibromopropanoate (56a)
BTsw ^ C O p C H aT
Bromine (5.57 g, 35 mmol) was added dropwise to a stirred solution of methyl 
acrylate (3.0 g, 35 mmol) in dichloromethane (50 cm^). The reaction mixture was 
left to stir for 4 h and then the solution was concentrated under reduced pressure 
to yield the desired compound as a pale yellow oil. Compound (56a) (8 .6  g, 
100%), did not require purification and was used directly in the synthesis of (51), 
ÔH (200 MHz; C^HClg) 3.68 (IH, m, BrCHzH), 3.88 (3H, s, CO2CH3), 3.98 (IH, m, 
BrCHzH) and 4.50 (IH, dd, BrCH).
Methyl a-bromoacrylate (51)
.CO2CH3
To a stirred solution of the dibromo- compound (56a) (4.0 g, 16.3 mmol) in 
dichloromethane (30 cm^) was added a solution of triethylamine (2.50 g, 25.0 
mmol) and the mixture stirred 6  h. The inorganic residue was filtered off and 
the filtrate was washed with acid (0.1 mol dm'3 HCl) (3 x 25 cm^). The organic 
fraction was concentrated under reduced pressure to yield the desired compound 
as a colourless oil (2.50 g, 93%); m /z  (Found: [M + H]+, 164.9553. Calc, for 
C4H6Br0 2 : m/z, 164.9551); Sr (200 MHz; C^HCb) 3.83 (3H, s, CO2CH3), 6.28 & 6.90 
(2 H, 2 X s, C=CH2); m/z (Cl) 167 & 165 (100,99%, [M + H]+), 119 (16, [CH2 0 2 ]+), 103 
(26, [C2H6 0 2 ]+) and 87 (89, [M + H - Br]+).
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Methyl 1,2-Dichloropropanoate (56b):rCIs^^COgCHs Cl
A stirred solution of methyl acrylate (5 g, 58.1 mmol) in dicloromethane (100 
cm3) was added a steady stream of chlorine gas at 0 °C for a period of 3-4 h (excess 
chlorine was passed into a sodium hydroxide scrubber). The reaction mixture 
was washed with a 1 0 % solution of sodium carbonate, until the washings were 
no longer acidic. The organic phase was then washed with cold water (3 x 100 
cm^). The organic fraction was dried (MgSO^), filtered and concentrated to give a 
yellow oil in quantitative yield, Sr (200 MHz; C^HClg) 3.7-4.0 (2 H, m, CH2CI), 3.85 
(3H, s, OCH3) and 4.45 (IH, m, CHCl).
Methyl a-chloroacrylate (97, X= Cl)
01^  C^OoCHo
To a pre-cooled solution of (56b) (10 g, 64 mmol) in dichloromethane (100 
cm^) at 0 °C was added dropwise triethylamine (9.7 g, 96 mmol) and the reaction 
was stirred overnight at room temperature. The reaction mixture was filtered, 
and the filtrate was washed with 0.5 mol dm~3 HCl (2 x 50 cm^), water (50 cm^), 
saturated NaHC0 3  solution (2  x 50 cm^) and finally water (150 cm^) before being 
dried (MgS0 4 ). The solvent was removed under reduced pressure to give the 
desired compound as a pale yellow oil (7.7 g, 100%), ô r  (200 MHz; C2HCI3) 3.82 
(3H, s, CO2CH3), 6.0 & 6.51 (2H, 2 x s, C=CH2).
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Methyl Dibromoacectate (91, X,Y= Br)
.CO2CH3
Dibromoacetic acid (10 g, 45 mmol) was dissolved in dry methanol (100 cm^), 
and to this stirred solution at 0 °C was added concentrated H2SO4 (5 cm^). The 
reaction mixture was left to stir overnight at room temperature. Saturated 
Na2COg solution (1 0 0  cm^) was added and any excess methanol was removed 
under reduced pressure. The desired ester was extracted from the aqueous phase 
using diethyl ether (2 x 150 cm^). The organic fractions were pooled, dried 
(MgS0 4 ) and the solvent removed under reduced pressure to give methyl 
dibromoacetate (91, X,Y= Br) (9.5 g, 91%), b.p. 180-181 °C (lit.,151 182-183 °C); Ôr 
(200 MHz; C^HClg) 4.85 (3H, s, OCH3) and 5.82 (IH, s, CHBr2); Ôc (75 MHz; C^HCb) 
31.70 (CH3), 54.10 (CHBr2) and 165.21 (CO2).
(±)-Dimethyl cïs-1-Bromocyclopropane 1,2-dicarboxylate (93, X= Br)
B r ^ ^^C02Mg
X
^ C 0 2 M g
A mixture of methyl dibromoacetate (91, X,Y= Br) (7 g, 30 mmol) and methyl 
acrylate (3.4 g, 40 mmol) was added to a stirred suspension of NaH (1.32 g, 33 
mmol, 60% in mineral oil) in dry toluene (50 cm^) at 0 °C. The reaction mixture 
was stirred at room temperature for 1 h, followed by refluxing for a period of 
24 h. The excess metal hydride was destroyed by the addition of water (5 cm^) 
and the volatile material was removed under reduced pressure to yield the 
residual oil, which was partitioned between water and ethyl acetate (1 :1; v /v , 10 0
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cm^). After further extraction with ethyl acetate (3 x 50 cm^), the organic fractions 
were pooled, dried (MgSO^) and the solvent removed under reduced pressure, to 
give a yellow oil. The crude oil was a 10:1 mixture of the l-bromo-cfs-(48) and 1- 
bromo-trflws-cyclopropane dicarboxylate dimethyl ester (47). The cis isomer was 
purified using flash chromatography on silica gel (5% ethyl acetate in hexane) 
(4.1g, 58%), Umax (Neat)/cm-l 3450, 3100, 1740, 1385, 1307, 1279, 1225, 1186 and 
1106; 6h (200 MHz; C^HCls) 1.69 (IH, dd, /  7,10, Ha), 2.12 (IH, t, /  7, Hp), 2.44 (IH, 
dd, /  7,10, 2 -H) and 3.60 & 3.73 (6H, 2s, 2 x OCH3); ôc (50.31 MHz; C^HCls), 22.59 
(C-3), 29.35 (C-2 ), 30.88 (C-1), 52.55 (C-2 -CO2CH3), 53.51 (C-I-CO2ÇH3) and 167.80 & 
169.08 (2  X CO2); (Rf 0.33, 5% ethyl acetate in hexane).
(±)*ds-l-Bromocyclopropane-l,2-dicarboxylic Add (95, X= Br)
B r ^ COgH
^ C O g H
. . .
Dimethyl l-bromocyclopropane-cis-l,2-dicarboxylate (48) (2 g, 8.4 mmol) was 
suspended in 6  mol dm"  ^HCl (80 cm^) and the solution was then refluxed for 2  
h. To the solution was added KOH (2 mol dm" )^ until the pH was between 9-10. 
The aqueous phase was washed with dichloromethane (2 x 50 cm^) acidified to 
pH 1 (6  mol dm'^ HCl) and extracted with ethyl acetate (3 x 50 cm^). The organic 
fractions were pooled, dried (MgS0 4 ) and removed under reduced pressure to 
give l-bromo-c/s-cyclopropane-l,2-dicarboxylic acid (95, X= Br) as a white solid 
which was recrystallised using ethyl acetate/light petroleum ether (1.75 g, 85%), 
m.p. 140 °C (lit.,152 140-141 °C); m/z (Found: [M + NH4 ]+, 225.9715. Calc, for 
C5H5 0 4 Br: 225.9715); Umax (Nujol)/cm-l 1700 (b), 1305, 1265 and 1212; 6 h (200 
MHz; 2H2O) 1.80 (IH, dd, J 6 ,10, H«) 2.02 (IH, dd, /  7.5,10, Hp) and 2.60 (IH, dd, /  
7.5,10, 2-H); Ôc (50.31 MHz; ^ O /N a O ^ H ) 23.48 (C-3), 31.62 (C-1), 32.41 (C-2) and
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171.86 & 173.67 (2 x CO2H); m /z (Cl) 226 (38%, [M + NH^j^), 148 (100, [M + NH4 
CH4N0 3 1 +), 105 (17, [C2H3N0 4 ]+) and 62 (15, [CH4N0 2 ]+).
(±)“DimethyI frflMS-l-Bromocyclopropane-l,2-dicarboxylate (94, X= Br)
'
Br-w COgMe
/
\
MeOgC
A mixture of methyl dibromoacetate (91, X,Y= Br) (10 g, 43 mmol) and methyl 
acrylate (4.8 g, 56 mmol), was added to a stirred suspension of NaH (1.9 g, 47 
mmol, 60% in mineral oil) in dry DMF (50 cm^) at 0 °C. The reaction mixture 
was stirred at 80 °C for 24 h. The excess metal hydride was destroyed by the 
addition of water (10 cm^). Volatile material was removed under reduced 
pressure and the residual oil was partitioned between water and ethyl acetate (1 :1; 
v /v , 100 cm^). After further extraction with ethyl acetate (3 x 50 cm^), the organic 
fractions were pooled, dried (MgS0 4 ) and the solvent was removed under 
reduced pressure to give a yellow oil. The crude oil was a 2:3 mixture of the 1- 
bromo-czs-(48) and l-bromo-trans-cyclopropanedicarboxylate dimethyl ester (47) 
(both isomers 6.54 g, 60%, as determined by ^H-NMR). The trans-isomer was 
purified using flash chromatography on silica gel (5% ethyl acetate in hexane) 
(3.9 g, 36%); Umax (Neat)/ cm'l 3460, 3100,1750,1385,1375,1320,1280 and 1225; ôr  
(200 MHz; C^HCW 1.85-2.05 (2H, m, %  and Hp), 2.60 (IH, dd, /  9 ,11 ,2-H) and 3.77, 
3.80 (6 H, 2s, 2  x OCH3); Ôc (50 MHz; C2HCI3) 22.58 (C-3), 29.93 (C-2 ), 30.43 (C-1),
52.69 (C-2 -CO2ÇH3), 34.09 (C-I-CO2CH3) and 167.76 & 168.67 (2  x CO2). (Rf 0.36,5% 
ethyl acetate in hexane).
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Method 2
(±)-Dimethyl tmrts-l-Bromocyclopropane-l,2-dicarboxylate (94, X= Br)
To a stirred suspension of potassium hydride (1.4 g, 12 mmol, 35% in mineral 
oil) in dry DMF (15 cm^), was added methyl bromoacetate (91, X= Br, Y= H), (1.8 g, 
12 mmol) and methyl a-bromoacrylate (97, X= Br) (2.0 g, 12 mmol) at 0 °C. The 
reaction mixture was stirred at room temperature for 10 h. The excess metal 
hydride was destroyed by the addition of water (2 cm^). Volatile material was 
removed under reduced pressure and the residual oil was partitioned between 
water and ethyl acetate (1:1; v /v , 50 cm^). After further extraction with ethyl 
acetate (3 x 20 cm^) the organic fractions were pooled, dried (MgSO^) and the 
solvent was removed under reduced pressure to give a yellow oil. The crude oil 
was a 1:5 mixture of the 1-bromo-czs- (4 8 ) and 1-brom o-fran s-  
cyclopropanedicarboxylate dimethyl ester (47) (both isomers 2.38 g 83%). The 
trans-isomer (47), was purified using flash chromatography on silica gel (5% 
ethyl acetate in hexane) (1.90 g, 6 6 %), Umax (Neat)/ cm"i 3460, 3100, 1750, 1385, 
1375, 1320, 1280 and 1225; 5h (200 MHz; C^HCls) 1.85-2.05 (2H, m, Ha & Hp), 2.60 
(IH, dd, J 9, 11, 2-H), and 3.77 & 3.80 (6H, 2s, 2 x OCH3); ôc (50.31 MHz; C^HCls) 
22.58 (C-3), 29.93 (C-2 ), 30.43 (C-1), 52.69 (C-2 -CO2CH3), 34.09 (C-I-CO2ÇH3) and 
167.76 & 168.67 (2  x CO2); (Rf 0.36, 5% ethyl acetate in hexane).
(±)-t#'fl«s-l-Bromocyclopropane-l,2-dicarboxylic Acid (96, X= Br)
'
Br4^ COgH
\
H O g C ^
Dimethyl l-bromocyclopropane-frans-dicarboxylate (47) (2  g, 8.4 mmol) was 
suspended in HCl (80 cm^, 6  mol dm'^) and the solution was refluxed for 2 h. To
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the solution was added KOH (2 mol dm“^ ) until the pH was between 9-10. The 
aqueous phase was washed with dichloromethane (2 x 50 cm^), acidified to pH 1 
(HCl, 6  mol dm-3) and extracted with ethyl acetate (3 x 50 cm^). The organic 
fractions were pooled, dried (MgS0 4 ) and removed under reduced pressure to 
give l-bromo-trflns-cyclopropane-l,2-dicarboxylic acid (96, X= Br) as a white solid, 
which was recrystallised using ethyl acetate/ light petroleum (1.41 g, 80%), m.p. 
174-5 °C (lit.,152 1 7 5  °c), (Found: C, 28.85; H, 2.30. Calc, for CgHgBrO :^ C, 28.70; H, 
2.40);m/z (Found: [M + NH4]+, 225.9715 Calc, for CsH9BrN0 4 : m /z, 225.9715); 
Umax (Nujol)/cm-l 1700 (b), 1290, 1242 and 1140; Ôr (200 MHz; % 2 0 ) 1.73, 1.94 
(2H, m. Hoc & Hp) and 2.61 (IH, dd, J 8 , 9, 2-H); ôc (50.31 MHz; 2H2O) 25.7 (C-3),
32.2 (C-2 ), 37.4 (C-1) and 171.8 & 174.9 (2  x CO2); m/z (Cl) 226 & 228 (40, 38%, [M + 
NH J+), 148 (1 0 0 , [M + NH4 ]+ - [CH4NO 3]-), 105 (19, [C2H 3N 0 4 ]+) and 62 (16, 
[CH4N02]+).
(±)-Dimethyl tmws-l-Chlorocyclopropane-l,2-dicarboxylate (94, X= Cl)
' 'I
C l ^ ^^COgMe
/
X
MeOgC
Compound (94, X= Cl) was prepared using methyl dichloroacetate (10 g, 70 
mmol), and methyl acrylate (6 .0  g, 70 mmol) in the presence of sodium hydride 
(3.08 g, 77 mmol, 60% in mineral oil) in dry DMF (100 cm^) at 0 °C, using the 
procedure described for compound (47) (method 1). The crude-diester was a 3:1 
mixture of the l-chloro-trans- (94, X= Cl) and 1-chloro-cis-cyclopropane- 
dicarboxylate dimethyl ester (93, X= Cl) (both isomers 10.2g, 76%, as determined 
by iH-NMR). The trans-isomer was purified using flash chromatography on 
silica gel (2 0 % ethyl acetate in hexane) to give the desired compound as a 
colourless oil (6 .8 g, 51%), (Found: [M + H]+, 193.0259. Calc, for C7H 10CIO4 : m /z.
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193.0268); Umax (Neat)/cm"l 2954, 1740, 1385, 1283, 1028 and 928; Ôr (200 MHz; 
C2HC1s) 1.92-1.96 (2H, d, /  8.5, %  & Hp), 2.67 (IH, t, /  8.4, 2-H) and 3.75 & 3.77 (6H, 
2 x s, 2 X OCH3); ÔC (50.31 MHz; C2HCI3) 23.51 (C-3), 31.19 (C-2), 42.79 (C-1), 53.11 
(C-2-CO2CH3). 54.34 (C-I-CO2CH3) and 167.90 & 169.41 (2 x CO2); m /z (Cl) 193 & 
195 (30, 10%, [M + H]+) and 161 & 163 (100, 31, [M + H - CH3 0H]+); (Rf 0.32, 20% 
ethyl acetate in hexane).
Method 2
(±)-Dimethyl tfa«s-l-Chlorocyclopropane-l,2-Dicarboxylate (94, X= Cl)
Compound (94, X= Cl), was prepared from methyl chloroacetate (1.8 g, 16.6 
mmol) and methyl-a-chloroacrylate (97, X= Cl) (2.0 g, 16.6 mmol) in the presence 
of KH (1.9 g, 16.6 mmol, 35% in mineral oil) in dry DMF (15 cm^) at 0 °C, using 
the modified procedure as described for method 2. The crude diester was a 5:1 
m ixture of the l-chloro-frflns-(94, X= Cl) and 1-chloro-cfs-cyclopropane- 
dicarboxylate dimethyl ester (93, X= Cl) (both isomers 2.56 g, 80%). The trans 
isomer was purified using flash chromatography on silica gel (20% ethyl acetate 
in hexane) (2.0 g, 64%), Umax (Neat)/ cm’l 2957,1735,1384, 1284, 1027 and 924; Ôr  
(200 MHz; C2HCI3) 1.92-1.97 (2H, d, /  8.5, H« & Hp), 2.70 (IH, dd, /  8.5,2-H) and 3.76 
& 3.79 (6H, 2 X s, 2 X OCH3); 0c(50.31 MHz; C2HCI3) 23.53 (C-3), 31.2 (C-2), 42.8 (C- 
1), 53.1 (C-2-CO2ÇH3). 54.4 (C-I-CO2ÇH3) and 167.9 & 169.4 (2 x CO2); m /z (Cl) 193 
& 195 (100, 35%, [M + H]+), and 161 & 163 (5, 4, [M + H - CH30H]+); (Rf 0.32, 20% 
ethyl acetate in hexane).
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(±)-Dimethyl cis-l-Chlorocyclopropane 1,2-dicarboxylate (93, X= Cl)
C i v . CO 2 CH 3
^ C O g C H g
Compound (93, X=C1), was prepared from methyl dichloroacetate (91, X, Y= 
Cl) (10 g, 70 mmol) and methyl acrylate (6.0 g, 70 mmol) using the procedure 
described for 1-bromo-czs -cyclopropanedicarboxylate dimethyl ester (93, X= Br). 
The crude diester was a 1:3 m ixture of the 1-chloro-frans-cyclopropane- 
dicarboxylate dim ethyl ester (94, X= Cl) and 1-chloro-cis- cyclopropane­
dicarboxylate dimethyl ester (93, X= Cl). The c/s-isomer was purified using flash 
chromatography on silica gel (20% ethyl acetate in hexane) (9.4 g, 70%), (Found: 
[M + H]+, 193.0265. Calc, for C7H 10CIO4: m /z, 193.0268); Umax (Neat)/cm-i 2956, 
1749,1379,1230 and 1122; ôh (200 MHz; C^HCla) 1.67 (IH, dd, J 3.5,5, % ) , 2.13 (IH, 
dd, /  4,5, Hp), 2.44 (IH, dd, /  4 ,5 ,2-H) and 3.75 & 3.82 (6H, 2 x s, 2 x OCH3); ôc (50.31 
MHz; C2HCI3) 22.8 (C-3), 30.41 (C-2), 32.1 (C-1), 52.5 (C-2-CO2C H 3), 53.0 (C-1- 
CO2ÇH3), and 166.6 & 169.0 (2 x CO2); m /z  (Cl) 193 & 195 (100, 36%, [M + H]+) and 
161 & 163 (46,15, [M + H - CH3OHI+ ); (Rf 0.26, 20% ethyl acetate in hexane).
(±)-tra«s-l-Chlorocyclopropane-l,2-dicarboxylic Acid (96, X= Cl)
c i v . COgH
/\
H O g C ^
Compound (94, X= Cl) (3.0 g, 16 mmol) was used to prepare the cyclopropane- 
dioic acid (96, X= Cl), using the general procedure as described for compound (96,
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X= Br). The desired compound was isolated and recrystallised from ethyl acetate 
in hexane (1:9), to give a white crystalline solid (2.3 g, 90%), m.p. 178-180 °C; 
(Foimd: C, 36.55; H, 2.85. Calc, for C5H5CIO4; C, 36.60; H, 3.05); m/z (Found: [M + 
H]+, 164.9963. Calc, for C5H6CIO4: m /z, 164.9955); Umax (Nujol)/cm-i 2925, 1697 
and 1450; 5h (200 MHz; 2H2O) 1.85 (IH, dd, 73,3 4 ,72,3 6, H„), 2.05 (IH, dd, 73,3 4 ,72,3 
9, Hp) and 2.80 (IH, dd, 7np,2 9,7na,2 6, 2-H); ôc (50.31 MHz; 2H 2O) 20.6 (C-3), 28.7 
(C-2), 41.1 (C-1) and 169.5 & 170.2 (2 x CO2); m/z (Cl) 165 & 167 (100, 40%, [M + 
H]+), 147 & 149 (59,20, [M + H - H20]+) and 129 (88, [M + H - 2 x H20]+).
(±)-cis-l-Chlorocyclopropane-l,2 -dicarboxylic Acid (95, X= Cl)
C l ^ CO2H
^C O sH
Compound (93, X= Cl) (3.0 g, 16 mmol) was used to prepare the cyclopropane- 
dioic acid (95, X= Cl), using the general procedure as described for compound (95, 
X= Br). The desired compound was isolated and recrystallised from ethyl 
acetate:hexane (1:9), to give a white crystalline solid (2.3 g, 90%), m.p. 120-122 °C; 
(Found: C, 36.90; H, 2.80. Calc, for C5H5CIO4: C, 36.60; H, 3.05); m/z (Found: [M + 
H]+, 164.9949. Calc, for C5H 6CIO4: m /z, 164.9955); Umax (Nujol)/cm-i 2923, 1699 
and 1455; ôh (200 MHz; 2H2O) 1.81 (IH, dd, J 7.5,10, H«), 2.25 (IH, t, J 10, Hp) and 
2.58 (IH, t, 710, 2-H); ôc (50.31 MHz; 2H 2O) 20.10 (C-3), 35.40 (C-2), 46.1 (C-1) and 
173.5 & 174.7 (2 x CO2H); m/z (Cl) 165 (100%, [M + H]+), 147 (59, [M + H - HzO]+) 
and 129 (88, [M + H - 2 x H20]+)
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(±)“Dimethyl cjs-l-Methylcyclopropane-l,2-dicarboxylate (93, X= CH3)
/
^COgCHg
To a stirred suspension of sodium hydride (3.25 g, 80 mmol, 60% in mineral 
oil) in dry toluene (50 cm^) was added a mixture of methyl a-chloropropionate 
(91, X= CH3, Y= Cl) (10 g, 80 mmol) and methyl acrylate (7.0 g, 80 mmol) at 0 °C. 
The reaction mixture was stirred at room temperature for 1 h  and then refluxed 
for 24 h. The excess metal hydride was destroyed by the addition of water (5 cm^). 
Volatile material was removed under reduced pressure and the residual oil was 
partitioned between water and ethyl acetate (1:1; v /v , 100 cm^). After further 
extraction with ethyl acetate (3 x 50 cm^) the organic fractions were pooled, dried 
(MgS0 4 ) and solvent was removed under reduced pressure to give a yellow oil. 
The crude oil was a 10:1 mixture of the l-methyl-cis-(93, X= CH3) and 1-methyl- 
frans-cyclopropane dicarboxylate dimethyl ester (94, X= CH3). The czs-isomer was 
purified using flash chromatography on silica gel (20% ethyl acetate in hexane) 
(10.2 g, 74%), m/z (Found: [M + H]+, 173.0806. Calc, for C8H 13O4: m /z, 173.0814); 
ÔH (200 MHz; C^HCW 1.06 (IH, dd, J 8,12, H«), 1.39 (3H, s, CH3), 1.8 (2H, m, Hp, 2- 
H), and 3.60 & 3.70 (6H, 2s, 2 x OCH3); ôc (50.31 MHz; C % C l3) 20.20 (C-3), 21.55 
(CH3), 29.09 (C-2), 32.56 (C-1), 52.7 & 52.70 (2 x OCH3) and 174.00 & 174.50 (2 x CO2); 
m/z (Cl) 173 (100%, [M + H]+) and 73 (91, [C3Hs02]+); (Rf 0.18, 20% ethyl acetate in 
hexane);
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(±)-Dimethyl tra«s-l-Methylcyclopropane-l,2-dicarboxylate (94, X= CH3)
CO 2 CH 3
H 3C 02C ^  H
Compound (94, X= CH3) was prepared using methyl a-chloropropionate (91, 
X= CHs, Y= Cl) (10 g, 80 mmol) and methyl acrylate (7.0 g, 80 mmol) in the 
presence of sodium hydride (3.25 g, 80 mmol, 60% in mineral oil) in dry DMF (50 
cm^), at 0 °C, using the procedure described for (94, X= Cl). The crude oil was a 
10:1 mixture of the l-methyl-tra«s -(94, X= CH3) and 1-methyl-cis-cyclopropane 
dicarboxylate dimethyl ester (93, X= CH3). The trans isomer was purified using 
flash chromatography on silica gel (20 % ethyl acetate in hexane) (10.2 g, 74%), 
m/z (Found: [M + H]+, 173.0821. Calc, for C8H 13O4: m /z, 173.0814); Ôh (200 MHz; 
C^HCls), 1.29 (IH, dd, 7 4, 7, H«), 1.39 (3H, s, CH3), 1.54 (IH, dd, /  4,9, Hp), 2.30 (IH, 
dd, J 7, 9, 2-H) and 3.69 & 3.70 (6H, 2s, 2 x OCH3); ôc (50.31 MHz; C^HCls) 13.52 (C- 
3), 21.57 (CHs), 28.16 (C-2), 34.83 (C-1), 52.4 & 52.8 (2 x OCH3) and 171.35 & 174.42 (2 
X CO2); m/z (Cl) 173 (13, [M + H]+), 97 (22, [M + H - CsH802]+) and 73 (100, 
[C3H502]'*’); (Rf 0.26, 20% ethyl acetate in hexane).
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(±)-cis-l-Methylcydopropane-l;,2 -dicarboxylic Acid (95, X= CH3)
COgH
^ C 0 2 H
A suspension of the diester (93, X= CH3) (3.0 g, 17 mmol) was in hydrochloric 
acid (3 mol dm"3, 33 cm^) was heated to reflux for 4 h. The solution was basified 
with potassium hydroxide (2 mol dm"^) until the pH was 9-10. The aqueous 
phase was washed with dichloromethane (2 x 50 cm^) and the aqueous phase was 
then acidified to pH  1 using hydrochloric acid (6 mol dm"^). The acidified 
solution was then extracted with ethyl acetate (3 x 50 cm^) and the organic phases 
were pooled, dried (MgS04) and concentrated to leave a white solid, which was 
recrystallised using ethyl acetate/hexane (1:9). The desired compound was 
isolated as a white crystalline solid (2.33 g, 95%), m.p. 139-140 °C (lit.,123 139-141 
°Cy, (Found: C, 51.05; H, 5.85. Calc, for C6H 8O4: C, 50.00; H, 5.60); m/z (Found: [M 
+ H]+, 145.0509. Calc, for 145.0501); Umax (Nujol)/cm"l 1683 (b), 1321, 1264 and 
1224; ÔH (300 MHz; ^HiO) 1.21 (IH, dd, 73,3 5,72,3 8, Ha), 1.34 (3H, s, CH3), 1.63 (IH, 
dd, 73,3 5,72,3 6, Hp) and 1.98 (IH, dd, 7na,2 8,7hP,2 6, 2-H); ôc (75 MHz; ^HzO) 17.80 
(CH3), 17.89 (C-3), 26.88 (C-2), 27.62 (C-1) and 173.17 & 174.68 (2 x CO2H); m/z (Cl) 
145 (84, [M + H]+ and 127, (100, [M + H - H20]+).
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(±)-fra«s-l-Methylcyclopropane-l,2-dicarboxylic Acid (96, X= CH3)
/
\
HOgC^
Compound (96, X= CH3), was prepared in the same manner as compound (95, 
X= CH3), using the diester (94, X= CH3) (3.0 g, 17 mmol) as the starting material. 
The desired compound was recrystallised ethyl acetateihexane (1:9) and isolated 
as a white crystalline solid (2.4 g, 98%), m.p. 168-170 °C (lit.,123 170 °C); (Found: C, 
50.05; H, 5.65. Calc, for CéHgO^: C, 50.0; H, 5.60); m/z (Found: [M + H]+, 145.0509. 
Calc, for 145.0501); Umax (Nujol)/cm 'l 1683 (b), 1307, 1246 and 1193; Ôr (200 MHz; 
C2H3Q2H) 1.25 (IH, dd, /3,3 6, /2,3 10, % ) , 1.38 (3H, s, CH 3), 1.70 (IH, dd, / 3,3 6, h ,3 
13, Hp) and 2.28 (IH, dd, /Ra,2 10,/Rp,2 13/ 2-H); ôc (50.31 MHz; C2H3O2H) 13.90 (C- 
3), 21.80 (CH3), 27.80 (C-1), 29.10 (C-2) and 174.18 & 177.53 (2 x CO2H); m/z (Cl) 145 
(78, [M + H]+, 130 (22, [M + H - CH3]+), 127 (100, [M + H - H20]+).
(±)-Dimethyl trfl«s-l-Ethylcyclopropane-l,2-dicarboxylate (94, X= CH2CH3)
CO 2 CH 3
H gC O gC ^ H
Com pound (94, X= CH2C H 3), was prepared using the general method as 
described for compound (94, X= CH3). The preparation was carried out using 
methyl (±)-2-bromobutyrate (91, X= Br, Y= CH2CH3) (10 g, 55 mmol) and methyl 
acrylate (4.7 g, 55 mmol) in the presence of sodium hydride (60% disp. in mineral 
oil, 2.2 g, 55 mmol) and dry DMF (100 cm^). The reaction tem perature was
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maintained between 40-60 °C. Following the general work up , the crude diester 
was found to be a mixture of the trans-l-ethyl- (94, X= CH2CH3) and czs-l-ethyl- 
cyclopropane dicarboxylate (93, X= CH2CH3) (5:1, as judged by ^H-NMR). The 
trans isomer was purified using flash chromatography on silica gel (20% ethyl 
acetate in hexane) (6.2 g, 65%), m/z (Found: [M + H]+, 187,0965 Calc, for C9HX5O4: 
m/z, 187.0970; Dmax (Nujol) /cm"l 1735, 1725, 1395, 1248 and 1022; 8h  (200 MHz; 
C2HCI3) 0.70 (3H, t, /  9, CH3CH2), 1.08 (IH, dd, /  5, 7, H«), 1.24 (IH, dd, /  5,10, Hp) 
1.49 (IH, m, AB splitting, CH3-CH-H) 1.65 (IH, m, AB splitting, /  5,10, CH3-CH-H) 
and 2.13 (IH, dd, /  7.5,10, 2-H); 6c  (50.31 MHz; C^HC^) 12.4 (ÇH3CH2), 20.9 (C-3), 
21.0 (CH3ÇH2) 27.4 (C-2), 33.6 (C-1), 52.4 & 52.6 (2 x OCH3) and 171.5 & 173.6 (2 x 
CO2); m/z (Cl) 187 (100%, [M + H]+), 155 (28, [M + H - CH30HJ+) and 125 (8, [M + H 
- 2 X 0 CH3]+); (Rf 0.45, 20% ethyl acetate in hexane).
(±)-l-Ethyl-trfl«s-cydopropane-l,2 -Dicarboxylic Acid (96, X= CH2CH3)
This compound (96, X= CH2CH3), was prepared in a manner identical to that 
for (95, X= CH3), using the diester (94, X= CH2CH 3) (4.0 g, 21.5 mmol) as the 
starting material. The desired compound was recrystallised ethyl acetate:hexane 
(1:9) and isolated as a white crystalline solid (3.23 g, 95%), m.p. 158-160 °C; 
(Found: C, 53.00; H, 6.45. Calc, for C7H 10O4: C, 53.15; H, 6.35); m/z (Found: [M + 
H]+, 159.0663 Calc, for C7H 11O4: m /z , 159.0657); Umax (Nujol) /c m 'l 2924, 1683, 
1457 and 1377; 6h  (200 MHz; C2H 3O2H) 0.91 (3H, t, /  7, CH3CH2), 1.26 (IH, dd, 
/3,3 4, /2,3 6, Ha), 1.46 (IH, dd, 73,3 4 ,7z,3 8, Hp) 1.75 (IH, m, AB splitting, /  7, CH3- 
CH-H) 1.90 (IH, m, AB splitting, /  7, CH3-CH-H) and 2.31 (IH, dd, Jna,2 6, /h |5,2 8,
2-H); 6c  (50.31 MHz; C2H3O2H) 12.5 (ÇH3CH2), 21.3 (C-3), 22.1 (CH3CH2) 28.3 (C-2),
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34.21 (C-1) and 174.50 & 176.60 (2 x CO2H); m/z (Cl) 159 (32%, [M + H]+ 141 (100, 
[M + H - H20]+) and 127 (19, [C7H n 03]+).
(±)-l,2-tm«s-Cyclopropanedicarboxylic Acid (96, X= H)
'
C O 2 H
y
H O g C ^
Com pound (96, X= H), was prepared in a manner identical to that for 
compound (95, X= CH3), using the commercially available (±)-diethyl trans-1,2- 
cylopropane dicarboxylate (5 g, 26.9 mmol) as the starting material. The desired 
compound was recrystallised ethyl acetate:hexane (1:9) and isolated as a white 
crystalline solid (3.3 g, 95%), m.p. 176-177 °C (lit.,123 177-177.5 °C); Umax 
(Nujol)/cm -l 1680, 1305, 1237 and 1190; Ôr (200 MHz; C % 3 0 % ) 2.85 (2H, m, 3- 
CH2) and 3.53 (2H, m, 1-H, 2-H); 6c  (50.31 MHz; C % 302H) 18.73 (C-3), 25.94 (C-1, 
C-2) and 178.28 (2 x CO2H); m/z (Cl) 131 (8%, [M + H]+, 108 (100, [M - OH6]+), 94 
(45, [M + H - 2 X H20]+), 57 (47, [C02HJ+).
(±)-traws-2-Methyl-Epoxysuccinic Acid (102)
HgC X  CO2H
Mesaconic acid (30 R= H) (20 g, 154 mmol), Na2W0 4 .H20  (5.1 g, 15.4 mmol) 
and water (450 cm^) were stirred together at room temperature. The dissolution 
of the solid acid was aided by the periodic addition of potassium hydroxide 
(2 mol dm-3). After the solid was completely dissolved the pH  of the solution
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was adjusted to 6.2 by the addition of potassium hydroxide (1 mol dm"^) and /  or 
H 2SO4 (1 mol dm”3). After 10 min of additional stirring at room temperature, an 
aqueous solution of hydrogen peroxide (6.3 g, 185 mmol) was added. The pH of 
the reaction mixture was kept between 5.8 and 6.8. The reaction mixture was 
heated to 65 °C for 3 h, followed by 75 °C for 1 h. The mixture was cooled down 
to room temperature and the mixture acidified to pH <2.0 with H2SO4 (6 mol 
dm"^), saturated with ammonium sulphate, and extracted with diethyl ether (5 x 
150 cm^). The organic fractions were dried (MgS0 4 ), filtered and evaporated 
under reduced pressure, to yield a white solid, which was recrystallised from 
diethyl e ther/ light petroleum (16.7 g, 74%), m.p. 165-167 °C; (Found: C, 41.10; H, 
4.10. Calc, for C5H6O5: C, 41.10; H, 4.15%); m /z  (Found: [M + H]+, 147.0295. Calc, 
for C5H 7O5: m /z, 147.0293); Umax (Nujol)/cm-l 1713; 6h  (200 MHz; 2H2O) 1.50 (3H, 
s, CH3) and 3.89 (IH, s, 3-H); ô r  (50.31 MHz; 2H2O) 15.09 (CH3), 60.51 (C-3), 61.35 
(C-2) and 172.89 & 175.15 (2 x CO2H); m /z (Cl) 147 (13%, [M + H]+), 129 (25, [M + H 
- H20]+) and 103 (100, [M + H - [C02]+).
(±)-Dimethyl-tmMS-2-Methyl-Epoxysuccinate (106)
H3C O^^COzCHa 
H3CO2C H
To a stirred solution of the epoxide (102) (0.5 g, 3.4 mmol) dissolved in a 
minimum volume of diethyl ether, was added dropwise, an ethereal solution of 
diazomethane at 0 °C. Diazomethane was added until the colour of the reaction 
mixture remained yellow, and the mixture was stirred for 30 m in at room 
temperature. The reaction mixture was purged with nitrogen for 20 min, after 
which the solvent was removed under reduced pressure to give the desired ester 
(106) (0.58 g, 97%), m /z  (Found: [M + H]+, 175.0598. Calc, for C7H 11O 5: m /z , 
175.0606); Umax (N eat)/cm 'l 2958, 1751, 1438 and 1387; Ôr  (200 MHz; C2HCI3) 1.60 
(3H, s, CH3), 3.79 (3H, s, C-2 OCH3) and 3.82 (4H, s, 3-H, C-4 OCH3); m /z (Cl) 175
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(98%, [M + H]+), 115 (100, [M + H - C2H 4021+), 89 (10, [C3H s0 3 ]+) and 73 (49, 
[C3H 5O2]'''); Rf(diethyl ether:hexane (3:2))= 0.47, (lit.,129 Rf(diethyl ether:hexane
(3:2))= 0.47).
(±)-l-MethyI tmMs-l,2-diamido[]V-(2R)-phenyl ethanol]cyclopropane (99)
O H
P h
To a dry solution of thionyl chloride (65.6 g, 486 mmol) was added in one 
portion the cyclopropanedicarboxylic acid (96, X= CH3) (7.0 g, 48.6 mmol) under a 
stream of nitrogen. The reaction mixture was stirred under nitrogen for a period 
of 15 min, before being refluxed for a period of 45 min. The reaction mixture was 
allowed to cool down to room tem perature, after which any excess thionyl 
chloride was removed under reduced pressure, leaving behind the diacid 
chloride as a solid crystalline product. The diacid chloride was dissolved in dry 
THF (20 cm^) and was used immediately in the next stage of the synthesis, 
without purification.
To a solution of (R)-2-phenylglycinol (13.3 g, 97.2 mmol) in dry THF (50 cm^) 
was added triethylamine (11.7 g, 116.6 mmol) at 5 °C. To this stirred solution was 
added dropwise (over 30 mins), the dry THF solution of the diacid chloride (from 
above) under nitrogen. The reaction mixture was left to stir overnight at room 
temperature after which time the solvent was removed under reduced pressure 
leaving behind a solid residue. The residue was dissolved in ethyl acetate (100 
cm^) and was washed with HCl (1 mol dm"^) solution (3 x 50 cm^) followed by 
water (3 x 50 cm^). The organic fractions were pooled, dried (MgS0 4 ) and
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concentrated under reduced pressure, to give the desired compound (99) as a 
white solid (16.53 g, 89%).
Chromatographic Resolution of (99)
The mixture of diastereomers (99), were resolved on t.Lc. grade silica gel using 
gradient-elution column chromatography. The diastereomers were loaded onto 
a packed column and eluted first w ith neat ethyl acetate (1 bed volume), 
secondly, with 2% methanol in ethyl acetate (1 bed volume) and finally by 
eluting the column with 4% methanol in ethyl acetate (continuous flow). The 
(jR, JR)-diastereomer (99a) came off the column first (Rf 0.21 2% methanol in ethyl 
acetate), followed by the (S,S)-diastereomer (99b) (Rf 0.15 2% methanol in ethyl 
acetate).
(IR, 2R)-l-Methyl-tm«s-l,2-diamido[Ar-(2R)-phenyl ethanoljcyclopropane (99a)
O H
P h
Ph.
H O
m.p. 60 °C; (Found C, 68.85; H, 7,0; N, 7.20. C22H26N2O4 requires C, 69.10; H, 6.85; 
N, 7,35%); m/z (Found: [M + H]+, 383.1960. C22H 27N 2O4 requires 383.1971); [a]D 
+30.6 (c 1.0 in MeOH); Umax (Nujol)/cm-l, 3438, 3355,1634 and 1073; Ôr (300 MHz; 
C2H302H) 1.33 (IH, dd, /3,3 7, J2,3 9, H„), 1.55 (IH, dd, /3,3 7, /2,3 14, Hp), 1.67 (3H, s, 
CH3), 2.45 (IH, dd, /Ha,2 9, /hp ,2 14, 2-H), 3.80-4.10 (4H, m, 2 x CH2OH), 5.22 (2H, 
m, 2 X CHCH2OH) 7.30 (lOH, m, 2 x CeHs) and 8.11 & 8.88 (2H, d, /  8,2  x NH); §c 
(75 MHz; C^HaO^H) 14.7 (CH3), 20.1 (C-3), 29.3 (C-1), 30.52 (C-2), 58.3, 58.5 
(C.HCH2OH), 66.8, 67.1 (CH2OH), 128.9, 128.9, 129.3 and 130.4 (aromatic), 142.2 
(ipso-C), 171.8 and 175.7 (2 x CO2); m/z (Cl) 383 (12%, [M + H]+), 246 (10, [M + H -
CgHiiNO]+), 138 (100, [CgHi2NO]+) and 127 (47, [C6H9N02]+).
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(IS, 2S)“l-Methyl-fmws-l,2-diamido[N-(2R)-phenyl ethanoljcyclopropane (99b)
H
s H P h
H O
m.p. 145-146 °C; m/z (Found: [M + H]+, 383.1973. C22H 27N 2O4 requires 383.1971); 
[ a ] D  -125.8 (c 1.0 in MeOH); Umax (Nujol)/cm-l 3648, 3375,1655 and 1075; 8 h  (300 
MHz; C2H302H) 1.28 (IH, dd, 73,3 6 ,72,3 10, H„), 1.31 (3H, s, CH3), 1.45 (IH, dd, 73,3 
6,72,3 13, Hp), 2.32 (IH, dd, 7np,2 13, 7h«,2 10, 2-H), 3.75 (4H, m, 2 x CH2OH), 5.05 
(2H, m, 2 X CHCH2OH), 7.20-7.40 (lOH, m, 2 x CgHg) and 7.95 & 8.75 (2H, d, 7 8 ,2  x 
NH); ÔC (75 MHz; C2H3O2H) 13.93 (CH3), 19.42 (C-3), 28.53 (C-1), 29.71 (C-2), 57.52 
& 57.75 (C H C H 2OH), 66.30, 66.0 (C H 2OH), 127.91, 128.1, 128.53 and 129.66 
(aromatic), 141.31 (ipso-C) and 171.83 & 175.74 (2 x CO2); m/z (Cl) 383 (100%, [M + 
H]+), 264 (12, [CsH9N]+) and 138 (2, [CgHi2NO]+).
(±)-l-Bromo-trfl«s-l,2-diamido[Af-(2jR)-phenyl ethanol]cyclopropane (98)
To a dry solution of thionyl chloride (3.49 g, 26 mmol) was added in one 
portion the cyclopropane dicarboxylic acid (96, X= Br) (0.54 g, 2.6 mmol), under a 
stream of nitrogen. The reaction mixture was stirred under nitrogen for a period 
of 15 min, before being refluxed for a period of 45 min. The reaction mixture was 
then allowed to cool down to room temperature after which time, any excess
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thionyl chloride was removed under reduced pressure leaving the diacid 
chloride as a solid crystalline product. The diacid chloride was dissolved in dry 
THF (5 cm^) and was used immediately in the next stage of the synthesis, 
without purification.
To a solution of (R)-2-phenylglycinol (0.70 g, 5.2 mmol), in dry THF (10 cm )^ 
was added triethylamine (0.63 g, 6.2 mmol) at 5 °C. To this stirred solution, was 
added dropwise (over 30 min) the dry THF solution of the diacid chloride (from 
above), under nitrogen. The reaction mixture was left to stir overnight at room 
temperature, after which time the solvent was removed under reduced pressure, 
leaving behind a solid residue. The residue was dissolved in ethyl acetate (100 
cm^) and washed with HCl (1 mol dm" )^ solution (3 x 15 cm^), followed by water 
(3 X 15 cm^). The organic fractions were pooled, dried (MgS0 4 ) and concentrated 
under reduced pressure to give the desired compound (98) as a white solid (0.98g, 
85%).
Chromatographic Resolution of (98)
The mixture of diastereomers (98) were resolved on t.l.c. grade silica gel using 
column chromatography. The diastereomers were loaded onto a packed column 
and eluted with ethyl acetate. Diastereomer-(S,S) (98b) came off the column first 
(Rf of 0.39 in ethyl acetate), followed by diastereomer-(R,R) (98a) (Rf of 0.15 in 
ethyl acetate).
Chapter 3: Experimental /  Methyl Aspartase Ammonia Lyase__________  145
(IS, 2S)-l-Bromo-frflMS-l,2~diamido[N-(2R)-phenyl ethanol]Cyclopropane (98b)
OH
Ph
Ph
HO'
m.p. 148-150 °C; (Found C, 56.35; H, 5.15; N, 6.05. C2iH23N2Br0 4  requires: C, 56.40; 
H, 5.20; N, 6.25%); w/z (Found: [M + H]+, 447.0927. C2 iH 23N 2Br0 4  requires 
447.0919); M d  -104 (c 1.0 in MeOH); Umax (Nujol)/cm-l 3651, 3384,1658 and 1074 ; 
ÔH (200 MHz; 1.83 (2H, m, H«, Hp), 2.62 (IH, m, 2-H), 3.85 (4H, m, 2  x
CH2OH), 5.10 (2H, m, 2 X CHCH2OH), 7.20-7.50 (lOH, m, 2  x CsHg) and 8.41 & 8.91 
(2H, d, /  8 ,2  X NH); ô c  (75 MHz; C ^ O ^ H ) 21.6 (C-3), 31.3 (C-2), 34.7 (C-1), 57.7,58.3 
(2 X ÇHCH2OH), 65.8, 66.1 (2 x CH2OH), 127.8-129.6 (aromatic) and , 140.8 & 141.1 
(2 X ipso-C) and 168.6 & 169.6 (2 x CO2); m/z (Cl) 449 & 447 (30, 29%, [M + H]+), 369 
(15, [M + H - Br]+), 351 (18, [M + H-BrH2 0 ]+), 138 (39, [CgHi2NO]+) and58 (100, [2x 
COH]+).
(IR, 2R)-l-Bromo-tm«s-l,2 -diamidoIN-(2 jR)-phenyl ethanoljcyclopropane (98a)
o
HO °
R H
R
m.p. 110-111 °C; (Found C, 56.85; H, 5.15; N, 6.05. C2iH23N2Br0 4  requires: C, 56.40; 
H, 5.20; N, 6.25%); [a]o +34.4 (c 1.0 in MeOH); Umax (Nujol)/cm-l 3650, 3378,1661 
and 1079 ; 5h (200 MHz; C^sO^H) 1.84 (2H, d, H„, Hp), 2.63 (IH, m, 2-H), 3.7-3.9 
(4H, m, 2  X CH2OH), 5.05 (2H, m, 2 x CHCH2OH), 7.20-7.50 (lOH, m, 2  x CeHs) and
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8.32 & 8 ,8 8  (2H, d J  8 , 2 x NH); ôc (50.31 MHz; C^HsO^H) 22.4 (C-3), 31.4 (C-2 ), 34.7 
(C-1), 58.6 & 58.7 (2 x CHCH2OH), 66.1 & 66.5 (2 x ÇH2OH), 128.3-129.9 (aromatic), 
141.1 and 141.3 (2x ipso-C) and 169.0 & 169.8 (2 x CO2); m/z (Cl) 447 (28%, [M + 
H]+), 369 (10, [M + H - Br]+), 351 (15, [M + H - [H2BrO]+) and 138 (35, [CgHi2NO]+).
(+)-(lS,2S)-l-Methyl"fmiis-cyclopropane-l,2-dioic Acid (1 0 1 b)
(lS,2S)-l-Methyl-trans-l,2-diamido[N-(2K)-phenylethanol]cyclopropane (99b) 
(1.49 g, 3.9 mmol) was suspended in a 3 mol dm"  ^ solution of H2SO4 (8  cm^, 24 
mmol), at 0 °C. This mixture was stirred for 10 min, before being heated to 70 °C. 
The reaction mixture was maintained at 70 °C for a period of 24 h after which 
time the reaction mixture was allowed to cool down to room temperature. The 
aqueous phase was extracted with diethyl ether (3 x 20 cm^). The organic 
fractions were pooled, dried (MgS0 4 ) and concentrated under reduced pressure to 
give the desired product as an off white solid. The crude product was 
recrystallised using ethyl acetate/ hexane (1:9), to leave the pure compound as a 
white crystalline solid (0.51 g, 91%), m.p. 168 °C; (Found: C, 49.80; H, 5.60. C6Hg0 4  
requires C, 50.0; H, 5.60%); m/z (Found: [M + H]+, 145.0499. C6H 9O4 requires: 
145.0500); [a]ü +191.4 (c 1.0 in MeOH); u^ax (Nujol)/cm-l 2925, 1683, 1456 and
1377; ÔH (200 MHz; C^HgO^H) 1.25 (IH, dd, J3,3 4, /2,3 6 , Ha), 1.40 (3H, s, CH3), 1.55 
(IH, dd, / 3,3 4, / 2,3 8 , Hp) and 2.29 (IH, dd, /Ha,2 6,/hP,2 8 , 2-H); ôc (50.31 MHz; 
C2H3Q2H) 13.9 (CH3), 21.8 (C-3), 27.8 (C-1), 29.1 (C-2), 174.2 and 177.6 (2 x CO2H); 
m/z (Cl) 145 (94%, [M + H]+), 130 (5, [M + H - CH3 ]+) and 127 (100, [M + H - 
H2 0 ]+).
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(-)-(lR,2R)“l-Methyl-tra«s-cyclopropane-l,2-dioic Acid (1 0 1 a)
HO
OH
This compound (1 0 1 a) was prepared in a manner identical to that for 
compound (101b), using the diastereomer (99a) (2.0 g, 5.24 mmol), and a 3 mol 
d m "3 solution of H2SO 4 (10.5 cm^, 31.4 mmol). The crude product was 
recrystallised using ethyl acetate/hexane (1:9) to leave the pure compound as a 
white crystalline solid (0.70 g, 93%), m.p. 168 °C; [a]o -191.4 (c 1.0 in MeOH); 
(Found: C, 50.00; H, 5.55. CeHgO^ requires: C, 50.00; H, 5.60%); m/z (Found: [M + 
H ]+145.0490. C6H9O4 requires 145.0500); Umax(Nujol)/cm-l 2925, 1683, 1456 and 
1377; ÔH (200 MHz; C^HsC^H) 1.24 (IH, dd, 73,3 4 ,72,3 6 , % ), 1.38 (3H, s, CH3), 1.54 
(IH, dd, 73,3 4 ,72,3 8 , Hp) and 2.28 (IH, dd, Jua,2 6 , 7h(3,2 8 , 2-H); ôc (50.31 MHz; 
C2H3 0 2 H) 13.9 (CH3), 21.8 (C-3), 27.8 (C-1), 29.1 (C-2 ) and 174.2 & 177.5 (2  x CO2H); 
m/z (Cl) 145 (100, [M + H]+), 130 (13, [M + H - CH3]+) and 127 (83, [M + H - H2 0 ]+).
(-)-(lS,2S)-l-Bromo traMS-cyclopropane-l,2-dioic Acid (100b)
OH
HO
This compound (1 0 0 b) was prepared in manner identical to that for 
compound (101b), using the diastereomer (98b) (0.43 g, 0.96 mmol), and a 3 mol 
d m s o l u t i o n  of H2 SO 4 (1.9 cm^, 5.8 mmol). The crude product was 
recrystallised using ethyl acetate/ hexane (1:9) to leave the pure compound as a 
white crystalline solid (0.19 g, 95%), m.p. 174-175 °C; (Found: C, 28.85; H, 2.35.
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CsHgBrO^ requires C, 28.75; H, 2.40%); [a]o  -91.43 (c 1.0 in MeOH); Umax 
(Nujol)/cm-l 1699,1290,1242 and 1139; ô r  (200 MHz; ^HzO) 1.72, 1.94 (2H, m. H» 
& Hp) and 2.60 (IH, m, 2-H); Sc (50.31 MHz; % 2 0 ) 25.7 (C-3), 32.2 (C-2), 37.5 (C-1) 
and 171.8 & 174.9 (2  x CO2H); m/z (Cl) 209 & 2 1 1  (42,38%, [M + H]+), 191 & 193 (35, 
33, [M + H - H2 0 ]+) and 129 & 131 (100,38, [M + H - Br]+).
(+)-(lR,2R)-l-Bromo-frans-cyclopropane-l,2-dioic Acid (100a)
This compound (100a) was prepared in a manner identical to that for 
compound (1 0 0 b), using the diastereomer (98a) (0.65 g, 1.45 mmol), and a 3 mol 
d m -3 solution of H2 SO 4 (2.9 cm^, 8.73 mmol). The crude product was 
recrystallised using ethyl acetate/hexane (1:9), to leave the pure compound as a 
white crystalline solid (0.28 g, 92%), m.p. 174-175 °C; (Found: C, 28.95; H, 2.25. 
CsH5Br0 4  requires C, 28.75; H, 2.40%); m/z (Found: [M + H]+, 208.9453. C5H6B1O 4 
requires 208.9449); [a]o +91.5 (c 1.0 in MeOH); Umax (Nujol)/cm-l 1699, 1291, 1245 
and 1143; Sr (200 MHz; 2H2O) 1.72 & 1.94 (2H, m, H„ & Hp) and 2.61 (IH, m, 2-H); 
Sc (50.31 MHz; % 2 0 ) 25.7 (C-3), 32.3 (C-2), 37.4 (C-1) and 171.8 & 174.9 (2 x CO2H); 
m /z (Cl) 209 & 211 (33,31%, [M + H]+), 191 & 193 (31,30, [M + H - HzO]+) and 129 
&131 (100,40, [M + H - Br]+).
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Enzyme Kinetics
3-Methylaspartate ammonia-lyase was purified by Dr. K. Morris from an E. 
coli cell growth containing the pSG4 plasmid.^^ The specific activity of the 
enzyme used in the kinetic studies, was 46-92 units (mg of protein)"!.
General Procedure for the Kinetic Inhibition Studies.
Experiments were performed at an incubation temperature of 30 °C, pH = 9, 
with[Mg2+] (MgCl2 .6 H2 0 ) = 20 mmol dm" ,^ [K+] (KCl) = 1 mmol dm" ,^ tris buffer 
(tris[hydroxymethyl]aminomethane) = 500 mmol dm" ,^ (2S,3S)-3-methylaspartic 
acid = 1-5 mmol dm"  ^ [inhibitor] (which was varied in concentration) and 
enzyme. The total volume of the enzyme assay ranged from 1-3 cm^. The 
specific activity of the enzyme used in these studies, ranged from 46-92 units mg" 
!, from which 25 jidm^ was diluted with phosphate buffer (750 pdm^, 10 mmol 
dm"3). The kinetic experiments performed were allowed to equilibrate to 30 °C 
before being initiated by the addition of 10  fxdm  ^of the diluted enzyme solution. 
Initial rates were measured in 1 or 3 cm  ^ quartz cuvettes (10 mm path length) 
and each rate measurement was carried out in triplicate. The kinetic reaction 
was followed directly spectrophotometrically at 240 nm (Shimadzu-UV-2101 PC), 
under the stated conditions. Kinetic data was analysed with Lineweaver-Burk 
plots.
Determination of Inhibition via ICgo Assays
The assays were based on the general procedure as described above. The 
assays were compared by varying different inhibitor concentrations (0 -1 0  mmol 
dm"3) against a fixed concentration of substrate (2  mmol dm" )^.
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Summary of Assay Conditions for Methylaspartase Inhibitors
CO2H C^OgH
X— CO,H
Reaction
Conditions
Stereo­
chemistry
X [Inhibitor] 
(mmol dm" )^
[Substrate] 
(mmol dm"3)
standard (+,-)-trans- H 0,20,30,40 1.0, 1.25,1.67, 2.5,5.0
standard (+,~)-cis- Me 0 ,3 ,7 1.0,1.25,1.67, 2,5, 5.0
standard (+,-)-trans- Me 0,0.1, 0.25, 0.5 0.2,0.25,0.4,0.6,2.0
standard (+,-)~trans- Et 0,1.0, 2.5, 5.0 1.0,1.25,1.67,2.5,5.0
standard (+,-)-trans- Cl 0,1.0, 2.5, 5.0 1.0,1.25,1.67,2.5,5.0
standard (+,-)-trans- Br 0 ,1 ,2 ,4 ,8 2.0
standard (lR,2R)~trans~ Br 0,1.0, 2.5, 5.0 1.0,1.25,1.67,2.5,5.0
standard (lS,2S)-trans- Br 0 ,3 ,6 ,1 0 2.0
standard (lS,2S)-trans- Me 0, 0.4, 0.8, 0.12 1.0,1.25,1.67,2.5,5.0
standard (lR,2R)-tran$- Me 0, 0.5, 0.67,1.0 1.0,1.25,1.67,2.5,5.0
std + (lS,2S)-trans- Me 0, 0.4, 0.8, 0.12 1.0,1.25,1.67,2.5,5.0
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Methyl 3-Hydroxy 2-methylene-3-phenylpropenoate (115)
O H
Benzaldehyde (24.6 g, 23.6 cm^, 0.232 mol), methyl acrylate (13 g, 13.6 cm^, 
0.151 mol) and l,4-diazabicyclo[2.2.2]octane (0.847 g, 75 mmol) were stirred 
together in a sealed flask for seven days at room temperature. The resultant 
mixture was washed successively with hydrochloric acid (6  mol dm" ,^ 50 cm^), 
sodium hydroxide (2 mol dm" ,^ 50 cm^) and saturated brine (50 cm^). The 
organic portion was diluted with diethyl ether (50 cm^), and then dried (MgSO^). 
The solvent was removed under reduced pressure to give a pale yellow oil, 
which was purified by distillation under reduced pressure to yield the desired 
compound (115) as a colourless oil, (26 g, 90%), b.p. 160 °C/18 mmHg; (Found: C 
68.70; H, 6.00. Calc, for C11H12O3 C, 68.50; H, 6.10%); Dmax(Neat)/cm-l 1723, 1631 
and 3467; Ôh (200 MHz; C^HClg) 3.35 (IH, s, CH), 3.75 (3H, s, OCH3), 5.57 (IH, s, 
CHOH), 5.89 & 6.38 (2H, s, C=CHz) and 7.40 (5H, m, Ph); Ôc (50.13 MHz; C^HCb) 
52.40 (OCH3), 73.52 (COH), 126.54, 127.23 and 128.30 (aromatic), 128.00 (C=CH2), 
141.81 (ipso-C), 142.56 (£=CH2 ) and 167.24 (CO2CH3).
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Methyl (E)-2-BromomethyIcinnamate (116)
The hydroxy ester (115), (10 g, 50 mmol) was suspended in hydrobromic acid 
(48%, 290 mmol) and concentrated sulphuric acid (1,5 cm^) and was stirred at 
room temperature for 12 h. The resulting solution was extracted with diethyl 
ether (3 x 50 cm^) and the pooled organic fractions were dried (MgSO^) and 
concentrated under reduced pressure to give a yellow oil. This was purified by 
distillation to yield the bromo ester (116) as a clear pale yellow oil (11.2 g, 97%), 
b.p. 160 °C /5  mmHg; (Found: C 52.0; H, 4.5. Calc, for CnHnOaBr: C, 52.0; H, 4.5%); 
Dmax (Neat)/cm-l 1718 and 1626; Ôh (200 MHz; C^HClg) 3.89 (3H, s, OCH3), 4.40 
(2H, s, CHzBr), 7.85 (IH, s, C=CH) and 7.25 & 7.85 (5H, m, Ph); Ôc (50.13 MHz; 
C2HC1s), 27.4 (CHzBr), 53.0 (OCH3), 129.1-129.4 (aromatic), 130.2 (C=CH), 134.7 
(ipso-C), 143.5 (£=CH) and 167.1 (CO2CH3).
Methyl (E)-2-Azidomethylcinnamate (117)
The bromo ester, (116), (2.0 g, 10  mmol) was heated to reflux in 50% aqueous 
acetone (50 cm^) for 4 h with sodium azide (0.616 g, 9.5 mmol). The resulting 
solution was concentrated to 25 cm  ^under reduced pressure, and the aqueous 
residue was then extracted with diethyl ether (3 x 50 cm^). The organic fractions 
were pooled, dried (MgSO^) and the solvent was removed under reduced
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pressure to yield the desired product as a pale yellow opaque oil, (1.95 g, 90%). 
The isolated product (117) was used directly in the following step without any 
purification; \)max(Neat)/crn-l 2109,1724 and 1632; Ôr (200 MHz; C^HClg) 3.90 (3H, 
s, OCRs), 4.19 (2 H, s, CH2N 3), 7.43 (5H, m, Ph) and 7.98 (IH, s, C=CH); ôc (50.31 
MHz; C^HCls) 47.5 (CH2N 3), 53.0 (OCH3), 127.1, 129.3 &130.1, (aromatic), 130.2 
(C=£H), 134.7 (ipso-C), 145.1 (C=CH) and 168.0 (ÇO2CH3); m/z (El) 59 (45%, 
[C2H3O2+]), 77.(18, [C6H6+]), 143 (100, [C11H11+]) and 175 (6 8 , [C11H11O2+]).
(±) Methyl Z-Benzyl-S-aminopropanoate. HCl (118)
A solution of the azido ester (117) (0.2 g, 0.92 mmol) in methanol (10 cm^) was 
stirred overnight with 2% palladium on charcoal (0.04 g) under hydrogen. After 
the reaction was complete (as monitored by t.l.c.), the reaction mixture was 
filtered, and concentrated under reduced pressure. To the crude oil was added an 
aqueous solution of HCl (5 cm^, 1 mol dm" )^ and the mixture was left to stir at 0  
°C for 30 min. The mixture was extracted with diethyl ether (3 x 10 cm^) and the 
aqueous phase was concentrated under reduced pressure. The solid residue, was 
recrystallised from water/ethanol to yield a white crystalline solid (0.125 g, 70%), 
m.p. 140 °C; (Found: [M + HJ+ 193.1094. C11H 15NO 2 requires 193.1099); Umax 
(Nujol)/cm -l 1732; Ô r  (200 MHz; 2H2O) 2.95 (2H, m, CH2), 3.12 (3H, m, CH2 & 
CH), and 3.71 (3H, s, OCH3); ôc (50.31 MHz; 2H 2O) 38.28 (CH3), 42.5 (CH), 47.5 
(CH2), 55.62 (CHz-Ph), 130.10-140.03 (aromatic) and 177.53 (C=0); m/z (Cl), 193 
(58%, [M + H]+), 176 (100, [CnHi2 0 2 ]+) and 91 (34, [CzH7]+).
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Methyl [N-acetyl]-3-Aminomethylcinnamate (1 2 1 )
OCH;
To a stirred solution of methyl (Z)-2-azidomethyl-3-phenylprop-2-enoate (117) 
(5 g, 23 mmol) in a dry solution of THF (50 cm )^ was added triphenyl phosphine 
(6  g, 23 mmol) under anhydrous conditions. The resulting mixture was stirred 
for 1 -2  h at room temperature until no further starting material remained (as 
judged by t.l.c). To the reaction mixture was added water (0.63 cm^, 35 mmol) 
and stirring was continued for a further 4 h, after which time the THF was 
removed under reduced pressure. The remaining oil was triturated in cold 
diethyl ether which resulted in the precipitation of triphenylphosphine oxide. 
The triphenylphosphine oxide was filtered off and the trituration procedure 
repeated until no traces of the oxide could be detected by t.l.c. To the filtrate was 
added water (20 cm^) and the mixture was extracted with diethyl ether (3 x 30 
cm^). The organic fractions were pooled, dried (MgSO^) and concentrated to yield 
the desired ester (120) as a pale yellow oil (4.1 g, 93%).
The ester (1 2 0 ) (1.0 g, 5.2 mmol) was dissolved in anhydrous THF (15 cm^) and 
the solution was allowed to stir at 0 °C. To the cold solution was then added 
dropwise, acetic anhydride (2.67 g, 26.7 mmol) and the resulting mixture was 
stirred at 0 °C for 2 h. The reaction mixture was concentrated under reduced 
pressure. The solid residue was recrystallised from ethyl acetate/light petroleum, 
to yield the desired compound as a white crystalline solid (0.95 g, 78%), m.p. 133- 
134 °C; m /z (Found: [M]+, 233.1048. C22H 27N 2O4 requires 233.1052); Umax 
(Nujol)/cm-1, 2253, 1701, 1438 and 1274; Ôr (200 MHz; C^HClg) 2.0 (3H, s, CH3), 
3.86 (3H, s, -CO2CH3), 4.35 (2H, d, CH2), 6.19 (IH, b, -NH), 7.31-7.64 (5H, m, Ph) and 
7.8 (IH, s, -C=CH-); ôc (50.31 MHz; C2HCI3) 23.83 (CH2), 37.31 (CH3CO), 52.77 
(CO2CH3), 128.9-130.15 (aromatic), 132.48 (C=CH), 132.66 (ipso-C), 134.60 (C=CH)
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168.85 (CH3CO) and 170.21 (CO2CH3); m/z (El) 233 (30%, [M]+), 201 (18, [M 
CH3 0 H]+), 190 (100, [M - C2H3 0 ]+) and 173 (15, [M - C2H6NO]+).
CHAPTER 4
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Appendix 1
Enzyme Kinetics
3-Methylaspartase catalyses a reaction in which a single substrate, (2S,3S)- 
methylaspartic acid (2 ), is converted into a single product, mesaconic acid (3 ) 
(Scheme 1.6). To understand some of the kinetic results presented here, simple 
Michaelis-Menten kinetics and inhibition of one substrate reactions have been 
described.
Michaelis-Menten Kinetics
Enzyme catalysis generally occurs via rapid and reversible formation of a 
complex, ES, between enzyme, E, and its substrate, S. The region of the enzyme 
to which the substrate binds, is known as the active site . This complex, breaks 
down in a slow step giving the product, P, and regenerating the enzyme (Scheme 
4.1).
L. ES
k.i
ES E + P
kh k.\, ki represents the rate constants for 
the individual steps.
Scheme 4,1: The Conversion of Substrate to Product in an Enzyme Catalysed
Reaction
In scheme 4.1, the breakdown of the ES complex to E + S is faster than the 
breakdown of ES complex to E + P. The equilibrium constant, K, is defined by:
[E][S]
[ES] equation 1
(where [E] and [S] are the concentrations of free enzyme and free substrate 
respectively). As the total concentration of substrate is much greater than the
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total concentration of enzyme, and thus we can set [ S l f r e e  little from [ S ] t o t a l /  and 
can be approximated to [ S l to ta l-
[ES]p  = -------------  equation 2
The fractional saturation, JF, of the enzyme is given by:
[E]+ [ES]
Thus, from equation 1,
[E][S]
Kp  ---------------  equation 3[E][S]
[E1 + ---------K
The total concentration of enzyme is written [E]o, then [ES] = F[E]o; thus from 
equation 3,
[E]o[S][ES] = ---------  equation 4K + [S]
The rate of product formation, v, is determined by the rate of [ES] breakdown, 
such that V = /c2 [ES],
[E]o [S].*. V = k i   equation 5
K + S
The maximum rate, Vmax/  will be observed when all the enzyme is in the 
form of the ES complex. (i.e, V^ max = ^2 [E]o)
Vmax [S]p = ----------  equation 6K + [S]
From this it can be seen that when [S] = K, the rate of product formation is 
half-maximal (v = y  max/2). K is termed the Michaelis constant, and is normally 
written as Km- Km is a crude measure of the affinity of an enzyme, for its 
substrate.
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When interpreting kinetic data, it is often difficult to determine the limiting 
value of v against [S], and therefore, by implication Km. This can be overcome by 
rearranging equation 6 so as to give a linear graphical representation. Some of 
the best known rearranged forms are given below:
(0 The Lineweaver-Burk plot^^^: This equation is obtained by taking 
reciprocals of the two sides of equation 6 yields:
1 Km 1 1— = ------------ h------- equation 7u [S ]  y  max y  max
Thus a plot of 1 /v  against 1/[S] gives a straight line of slope Km/y  max/ with x 
and y intercepts of - 1/Km and 1/ymax respectively (Fig. 4.1, A).
in) The Eadie-Hofstee plot^55,l56; Equation 6 can be rearranged to give:
V ymax
[S] Km Km equation 8
Thus a plot of v/[S] against v gives a straight line of slope - 1/Km and with an 
%-axis intercept of ymax (Fig- 4.1, B).
iiii) The Hanes plot^^ :^ Equation 6  is rearranged to give:
[S] [S] „4-------  equation 9
V y max V max
Thus a plot of [S]/v against [S] is linear with a slope of 1/ymax and an x-axis 
intercept of -Km (Fig. 4.1, C).
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slope = 1/Vmax
1/v-1/Km
1/Vmax
1/[S]
slope = -1 /Km lS]/v
v/[Sl Vmax .1/Km
[S]V
Figure 4,1: Graphical Representation of Enzymic Data
Inhibitors of enzyme-catalysed reactions are important as they can give an 
insight at the molecular level, into the active site structure and catalytic 
mechanism of the enzyme. Since the cyclopropane inhibitors designed for MAL, 
were found to behave as reversible inhibitors. I shall confine my attention to 
reversible inhibitors.
General Overview of Inhibition
Enzymes are known to be irreversibly inactivated by heat or chemical 
reagents. They can also be reversibly inhibited by the non covalent binding of 
ligands. There are four main types of reversible inhibition, each of which will be 
discussed here.
Enzyme-catalysed reactions usually follow the general scheme (Scheme 4.2), 
as below.
K:El
El
ES ES
K,ESI
ESI
E + P
Scheme 4,2: A General Overview of Inhibition in Enzyme-Catalysed
Reactions
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We can follow this general scheme when dealing with different types of 
inhibition.
(i.) Competitive Inhibition:
In this case, the inhibitor. I, binds reversibly to the active site of the enzyme 
and prevents substrate, S, binding, and vice versa. I and S therefore compete for 
the active site and I is said to be a competitive inhibitor. It follows that K^si = 
and the general kinetic equation for the Lineweaver-Burk plot becomes:
1  ^ , Kes _ [^3 _1
V Vmax Vmax [S]
equation 10
The effect of the inhibitor on the Lineweaver-Burk plot is shown in Fig. 4.2 
Vmax is  unaffected but the apparent is increased by a factor (1 + [I ] /K e i). 
Effectively, the inhibitor pulls some of the enzyme over into the form of the El 
complex. When the concentration of S is increased sufficiently, the effect on the 
rate can be overcome.
With Inhibitor
1 /v
No Inhibitor
-l/Kmd+ra/Kp,) 1/Vmax
1/[S]
-1/Km
Figure 4.2: Effect of a Competitive Inhibitor on a Lineweaver-Burk Plot
The Lineweaver-Burk plot has the disadvantage of compressing the data 
points at high substrate concentrations into a small region and emphasising 
points at lower concentrations. It can therefore be inaccurate when determining
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Km values. Ki values can be determined by the application of a secondary plot. 
The secondary graph, is a plot of the gradient, m, from the Lineweaver-Burk plot, 
versus inhibitor concentration, [I], and is of the form:
Km Km[I]m = H  equation 11
Vmax VmaxKi
KmIt can be seen that the gradient of this secondary plot is ---------  and the y-
VmaxKi
Kmintercept is at
Vmax
^ [ I ]1h-----K
apparent Km As ------------------ = -----
apparent Km, a plot of the ------------------- v e r s u sapparent Vmsx Vmax  ^  j  apparent Vmax
inhibitor concentration, [I], also gives the same gradient and y-intercept as 
described above. The apparent K m  and V m a x  values are obtained via non-linear 
regression on the substrate, [S], versus the rate, (u), plot.
(ii) Uncompetitive Inhibition:
When the inhibitor. I, cannot combine with E, but only combines with the ES 
complex, this is known as uncompetitive inhibition {i.e. when Kgi = <«). The 
general kinetic equation used for uncompetitive inhibition is:
1 1
V  V imax
14. “
Kesi
4 - - ^  equation 12
Vmax [S ]
The effect of the inhibitor on the Lineweaver-Burk plot is shown in Fig. 4.4.
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With Inhibitor
1/v
No Inhibitor(1+[I]/K ESi)
Vmax
Km 1/Vmax
1/IS]
-1/Km
Figure 4.4: Effect of an UnCompetitive Inhibitor on a Lineweaver-Burk Plot
For uncompetitive inhibition, both Km and Vmax are affected to the same 
degree, by the inhibitor giving rise to parallel lines.
ini) Non-Competitive Inhibition:
When the binding of substrate, S, to the enzyme does not affect the binding of 
inhibitor. I, (i.e. Kesi = Kni) then this is known as non-competitive inhibition. 
The general kinetic equation used for non-competitive inhibition is:
1 1 r I D ] K es r [111
—  = ------- 1 + — +  ■ 1 + —
V 1/max KEI_ Vmax K m . [S] equation 13
The effect of the inhibitor on the Lineweaver-Burk plot is shown in Fig. 4.3.
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With Inhibitor
1/v
No Inhibitor
Vmax
1/Vmax
1/[S]
-1/Km
Figure 4,3: Effect of a Non-Competitive Inhibitor on a Lineweaver-Burk Plot
The Km remains unaffected, but Vmax is decreased by a factor of 1 / ( 1 + ( [ I ] / K e i )). 
Addition of inhibitor pulls both E and ES over into inactive forms (El and ESI 
respectively), but does not effect the distribution between them. Hence, 
increasing the concentration of S cannot overcome the effect of the inhibitor on 
the rate.
(iv) Mixed Inhibition
When the binding of substrate, S, to the enzyme affects the binding of 
inhibitor. I, such that Xesi Is different from Kei, the inhibition is termed mixed. 
In this case, both Km and Vmax are altered. The cross-over point is found in 
either of the negative x quadrants.
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Lineweaver-Burk Plot for (±)-tmws-Cyclopropane 1,2-Dioic Acid
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Lineweaver-Burk Plot for (±)-cis-l-Methylcyclopropane 1,2-Dioic Acid
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Lineweaver-Burk Plot for (±)-tr/ïus-l-Methylcyclopropane 1,2-Dioic Acid
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Lineweaver-Burk Plot for (±)-traMS-l“Ethylcydopropane 1,2-Dioic Acid
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Lineweaver-Burk Plot for (lR,2jR)-l-Bromocyclopropane 1,2-Dioic Acid
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Lineweaver-Burk Plot for (lS,2S)-l-Methylcyclopropane 1,2-Dioic Acid
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Lineweaver-Burk Plot for (lR,2R)-l-Methylcyclopropane 1,2-Dioic Acid
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Lineweaver Burk Plot for (lS,2S)-l-Methylcyclopropane 1,2-Dioic Acid in the 
Presence of Ammonia (10 mmol dm" )^
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IC50 Plot of (±)-l-Bromocyclopropane 1,2-Dioic Acid
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Crystallography Data
(lR,2J^)-l“Methylcyclopropane 1,2-dicaboxylic acid (101a) 
Intramolecular Bond Angles (°) Involving the Nonhydrogen Atoms
atom atom atom angle atom atom atom angle
C(5) N (l) C(6) 120.7(9) 0(9) 0(8) 003) 118(1)
C(14) N(2) C(15) 120.7(9) 0(8) 0(9) 0(10) 120(1)
C(2) C(l) C(3) 57.9(6) 0(9) 0(10) 001) 122(1)
C(2) C(l) C(4) 119.5(8) 0(10) 001) 002) 118(1)
C(2) C(l) C(5) 114.5(9) 0(11) 002) 003) 120(2)
C(3) C(l) C(4) 119.3(9) 0(8) 003) 002) 121(1)
C(3) C(l) C(5) 114.1(9) 0(3) 0(14) N(2) 123.6(9)
C(4) C(l) C(5) 117.8(9) 0(3) 004) 0(2) 124(1)
C(l) C(2) C(3) 59.0(6) N(2) 004) 0(2) 112.8(9)
C(l) C(2) C(14) 123.2(9) N(2) 005) 006) 107.3(9)
C(3) C(2) C(14) 119.8(9) N(2) 005) 007) 113.2(8)
C(l) C(3) C(2) 63.1(7) 0(16) 005) 007) 108.2(9)
0(1) C(5) N (l) 125(1) 0(4) 006) 005) 113.8(9)
0(1) C(5) C(l) 119(1) 0(15) 007) 008) 124(1)
N (l) C(5) CO) 115(1) 0(15) 007) 0(22) 118.4(9)
N (l) C(6) C(7) 108.9(9) 0(18) 007) 0(22) 117(1)
N (l) C(6) C(8) 110(1) 0(17) 008) 009) 123(1)
C(7) C(6) C(8) 117.3(9) 008) 009) 0(20) 119(1)
0(2) C(7) C(6) 112(1) 009) 0(20) 0(21) 121(1)
C(6) C(8) C(9) 120(1) 0(20) 0(21) 0(22) 121(1)
C(6) C(8) 0(13) 121(1) 007) 0(22) 0(21) 119(1)
Intramolecular Distances (Â) Involving the Nonhydrogen Atoms
atom atom distance atom atom distance
0(1) 0(5) 1.25(1) 0(6) 0(8) 1.55(1)
0(2) 0(7) 1.35(2) 0(8) 0(9) 1.40(1)
0(3) 0(14) 1.23(1) 0(8) 003) 1.35(1)
0(4) 006) 1.43(1) 0(9) 0(10) 1.36(2)
NO) 0(5) 1.34(1) 0(10) 001) 1.36(2)
NO) 0(6) 1.46(1) 0(11) 002) 1.39(2)
N(2) 004) 1.34(1) 002) 003) 1.39(2)
N(2) 005) 1.47(1) 005) 006) 1.55(2)
0(1) 0(2) 1.56(1) 005) 007) 1.53(1)
0(1) 0(3) 1.49(1) 007) 008) 1.36(1)
0(1) 0(4) 1.52(1) 007) 0(22) 1.40(1)
0(1) 0(5) 1.51(1) 008) 009) 1.35(1)
0(2) 0(3) 1.48(1) 009) 0(20) 1.36(2)
0(2) 004) 1.47(1) 0(20) 0(21) 1.33(1)
0(6) 0(7) 1.55(2) 0(21) 0(22) 1.37(1)
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(lS,2S)-l-Bromocyclopropane 1,2-dicarboxylic acid (100b) 
Intramolecular Bond Angles (°) Involving the Nonhydrogen Atoms
atom atom atom angle atom atom atom angle
C(13) NO) C(14) 125(2) C(8) C(7) C(12) 114(2)
C(4) N(2) C(5) 122(2) C(7) C(8) C(9) 122(2)
Br(l) CO) C(2) 113(1) C(8) C(9) COO) 120(3)
Br(l) CO) C(3) 115(1) C(9) COO) COD 119(3)
Br(l) CO) C(4) 116(1) COO) COD C02) 120(3)
C(2) CO) C(3) 59(1) C(7) C(12 COD 125(2)
C(2) CO) C(4) 120(1) 0(3) C03) NO) 120(2)
C(3) CO) C(4) 122(2) 0(3) C(13) C(2) 123(2)
C(l) C(2) C(3) 56(1) NO) C03) C(2) 117(2)
C(l) C(2) C03) 125(2) NO) C04) C05) 110(2)
C(3) C(2) C03) 124(2) NO) C(14) C(16) 112(1)
C(l) C(3) C(2) 65(1) C05) C04) C(16) 111(2)
0(1) C(4) N(2) 125(2) 0(4) C(15) C(14) 108(2)
0(1) C(4) CO) 117(2) C(14) C(16) C(17) 123(2)N(2) C(4) CO) 118(2) C(14) C(16) C(21) 123(2)
N(2) C(5) C(6) 109(1) C07) C(16) C(21) 114(2)
N(2) C(5) C(7) 116(2) C(16) C(17) C(18) 123(2)
C(6) C(5) C(7) 113(2) C(17) C(18) C(19) 121(2)
0(2) C(6) C(5) 112(2) C(18) C(19) C(20) 116(2)
C(5) C(7) C(8) 119(2) C09) C(20) C(21) 122(2)
C(5) C(7) C02) 127(2) C06) C(21) C(20) 125(2)
aolecular Distances (Â) Involving the Nonhydrogen Atoms
atom atom distance atom atom distance
Br(l) CO) 1.97(2 C(5) C(7) 1.49(3)
0(1) C(4) 1.23(2) C(7) C(8) 1.46(3)
0(2) C(6) 1.39(2) C(7) C(12) 1.34(3)
0(3) C03) 1.24(2) C(8) C(9) 1.36(3)
0(4) C05) 1.39(2) C(9) COO) 1.38(3)
NO) C03) 1.37(2) COO) COD 1.37(3)
NO) C04) 1.45(2) COD C02) 1.37(3)
N(2) C(4) 1.32(2) C04) C(15) 1.53(3)
N(2) C(5) 1.44(2) C(14) C06) 1.50(2)
CO) C(2) 1.57(2) C(16) C07) 1.40(3)
CO) C(3) 1.45(2) C(16) C(21) 1.36(2)CO) C(4) 1.47(2) C07) C08) 1.38(2)
C(2) C(3) 1.49(2) C(18) C09) 1.41(3)
C(2) C03) 1.39(2) C09) C(20) 1.35(3)
C(5) C(6) 1.58(2) C(20) C(21) 1.37(2)
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(±)-3,5-&ïs[Carbomethoxy]isoxazoline-N-oxide
Intramolecular Bond Angles (°) Involving the Nonhydrogen Atoms
atom atom atom angle atom atom atom angle
N (l) 0(1) C(3) 105.7(2) 0(1) C(3) C(2) 106.0(2)
C(4) 0(4) C(5) 115.4(2) 0(1) C(3) C(6) 108.8(2)
C(6) 0(6) C(7) 116.7(2) C(2) C(3) C(6) 112.4(2)
0(1) N (l) 0(2) 112.9(2) 0(3) C(4) 0(4) 125.2(3)
0(1) N (l) CO) 111.2(2) 0(3) C(4) CO) 120.9(3)
0(2) NO) CO) 135.9(2) 0(4) C(4) CO) 113.9(2)
N (l) CO) C(2) 111.9(2) 0(5) C(6) 0(6) 126.0(3)
N (l) CO) C(4) 125.2(3) 0(5) C(6) C(3) 125.2(3)
C(2) CO) C(4) 122.8(2) 0(6) C(6) C(3) 108.8(2)
C(l) C(2) C(3) 101.2(2)
Intramolecular Distances (A) Involving the Nonhydrogen Atoms
atom atom distance atom atom distance
0(1) NO) 1.450(3) 0(6) C(6) 1.323(3)
0(1) C(3) 1.444(3) 0(6) C(7) 1.453(3)
0(2) NO) 1.233(3) NO) CO) 1.295(3)
0(3) C(4) 1.200(3) CO) C(2) 1.489(4)
0(4) C(4) 1.338(3) CO) C(4) 1.468(4)
0(4) C(5) 1.449(3) C(2) C(3) 1.529(4)
0(5) C(6) 1.184(3) C(3) C(6) 1.518(4)
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